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Abstract  
Background: Measuring unsafe abortion is essential to understand the magnitude of 
the problem and monitor progress in women’s reproductive health. However, legal and 
societal constraints in high-burden contexts foster underreporting of induced abortions 
which makes obtaining accurate estimates challenging. My PhD examines the 
methodological challenges around defining and measuring unsafe abortions using 
Zambia as my country context.  
Methods: First, I conducted interrupted time series analysis on admissions for 
abortion-related complications and deaths from 2007-2015 at University Teaching 
Hospital (UTH), Lusaka to assess the impact of key contextual changes. Second, I 
collected data from women hospitalized for abortion-related complications in three 
provinces to estimate the incidence of abortion-related near-miss in 2014. Third, I 
compared estimates of the incidence of induced abortion in the three provinces using 
data from 3 methodological approaches.  
Results: The prevalence of unsafe and induced abortion is high in Zambia.  Following 
the release of clinical guidelines in May 2009, there was an immediate decline in the 
absolute number of abortion complications by 86 cases (p=0.003). The abortion-related 
near-miss incidence rate was 72 per 100,000 women, and it was feasible to apply the 
adapted WHO near-miss criteria in Zambia. Estimates of the incidence of induced 
abortion per 1000 women ranged from 30 to 80. There was variation in the proportion 
of women estimated to seek facility care for abortion-related complications in each 
approach. 
Conclusion:  The burden of unsafe abortion is high in Zambia despite its liberal law. 
Although there is no gold standard method to measure the burden of unsafe abortion, 
my findings suggest there is scope to improve use of available data to describe the 
burden of the most unsafe abortions and evaluate the impact of interventions on 
abortion-related indicators in restrictive contexts.  
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Chapter 1. Introduction 
Unsafe abortion is the most easily preventable cause of maternal mortality and a 
leading cause of disability amongst women of reproductive age (1). Recently published 
studies estimate that unsafe abortions may account for between 8% (2) and 15% (3) of 
maternal deaths. An abortion performed under safe and sterile conditions is a safe 
medical procedure with less risk of mortality and morbidity than childbirth (4). Most 
unsafe abortions occur in low- and middle-income countries where there are legal 
restrictions and/or societal stigma surrounding terminations of pregnancy (5). It has 
been estimated that seven million women in these contexts were treated for 
complications attributed to unsafe abortions in 2012(6). These complications also 
impose serious economic costs on individuals, families and society (7,8). Whilst 
mortality is a small and declining consequence of unsafe abortion (9), a substantial, but 
poorly quantified burden of morbidity persists (6,10,11). The major acute 
complications and underlying causes of death are sepsis, haemorrhage and traumatic 
injury (12), while in the medium to long-term women are at risk of chronic pelvic pain, 
tubal blockage and secondary infertility.   
Defining and measuring unsafe and induced abortions is essential for monitoring 
progress in women’s reproductive health. However, there are important 
methodological challenges to obtaining accurate estimates of the burden, which relate 
to the conceptualisation of safety, the applicability of the definition of unsafe abortion 
to measurement, and medical and contextual changes in the provision of abortion. 
These, in turn, make the monitoring and evaluation of programs and policies to reduce 
unsafe abortions challenging.  
The World Health Organization (WHO) definition of an unsafe abortion is “the 
termination of an unintended pregnancy either by persons lacking the necessary skills 
or in an environment lacking the minimum medical standards or both.” In restrictive 
contexts, operationalizing this definition for measurement is difficult because legal and 
societal restrictions diminish the willingness of women and providers to report induced 
abortions and the conditions in which they take place (13). The increased availability of 
both legal and illegal medical abortion (MA) has altered the safety conditions under 
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which women in low- and middle-income countries obtain induced abortions(6), 
particularly since 2005, when WHO included misoprostol and mifepristone on the list 
of essential medications (14). Recent updates to the WHO guidelines as to who can 
safely provide induced abortions reflect its ease of use (15). These updates give details 
of conditions when self-provision of MA by women and provision by non-clinician 
cadres of health workers1 may be appropriate (15).  
Pregnancy terminations induced by MA have a similar clinical presentation to 
miscarriages and the two are not easy to differentiate. As MAs are easy to conceal, it is 
even more complex to obtain accurate data on the number of induced abortions and 
to calculate the proportion of these that are unsafe according to WHO guidelines. 
Hence, there continues to be considerable uncertainty around available estimates of 
the incidence of induced and unsafe abortion. Additionally, estimates of the sequelae 
of unsafe abortion, such as abortion-related mortality or morbidity rates and ratios, are 
expected to underestimate the true burden(16), and are usually not representative of 
the population.  
To understand the magnitude of the problem and facilitate monitoring and evaluation 
of abortion-related programs and policies, there is a need to improve the measurement 
of unsafe abortions. The overall aim of this thesis is to contribute to refinements to the 
conceptualization of unsafe abortion and its measurement in low- and middle-income 
countries where the burden is greatest, taking into account technological changes in 
medical provision.  My research for this PhD was conducted in Zambia. Zambia has 
among the most liberal abortion laws in Sub-Saharan Africa (17) which enable research 
into induced abortion to be carried out. Although there are no national data on the 
incidence of safe or unsafe abortion (18) and abortion-related morbidity, a substantial 
proportion of abortions are estimated to be unsafe (70%)(19), and the Zambian 
government estimates that 30% of maternal mortality is attributable to unsafe abortion 
(17). This reflects the overall restrictiveness of the context which is engendered by 
societal stigma regarding abortion (20) and poor knowledge of the law relating to 
abortion by women and providers (18,21). Estimating the burden of unsafe abortion in 
                                                        
1 This includes pharmacists, pharmacy workers, lay health workers and doctors of complementary medicine 
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Zambia will quantify the need for comprehensive abortion care and family planning and 
help make the case for greater access to these services by women. 
1.1 Outline of Thesis 
This is a “research paper style” thesis with three unpublished research papers 
presented as chapters.  
Chapter two presents a background to the research questions addressed by the thesis. 
It details how unsafe abortions have been defined and measured, the effect of MA on 
changing measurement methods, the indicators used to describe the burden of unsafe 
abortion, the limitations of the available approaches and data sources used to measure 
these indicators. I then propose improvements to these methods. 
Chapter three outlines the overall aim and study objectives, describes the reproductive 
health context of Zambia where the research was conducted and discusses my doctoral 
research within the larger project in which it was conducted. There is no overall 
methods chapter because the study design and methods used to address each 
objective differ. Detailed methods for each study are presented in individual results 
chapters (chapters 4-6) to avoid repetition.  
Chapter four presents the first research paper entitled “How do policy changes affect 
trends in abortion-related complications and deaths? A segmented regression analysis 
of Zambian hospital data”. Addressing objective one, this paper describes trends in 
hospitalizations for abortion-related admissions in the largest hospital in Zambia 
between 2006 and 2015 and examines the impact of two contextual changes on these 
trends: (i) the introduction of clinical guidelines to reduce abortion-related morbidity 
and mortality, and (ii) the availability of MA in pharmacies. 
Chapter five presents the second research paper entitled “Incidence of abortion-
related near-miss complications in Zambia: a cross-sectional study in Central, 
Copperbelt and Lusaka Provinces”. This paper addresses the second PhD objective and 
presents the results of field-testing a proposed operational definition of unsafe 
abortion in Zambia. It describes the experience of collecting data on abortion near-miss 
using standardized WHO criteria from routine hospital records in a low- and middle-
 16 
income context. It also presents the incidence of near-miss in three provinces in 
Zambia.  
Chapter six presents the third research paper which addresses objective three of my 
PhD, “How do the numbers compare? Estimating the incidence of induced abortion in 
Zambia with indirect methods using community and facility data”. I present the results 
from applying three approaches to estimating the incidence of induced abortion in 
restrictive contexts. Two approach used health facility data, whilst the third was an 
indirect approach within a community-based household survey. In this paper, I describe 
how the methods were adapted for the Zambian context, examine the strengths and 
limitations of the methods used and discuss the estimates generated.  
Finally, chapter seven synthesizes the main findings from these studies, discusses the 
internal consistency of my results and their combined implications for researchers 
regarding measurement of unsafe abortion and provides recommendations for Zambia 
to improve access to safe abortion care and for future research on this topic. 
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Chapter 2. Defining and measuring unsafe abortion  
There is substantial social and political sensitivity around the topic of induced abortion, 
making research, monitoring and evaluation, and advocacy on the topic challenging. In 
this chapter, I first provide definitions of abortion-related terms relevant to this thesis, 
and continue with a brief historical overview of how the current WHO definition of 
unsafe abortion was developed, the challenges of using this definition for 
measurement, and how its interpretation has evolved. I then discuss the impact of 
increased access to MA on quantifying the burden of unsafe abortion, describe the 
commonly-measured indicators of unsafe abortion in high-burden contexts, and 
outline the limitations of methods used to measure them. For each indicator, I explore 
ways of improving its measurement. Finally, I briefly explore recent research on 
improving the definition and measurement of unsafe abortion.   
2.1 Definition of terms 
An abortion is defined as the loss of pregnancy before foetal viability i.e. before a foetus 
becomes capable of independent extra-uterine life (22). 
An induced abortion, also known as a termination of pregnancy, is an abortion initiated 
by deliberate action undertaken with the intent of terminating pregnancy (22).  
A spontaneous abortion is one which is not induced, even if an external cause is 
involved such as trauma or communicable disease (22). 
An unsafe abortion is defined by the WHO as “the termination of an unintended 
pregnancy either by persons lacking the necessary skills or in an environment lacking 
the minimum medical standards or both.” (23)  
“The persons, skills and medical standards considered safe in the provision of abortion 
are different for medical and surgical abortion and also depend on the duration of the 
pregnancy. What is considered ‘safe’ should be interpreted in line with current WHO 
technical and policy guidance.” (24) 
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2.2 The evolution of the WHO definition of unsafe abortion 
In the late 1980s, research into morbidity and mortality associated with  abortions 
obtained in precarious situations focused on quantifying and reducing illegal abortions 
(25). This was probably due to an observed correlation between restrictive abortion 
laws and the large number of morbidity and mortality events in such contexts. 
Countries considered to have restrictive laws, also commonly described as countries 
where abortion is “illegal”, are those where abortion is prohibited altogether or 
permitted only to save a woman’s life. This description currently applies to 66 
countries, the majority of which are in the global south (26). In 1997 there were 54 
such countries (27).  
In 1992 a WHO technical working group of experts discussed the need to focus on the 
safety of abortion services rather than the legality of abortion. They used the term 
“unsafe abortion” in their report, published in 1993, concluding that legality or illegality 
of services may not be the defining factor of abortion safety. They stated that the safety 
of abortion encompasses both “elective induced abortions and the treatment of 
spontaneous or incomplete abortions” (23). Research conducted before this 
consultation supported the shift from legality to safety because of the many challenges 
raised in identifying and quantifying illegal abortions (25).  Also, even in countries with 
liberal abortion laws, the societal context or health system challenges may convince 
women to resort to unsafe abortions (28,29). The WHO working group described in 
greater detail the characteristics of unsafe abortions that are included in the 
frequently-quoted definition, such as absent or inadequate provider skills, hazardous 
techniques and unsanitary facilities. Since the publication of their report, the language 
and focus of research has firmly shifted from the legality of abortions to the concept of 
abortion safety (23).  
2.3 Inconsistencies between the wording of the WHO definition of 
unsafe abortion and the way it has been used to generate 
estimates  
Between 1992 and 2014, the definition of unsafe abortion that had emerged from the 
working group consultation began to be operationalized for the epidemiological 
measurement of unsafe abortion and its sequelae. In most countries, research 
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describing the burden of unsafe abortion has focused on estimating the national 
incidence of induced abortion (30–34) and/or the number of women hospitalized for 
abortion-related complications (35–38). No national studies have reported on the 
incidence of unsafe abortion itself. Global estimates have reported on global and 
regional numbers and incidence of unsafe and induced abortions, hospitalizations for 
abortion-related complications and the proportion of unsafe abortions out of all 
induced abortions (5,6,39). In the following paragraphs, I will discuss two important 
discrepancies between how the WHO definition is worded and how it has been 
practically applied to measure the global burden of unsafe abortion. 
First, abortion safety has typically been conceptualized from a biomedical (clinical and 
public health) perspective, and the WHO definition of safety is a process-oriented one. 
In reality, most induced abortions in restrictive contexts are unreported or 
underreported in surveys and medical records (5,25,40). Hence, it is not usually feasible 
to verify the process (standards of clinical care) under which the majority were 
performed to identify what was unsafe. National and global indicators are usually 
generated using health facility-based outcome data on admissions for all abortion-
related complications. These data are adjusted to derive indicators such as incidence 
of hospitalizations due to induced abortions and the incidence of induced abortions 
within a country. The most frequently used approach to adjust health facility data 
involves applying a multiplier. This is usually calculated using data from interviews 
aimed at understanding the process of abortion from experts who are knowledgeable 
about abortion in a context. They are asked a series of questions to estimate the 
proportion of induced abortions that result in complications but do not receive care in 
health facilities. However, majority of experts that have been interviewed in studies are 
experienced health professionals who are most likely drawing on their clinical 
experiences with patients to extrapolate how women are obtaining 
abortions(31,32,34). Hence their perspectives are more likely to be related to changing 
patterns in hospitalization and not on first-hand knowledge of how women procure 
abortions. National estimates of the incidence of induced abortions obtained after 
applying the multiplier to health facility data are then incorporated into global 
estimates of induced and unsafe abortion. Thus, in practice, data on the health 
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outcomes of an unsafe abortion process (morbidity and mortality) provide the basis for 
estimates meant to represent the process of all unsafe and all induced abortions.  
Second, to arrive at the global incidence of unsafe abortions, abortions have usually 
been classified into safe or unsafe, largely based on the legality of abortion in a country 
despite the caveat provided by the technical group. In global estimates calculated since 
1992 (5,16,39), all illegal abortions are assumed to be unsafe, even if in practice 
clinically safe technologies for abortion are readily available and performed by 
practitioners with relevant clinical training. This is the case, for example, in Latin 
America where MA has been reported to be widely available since the 1990s; or in 
Nigeria where, despite legal restrictions, interventions to train private sector providers 
in abortion care have been successful, leading to substantial uptake of these services 
by women and subsequent good health outcomes (41). One explanation for the 
assumption that all illegal abortions are unsafe is that the clandestine nature of illegal 
abortion is likely to be associated with reduced access to emergency care, predisposing 
women to greater health risk (42). It is also the case that using legality to classify 
contexts as safe and unsafe is easier for generating global estimates than attempting 
to analyse the unique situation of each country (24). Indeed a 2010 paper by WHO 
researchers indicates that “operationally estimates of induced abortion are intended to 
capture abortions that carry greater health risks than those carried out for officially 
accepted reasons under the laws of the country concerned” (43). The exception to this 
blanket rule in global estimates is that in countries where the laws are liberal and there 
is empirical evidence of both safe and unsafe abortions such as Nepal, India, Cambodia, 
South Africa and Ethiopia, the numbers of both types of abortions have been estimated 
(5).   
This dichotomization of safety into two broad groups (safe and unsafe) fails to 
acknowledge that induced abortions occur on a multidimensional scale of resources, 
methods and skills (42). Whilst the legal context has a great impact on abortion 
provision and access within the formal healthcare system (2, 20, 21), countries differ in 
the de-facto application of the law. Moreover, it ignores the importance of other 
factors such as the enforcement of the law, social stigma associated with induced 
abortion, strength of the health system and quality of care provided, and status of 
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women. The prevalent clinical practice in each context influences the probability that 
induced abortion cases will develop severe complications and/or access post abortion 
care services. Hence, global estimates of unsafe abortion where all legal abortions are 
classified as safe and non-legal abortions as unsafe(22) are inaccurate as abortion 
practice and outcomes are not uniform in similar legal contexts. 
2.4 Recent updates on how the WHO definition of unsafe abortion 
should be interpreted  
A publication by WHO officers in 2014(24) was intended to correct the inconsistent 
interpretation of their definition, and to discuss how it could be operationalized for 
measurement. It emphasized that technical guidelines on the safe provision of abortion 
care are evolving and that the conceptual definition should be accompanied by this 
explanatory note: “The persons, skills and medical standards considered safe in the 
provision of abortion are different for medical and surgical abortion and also depend on 
the duration of the pregnancy.  What is considered “safe” should be interpreted in line 
with current WHO technical and policy guidance.” Table 2-1 describes the current 
standards of care for safe abortions using different methods and at various gestational 
ages according to WHO.  However, these WHO guidelines do not provide 
recommendations for second trimester post abortion care (PAC), and there is a lack of 
high quality, comparable data within published literature on this aspect of care (44). 
The publication also discussed the limitations of dichotomizing safety since risk occurs 
across a continuum. It ultimately proposed that a multidimensional approach to 
assessing risk and determining the safety of induced abortion should be developed. 
This might include immediate determinants such as method of termination used and 
gestational age, and underlying social determinants such as legal context, service 
availability, level of stigma, women’s access to information on abortion, and women’s 
age and socioeconomic status. The proposed multidimensional approach to safety may 
expand the definition from one with a biomedical focus to one that importantly 
incorporates women’s views on what a safe abortion is. For example, the most critical 
components of a safe abortion for Kenyan women , as highlighted in a 2015 paper by 
Izugbara et al, could be the confidentiality offered by providers and affordability (45).  
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While this amendment helped to clarify how WHO envisions the interpretation of the 
definition of an unsafe abortion for research, it does not clearly outline how safety will 
be measured in light of the process versus outcome discussion. This is important in an 
era of increased access to MA and will be discussed in the next section. Additionally, 
since guidelines and their application are evolving, estimates of unsafe abortions 
generated during different periods of time and in different contexts may have different 
meaning and implications. It will be important to monitor and account for this in future 
estimates.
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Table 2-1: Summary of WHO evidence-based standards-of-care for safe abortion care provision 
Type of procedure Gestational age Surgical abortion Medical abortion Anticipated complication rates for procedures 
Termination of 
pregnancy 
Up to 9 weeks Vacuum aspiration Mifepristone (200mg). After 24-48 hours, 800 
mcg misoprostol buccally, sublingually or vaginally 
for one dose 
OR 
800ug misoprostol administered vaginally or 
sublingually. Up to 3 repeat doses can be 
administered at 3 hour intervals but no longer 
than 12 hours 
a. Abortion not completed (Mifepristone and 
Prostaglandin compared with vacuum 
aspiration)1  
Moderate.* RR (95% CI): 2.12 (0.37 to 12.06)   
b. Blood transfusion (Vacuum aspiration 
compared with dilatation and curettage)2 
Moderate.* RR (95% CI): 0.21 (0.01 to 4.12)  
c. Repeat uterine evacuation (Vacuum 
aspiration compared with dilatation and 
curettage)2 
Low.* RR (95% CI): 0.67 (0.11 to 3.95)   
 
9-12 weeks Vacuum aspiration Mifepristone (200mg). After 36-48 hours, 800 
mcg misoprostol vaginally followed by 400 mcg 
vaginally or sublingually every 3 hours for a 
maximum of 5 doses of misoprostol 
OR 
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800ug of misoprostol administered vaginally or 
sublingually. Up to 3 repeat doses can be 
administered at 3 hour intervals but no longer 
than 12 hours 
 
Above 12-14  weeks Dilatation and 
evacuation. This 
should be preceded 
by cervical 
preparation. 
Mifepristone (200mg). After 36-48 hours, 400 
mcg misoprostol orally or 800 mcg vaginally 
followed by 400 mcg vaginally or sublingually 
every 3 hours for a maximum of 5 doses of 
misoprostol, administered in a healthcare facility  
OR 
400ug of misoprostol administered vaginally or 
sublingually repeated every 3 hours for up to 5 
doses  
a. Additional curettage required to complete 
evacuation (Dilatation and evacuation 
compared with Mifepristone and 
Misoprostol)3 
Low.* RR (95% CI): 0.06 (0 to 1.43)   
b. Bleeding requiring a transfusion (Dilatation 
and evacuation compared with 
Prostaglandin F2 alpha)3 
Low.* RR (95% CI):  0.17 (0.01 to 3.6)  
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Management of 
incomplete abortion 
<13 weeks Vacuum aspiration 600mcg single oral dose of Misoprostol or 400mcg 
single dose sublingually 
a. Death (misoprostol compared with 
expectant management)4 
Very low.* RR (95% CI):  2.91 (0.12 to 70.05)  
b. Death (misoprostol compared with surgery)4 
Very low.* RR (95% CI): 1.00 (0.04 to 22.64) 
c. Blood transfusion (misoprostol compared 
with expectant care)4 
Very low.* RR (95% CI):  3.07 (0.13 to 74.28)  
d. Blood transfusion (misoprostol compared 
with surgery)4 
Very low.* RR (95% CI):  1.73 (0.19 to 16.08) 
e. Need for subsequent surgical evacuation 
(misoprostol compared with expectant 
management)4 
Low.* RR (95% CI): 0.62 (0.17 to 2.26)   
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Care preceding 
abortion 
All women having a surgical abortion should receive prophylactic antibiotics. 
All women should be routinely offered pain medication during medical and surgical abortions 
Care post abortion Contraceptive counselling and commodities should be provided to all women after abortion 
There is no medical need for a routine follow-up visit following uncomplicated surgical abortion or medical abortion using mifepristone followed by 
misoprostol. However, women should be advised that additional services are available to them if needed or desired. 
 
Adapted from World Health Organization. (2012). Safe abortion: technical and policy guidance for health systems. WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, 
Switzerland: World Health Organization. Retrieved from http://apps.who.int/iris/bitstream/10665/70914/1/9789241548434_eng.pd 
*Grading of risk (very low, low, moderate) is according to the World Health Organization evidence GRADE criteria informing the technical guidance document 
(http://apps.who.int/iris/bitstream/10665/75840/1/WHO_RHR_12.10_eng.pdf?ua=1) 
1. Say L et al. Medical versus surgical methods for rst trimester termination of pregnancy. Cochrane Database of Systematic Reviews, 2005, (1):CD003037 updated 2010.  
2.  Kulier R et al. Surgical methods for rst trimester termination of pregnancy. Cochrane Database of Systematic Reviews, 2001, (4):CD002900.  
3. Lohr PA, Hayes JL, Gemzell-Danielsson K. Surgical versus medical methods for second trimester induced abortion. Cochrane Database of Systematic Reviews, 2008, (1):CD00671
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2.5 Medical abortion, its impact on how women access abortions, and 
on the definition and measurement of unsafe abortion.  
Medical abortion (MA) is the use of medication instead of surgical methods to 
terminate pregnancies. In the past, most unsafe abortions tended to be invasive, 
frequently resulting in clinically severe morbidity or death (16). These methods 
included the insertion of sharp objects by women, traditional practitioners, or non-
qualified workers in health facilities and poorly conducted procedures with sharp 
equipment such as curettes by medical providers. However the use of MA, which is a 
much safer method for clandestine pregnancy terminations, is increasing in restrictive 
contexts (46). Whilst this usually heralds improved abortion outcomes for women(47), 
it generates more challenges for the measurement of the burden of unsafe abortions 
as mentioned in the introduction.  
The pharmacological agents most often used for MA are misoprostol alone or in 
combination with mifepristone (Table 2-1). Others that can be used include approved 
agents like methotrexate (in combination with misoprostol), and gemeprost (in 
combination with mifepristone). There are also agents used to stimulate uterine 
contraction but with limited safety information, such as intra-amniotic hypertonic 
saline or hyperosmolar urea, ethacridine lactate, oxytocin and other prostaglandin 
analogues (48).  
Misoprostol is a prostaglandin E1 analogue that was initially registered in many 
countries for the treatment of gastric ulcers caused by non-steroidal anti-inflammatory 
drugs in the late 1980s (49). Following its registration, it was realized by clinicians and 
pharmacists that its side effects made it highly effective for inducing abortions and in 
many Latin American countries it was frequently used to terminate pregnancies illegally 
(50,51). It is particularly appropriate for use in low- and middle-income countries, 
because it is inexpensive, easy to use and heat stable. Mifepristone blocks the action 
of progesterone on the uterus and was initially approved for use as an abortifacient in 
China and France in 1988 (52,53). However, it is expensive and needs to be used in 
combination with misoprostol to induce an abortion. Misoprostol is less effective alone 
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as a MA drug (73-95%) than in combination with mifepristone (94-97%)(54). In 2005, 
WHO included misoprostol and mifepristone in the essential drug list for the induction 
of labour and abortion (14). This was a step towards facilitating the registration of these 
drugs in low- and middle-income countries. However, as of 2015, mifepristone was only 
registered in 61 countries (55), and in 2012 misoprostol was registered in over 90 
countries (53).  
Clinically, a MA induced using optimally-prescribed misoprostol and mifepristone 
(Table 2-1) is not distinguishable from a spontaneous abortion (56); both are usually 
accompanied by uterine cramps and prolonged menstrual-like bleeding. Side effects of 
MA drugs include nausea, vomiting, diarrhoea, fever, incomplete abortion, 
haemorrhage and, very rarely, infection. If the termination fails, there is a risk of 
congenital abnormalities in the foetus associated with misoprostol use in early 
pregnancy (57,58). The absolute risk of abnormalities after misoprostol exposure is 
estimated to be approximately 1% (59). Evidence from studies among women and 
providers suggests that in restrictive contexts, the private sector and black markets play 
a significant role in providing women with access to MA (60–62). Within the private 
sector, private pharmacies and drug stores, which are often poorly regulated, are the 
most important sources of MA drugs for women seeking to terminate pregnancies (63).  
Increasing self-use of MA is likely to “temporarily increase and/or ultimately decrease 
estimates of indicators of the burden of unsafe abortion” (64).  Studies on abortion-
related morbidity and mortality from Latin American countries where misoprostol has 
been available over the counter in pharmacies since the early 1990s suggest that, 
overall, increased use of MA reduces the proportion of severe abortion-related 
complications observed in hospital admissions.  This phenomenon occurs  even when 
the abortion is accessed illegally and/or the quality of provider information on how to 
take the drugs is suboptimal (50,65,66). However, the extent of MA use is unknown 
and attempts at clarification include interviews with women and/or providers, mystery 
client studies and wholesale data from the national level. It is, however, difficult to link 
pharmacy and mystery client interview data to individual women, which is necessary 
to ascertain the number of women unsafely terminating pregnancies using MA and the 
outcomes of such termination in restrictive contexts.  
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In an evolving abortion provision context, estimating the burden of unsafe medical 
abortions using the process-based WHO definition is even more challenging than for 
surgical procedures. Within the definition and its accompanying guidelines there is still 
a lack of clarity on the description of the appropriate provider for MA i.e. “person 
lacking the necessary skills” since women can self-administer MA drugs safely at home. 
In July 2015, WHO recommendations pertaining to provision of safe abortion care by 
different cadres included ‘women at home’ as a category of safe MA providers in the 
first trimester. However, the recommendation adds a proviso for this category, “in 
contexts where the woman has access to appropriate information and to health services 
should she need or want them at any stage of the process”(15). It is not clear what is 
meant by “context” in this recommendation. However, if the woman’s context is 
interpreted as her country of residence, as is usual in global estimates, the classification 
of safe MA contexts for self-administration as outlined becomes complicated. Access 
to appropriate information and health services is likely to differ by sociodemographic 
characteristics such as age, education, economic status, and place of residence. Hence, 
according to the WHO description, it is unlikely that many restrictive contexts would 
meet the criteria for women to be considered safe MA providers at the national level. 
This is similar to the problem of classifying induced abortions in countries as 
safe/unsafe on the basis of legality where laws may be theoretically similar, but the 
reality varies considerably and actually determines access to safe abortions.  
Another challenge is that of collecting data on the safety of the MA process from 
women or providers. In practice, MA drugs can be procured by women from many 
sources (legal and illegal) who keep only limited records. Women can deny usage, and 
there is no readily available laboratory means of confirming use for measurement 
purposes. Thus, using MA, women can terminate pregnancies successfully at home, or 
commence the process and seek hospital admission for unsuccessful terminations or 
ongoing abortions whilst pretending they are spontaneous abortions (56). Since 
research shows that women underreport their induced abortions when asked directly 
(67), it is also unlikely that the process of an unsafe MA can be reliably estimated from 
asking women retrospective survey questions.  
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On the other hand, hospital studies from Latin America, where abortion laws are fairly 
restrictive but misoprostol has been readily available for many years, suggest that 
health facility outcome data remains exploitable for women who obtain unsafe MAs. 
These studies suggest that there are still a substantial number of admissions for 
abortion-related outcomes from hospital data (50,65,68,69). However, there are 
changes in overall patterns of admission with a reduction in the number of severe 
abortion-related complications admitted over time. It is important to note that whilst 
outcome data will be more readily available, because of the similarities in presentation, 
it will be more challenging to distinguish between medically induced unsafe abortions 
and spontaneous abortions from individual health facility records. There is therefore a 
need for additional research to understand how the increasing use of MA may affect 
patterns of hospitalization for morbidity and mortality in contexts other than Latin 
America. This will enable us to make the best use of readily available outcome-data to 
generate abortion estimates in evolving abortion contexts.  
2.6 Indicators and methodological approaches frequently used to 
measure the burden of unsafe abortion in restrictive contexts  
As a result of methodological challenges to identifying and quantifying unsafe abortion 
(9,42), all approaches used to estimate the burden of unsafe abortions are subject to 
error such as systematic misclassification (13,70). Due to the lack, or questionable 
quality, of data in restrictive contexts, approaches where women are not asked direct 
questions about their abortion experiences are most frequently employed. The most 
common indicators measured are:  
I. The number/rate of hospitalizations for abortion-related complications (all 
complications or complications due to induced abortions)  
II. The incidence rate/ratio of induced abortions.  
Complications (morbidity and mortality) are outcome-based indicators, while the 
incidence of induced abortions conceptually incorporates process and outcomes. 
Whilst in reality, induced abortions consist of both safe and unsafe abortions, there has 
been only one national study providing estimates of the incidence of unsafe and safe 
abortions (Singh et al 2010)(71)(31). However, safe/unsafe is confounded with 
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legal/illegal abortions in this study. Usually, studies in restrictive contexts measure this 
indicator to describe the extent of need for abortion services within the country and to 
show how many women are at risk of unsafe abortions. Rates are usually presented per 
1000 women of reproductive age and ratios per 100 live births.  
2.6.1 Data sources 
The major sources of data used to estimate these indicators are registers and medical 
records in health facilities. Surveys among women have been conducted less frequently 
for reasons highlighted above. Data from health facilities include details of all 
admissions for abortion-related complications including morbidity and mortality due to 
both spontaneous and induced abortions. These data are typically adjusted to estimate 
the number of abortion-related complications due to induced (often assumed to be 
unsafely induced) abortions by estimating and subtracting the number of miscarriages. 
To extrapolate the number of induced abortions in the population, the estimated 
number of hospitalizations due to induced abortions is adjusted to account for those 
unsafe procedures not identified in the health facility data.  
When survey data are collected, a direct approach to interviewing women about their 
own abortions is most often used (42). This information can be used to estimate many 
2-1of the indicators of the burden of unsafe abortion that are measured using hospital 
data.  However, survey data can also be an indirect data source when the survey 
methodology is used to collect data from the respondent about abortions other women 
have obtained.  
Figure 2-1 shows how unsafe abortions can be defined based on processes or 
outcomes, and how these are connected to direct and indirect approaches to 
measurement. It highlights the two major sources of data for each approach discussed 
above, shows how surveys may also be an indirect approach to measurement and 
summarizes how the data collected are used to generate the common indicators of the 
burden of unsafe abortion.  
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Figure 2-1 Approaches to defining unsafe abortion, and the common data sources 
and indicators for measurement 
 
Subsequent sections will describe the data sources and common indicator(s) at each 
step of “indirect data sources and measurement indicators” within. Figure 2-1 and 
propose measures to improve the use of data from indirect approaches to estimate 
indicators of the burden of unsafe abortion. 
2.6.1.1 STEP 1- Health facility data on all abortion-related complications 
The most common indicators derived from these data include: (i) annual number of 
women with abortion complications treated in health facilities and (ii) incidence 
rate/ratio of abortion complications in health facilities. Others include the proportion 
of high-severity, moderate-severity or low severity complications and case fatality rate 
for complications in hospital. 
The major limitation of the data and these estimates is that they do not capture all the 
morbidity and mortality in the general population as legal, geographical and social 
barriers restrict women’s access to and use of healthcare for abortion-related 
complications (15, 16). Additionally, cases may go undetected if women are admitted 
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outside obstetrics/gynaecology departments; for example, in outpatient or emergency 
departments or in private wards, and data collection systems are not put in place to 
capture their details. Hence, abortion morbidity and mortality data collected on all 
complications within facilities and the indicators listed are often not representative of 
real experience in the catchment community (72). Another important factor to 
consider is that because the number of admissions for abortion-related complications 
is affected by changes in access to safe abortion methods, changes in access to and use 
of health facility care by women, and quality of healthcare, it can be difficult to compare 
this indicator over time in one context and also between different contexts. 
However, data on all morbidity in health facilities still have important uses. One such 
use is to track changes in abortion-related outcomes after the introduction of laws, 
regulations or policies that affect the safety of abortion within a specific context. 
Routine country-level health facility data or data from high-level hospitals with large 
catchment populations can yield valuable historical/trend information on unsafe 
abortion outcomes and how they have changed with contextual events (73). Data on 
the number of women hospitalised for abortion-related complications are particularly 
easy to collect from facilities or Ministries of Health compared with hospital studies on 
morbidity, which require more detailed data collection from patient records or 
community surveys. Despite their limitations, these data can be used to investigate the 
immediate or long-term consequences of policy changes, which are hard to evaluate 
via other rigorous means such as randomized trials. A few studies exploring the 
association between legislative changes and changes in levels of abortion-related 
morbidity and mortality in hospital admissions have been conducted in Nepal (73,74), 
Ethiopia (75), South Africa (76,77), Dominican Republic (65), Iran (78) and  Brazil (69). 
Only the study in Nepal used a rigorous quasi-experimental time series design to 
evaluate the effect of legislative change on abortion-related admissions. The others 
have used a before and after approach (75,77,78) or simply described numbers 
hospitalized over time (65,69). A before and after approach does not account for 
natural trends over time that may explain differences in the outcome of interest other 
than the policy or intervention being examined. Additionally, there may be regular 
fluctuations in the outcome independent of other factors due to seasonality which can 
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obscure the effect of an intervention/policy (79). Time-series analysis provides the 
opportunity to explore changes in trends for abortion-related outcomes following a 
defined contextual event whilst controlling for the biases encountered with statistical 
analyses that do not account for the nature of longitudinal data (79). Nevertheless, 
causal links between changes in trends and contextual changes cannot be inferred from 
these methods. Since greater access to safe abortion is often preceded by an event 
such as legal/policy change, improvement in the health systems capability, or approval 
of MA, the availability of hospital data on abortion-related outcomes is an opportunity 
to start to understand which systemic-level changes improve outcomes for women. 
2.6.1.2 STEP 2- Abortion-related complications due to induced/unsafe abortions 
The true cases of interest are complications due to unsafely induced abortions. 
Indicators that extrapolate complications due to induced abortions from primary 
hospitalisation data include the annual number of women with abortion complications 
due to induced abortions treated in health facilities and the incidence rate of induced 
abortion complications in health facilities. The latter indicator has also been described 
as the incidence rate of unsafe abortions (instead of induced)(6) on the basis that they 
are most likely to be the result of unsafe abortions if the woman requires 
hospitalisation.  
Abortion-related mortality has been the adverse outcome of greatest interest for 
highlighting the health burden of unsafe abortions. Objectively, an abortion-related 
death is most likely to occur after an unsafe abortion (80,81). However, compared with 
abortion-related morbidity, mortality has a low incidence at sub-regional levels and 
within individual hospitals. Its relative rarity limits its practicality for tracking changes 
and the impact of interventions over time, or for understanding common deficiencies 
in clinical care and other determinants. Moreover, abortion deaths are reported to be 
the most substantially underestimated cause of maternal death (7, 17).  For example, 
according to research using multiple bias analysis to quantify systematic error in the 
estimation of abortion-related mortality, deaths may be underestimated by as much as 
a factor of eight (82). 
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Research suggests that there is a substantial but poorly quantified burden of abortion 
morbidity for every abortion death that occurs (10,83). A 2012 systematic review by 
Adler et al, estimates 4195 morbidities per 100,000 live births (range 1667-10,335) in 
countries where abortion is considered unsafe compared with abortion–related 
mortality ratios of 37 and 12 per 100,000 live births in Africa and South Asia respectively 
(10). However, it is challenging to accurately distinguish between complications caused 
by induced and spontaneous abortions, which can also lead to biased estimates (67).  
Methods proposed to perform this task have many limitations. The WHO Figa-
Talamanca methodology, developed in 1986, attempted to classify post-abortion cases 
into induced  (certainly induced, probably induced or possibly  induced) or spontaneous 
cases using the clinical criteria shown in Table 2-2 (25). These criteria comprise details 
that should be easy to obtain from medical records. 
Table 2-2 WHO Figa-Talamanca criteria used for reclassification of abortion cases 
 
 Criteria Certainly induced 
abortion 
Probably induced 
abortion 
Possibly induced 
abortion 
Spontaneous 
1 Woman’s statement that 
she had an induced abortion 
Classify in this 
category if  (1) OR  
(2) OR  (3) is 
present 
Not present Not present Not present 
2 Health worker or relative’s 
statement if woman died 
due to abortion 
Not present Not present Not present 
3 Evidence of genital trauma 
or foreign body 
Not present Not present Not present 
4 Sepsis or peritonitis or 
admission thereafter 
This criterion may 
be present or not 
present 
Classify in this 
category if criteria  
(4) AND  (5) are 
present 
Classify in this 
category if criteria  
(4) OR  (5) is present 
Not present 
5 Pregnancy unplanned  (use 
of contraception during the 
cycle of conception) 
This criterion may 
be present or not 
present 
Classify in this 
category if criteria  
(4) OR  (5) is present 
Not present 
 Source Figà-Talamanca et al.  (1986)(25).  
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Its limitations include poor definition of clinical criteria, unclear distinction between the 
real meaning of the probable and possible categories of induced abortion (42), and the 
use of contraceptive status before the index abortion as the sole marker of pregnancy 
intention. Pregnancy intention is a complex concept that cannot be solely captured by 
use of contraceptive at the time of conception (84,85). Contraceptive use is affected 
by many factors. In contexts where contraceptive prevalence is low for access or socio-
cultural reasons, and unmet need is high, many women do not intend to conceive but 
do not use contraception. Furthermore, unplanned or unintended pregnancies can 
abort spontaneously (86).  
A subsequent study attempting to validate the Figa-Talamanca criteria suggests that 
they underestimate levels of unsafe induced abortion (86). Amongst those women who 
had clinical evidence of having induced an abortion (N=38), only 5% declared they had 
induced an abortion. Additionally, amongst those women who reported having an 
abortion (N=27), the majority (95%) had no clinical evidence of doing so and were 
classified as low morbidity. This suggests that many women who had undergone 
induced abortions were missed using this classification. It also implies that the probably 
and possibly induced abortion categories are likely to underestimate women with 
induced abortions as the majority of women identified as having obtained an abortion 
had no signs of infection. 
Rees et al. proposed refining the methodology by shifting away from a focus on induced 
abortions and classifying post-abortion cases into low, moderate and high severity 
complications (see Box 2-1) (87). They argued that the safety of the abortion is more 
important than its origin (induced versus spontaneous) because both can present with 
complications, and the role of an effective health system is to provide adequate care 
regardless of the cause. Additionally, they surmised that in restrictive contexts, 
estimating the burden of abortion-related morbidity and its cost to the health system, 
instead of focusing on its origin, is an important tool to advocate for legislative change 
regarding abortion. In their 1997 study in South Africa, middle and high severity 
categories were used as markers of unsafe abortion (87). This method is the basis of 
the prospective morbidity methodology (PMM) which is the most frequently used 
morbidity classification for abortion-related complications (31,37,38,87–89). 
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Box 2-1 Definition of categories for incomplete abortion hospitalization 
 
 
 
 
 
 
 
 
More recently, Singh et al (2015) utilized a different approach to estimate the global 
number of hospitalizations for unsafe abortions. Applying an assumption first applied 
by Singh and Wulf to hospital admission data in 1991(90), they extrapolated the 
number of admissions due to induced abortions by estimating the number of 
miscarriages and subtracting them. They assumed that women having first trimester 
miscarriages will not usually need medical care in health facilities whilst those occurring 
in the second trimester (13-21 weeks) are more likely to need and seek such care. The 
proportion of second trimester miscarriages out of all live births was estimated using 
data from clinical studies whilst the proportion needing health facility care was 
estimated using data from interviews with in-country experts. These assumptions are 
now a component of the Abortion Incidence Complications Method (AICM), which is 
described in greater detail in Chapter 6 (section 6.3.1.1). One limitation of this 
approach is that the clinical studies providing data for this assumption were conducted 
in a high-income country in the early 1980s (91,92).  This may therefore not be 
representative of all populations and does not account for factors like HIV or 
malnutrition, and diseases such as malaria in low- and middle-income countries. 
Additionally, there is little research on health facility care seeking patterns of women 
for first trimester abortions. Whilst early first trimester pregnancies, i.e. before 7 
Level of Severity    Criterion 
Low (requires all criteria)   Temp. < 37.3 degrees Celsius 
     No clinical signs of infection 
     No system or organ failure  
     No suspicious findings on evacuation 
 
Moderate (requires ≥1 criterion)  Temp. 37.3–37.9 degrees Celsius 
     Localized peritonitis (tender uterus, discharge) 
     Offensive products of conception 
 
High (requires ≥1 criterion)  Death 
     Shock 
     Evidence of foreign body/mechanical injury* 
     Organ or system failure 
     Temp ≥38 degrees Celsius 
     Pulse > 119 beats/minute 
     Generalized peritonitis 
 
*Does not include physical evidence of misoprostol tablets.  
 
(Source: adapted from Rees et al.  (1997) (87)) 
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weeks, may be miscarried without knowledge of the pregnancy, those between 7 and 
13 weeks may be recognized but there is little empirical research examining what 
women do when they miscarry at these gestations. Furthermore, the methods used to 
collect this information, from experts, on the proportion of women who seek care for 
late miscarriages are subjective.    
The growing use of MA makes it more challenging to objectively identify complications 
of unsafe abortions using descriptive criteria such as the Figa-Talamanca or the PMM.  
One way to identify the most unsafe abortions using outcome data, and to improve the 
population representativeness of morbidity data from health facilities, is to specify a 
level of morbidity that can be objectively attributed to an unsafe abortion process. This 
can be achieved by restricting the measurement of morbidity to complications so 
severe that they are most likely due to an unsafe process. Such cases are likely to be 
found within a health facility or to be a woman who died in the community. Indeed, 
very severe acute abortion complications are the most objective outcomes of unsafe 
abortions conducted under the riskiest conditions; they are also the consequences that 
interventions aim to eliminate completely.  
2.6.1.2.1 The case for using abortion-related near-miss as an indicator of unsafe 
abortion  
Developments in measuring obstetric morbidity demonstrate the importance of 
describing and quantifying such severe acute maternal morbidity - also known as near-
miss when the woman survives a near-death experience (26-29). A maternal near-miss 
has recently been defined by the WHO as “A woman who nearly died but survived a 
complication that occurred during pregnancy, childbirth or within 42 days of 
termination of pregnancy”(93). Other definitions have specified as an underlying 
hypothesis that near-miss cases are women who survive because of chance or good 
hospital care (94,95). In other words, the likelihood that these women would have 
survived in the community without advanced treatment is very low (10,38). Figure 2-2 
describes the spectrum of abortion-related morbidity, showing how a woman can 
either become a near-miss or die as the worst outcomes. 
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Figure 2-2 The spectrum of abortion-related morbidity: from non-complicated 
abortions to near-miss and maternal death 
Source Adapted from Say et al.(2009)  (93)  
Near-miss is best measured using facility data for this reason and also because self-
reports of complications by women lack specificity (96,97). Severe morbidity and 
abortion near-misses are most likely, but not exclusively, to be the result of induced 
and illegal rather than spontaneous abortions (10). They occur more commonly than 
mortality, but not in numbers likely to overburden data capturing personnel in facilities 
(98). Table 2-3 outlines if and how the abortion near-miss indicator addresses the 
measurement issues discussed above. 
Table 2-3 How my proposed unsafe abortion near-miss indicator addresses the 
limitations of other abortion indicators 
 
Limitations of the indicator of 
unsafe abortion: admissions 
for abortion-related 
complications (all admissions 
or those dues to induced 
abortion) and abortion-related 
mortality* 
Addressed by new 
definition (Yes, 
probably, No) 
How the definition addresses the challenge 
Non-representativeness of 
indicators 
Yes By using stringent criteria requiring hospital care to define a 
near-miss. Abortion near-misses are usually only identifiable at 
health facilities. Data available from facility records when 
divided by a population level denominator are more 
representative of the study population than other indicators 
currently used. 
Cannot distinguish induced 
from spontaneous abortion. 
Probably Near-misses are more likely to be from induced than 
spontaneous abortions 
Difficulty with tracking over 
time due to rarity of indicator 
like mortality 
Probably Research suggests that near-miss occurs in greater numbers 
than mortality. Thus it may be easier to compare estimates over 
time and to determine national trends 
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Not comparable in different 
contexts 
Yes By defining near-miss using the standardized WHO definition 
which has been validated in different contexts, the incidence of 
abortion near-miss is comparable between countries regardless 
of the restrictiveness of the abortion law 
*We did not compare the near-miss indicator with the incidence of induced abortions because in reality induced 
abortions consist of both safe and unsafe abortions. Furthermore, with the advent of misoprostol abortions are likely 
to be safer in restrictive contexts hence it may be less appropriate to use all induced abortions to track safety in the 
short to medium term. 
2.6.1.2.2 Defining and measuring abortion-near-miss 
By defining near-miss complications with stringent criteria, such that almost all cases 
would have been seen in facilities or would have died, it is postulated that the burden 
measured using hospital-based data may be more representative of the general 
population burden (19) than the figure obtained by measuring mortality in a similar 
way. Thus, near-miss complications are a more accurate indicator than abortion-
related mortality, which is substantially underestimated when measured using hospital 
data.  
Near-miss events lie along the continuum of morbidity between good health and 
mortality. This presented challenges for researchers to reach consensus on discrete 
cut-off points and/or uniform case-identification criteria that capture life-threatening 
complications in sufficient numbers to be useful for evaluation, serve as a suitable 
proxy for mortality, be measured routinely, and to be comparable in different 
contexts(98–100).  
In the early stages of applying this indicator, researchers used two approaches to 
measuring maternal near-miss: complication-based or organ-system dysfunction. 
These approaches use three types of markers: clinical, management and laboratory, 
each with its advantages and disadvantages, as shown in Table 2-4.
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Table 2-4 Categories of indicators that have been used to measure near-miss: 
advantages and disadvantages 
 
Near-miss indicator Examples of 
categories under 
each set of 
indicators used 
Advantages Disadvantages 
Clinical indicators related to a 
specific disease entity  (such as 
Waterstone et al) (92)  
Severe 
Preeclampsia 
Eclampsia 
HELLP syndrome 
Severe 
haemorrhage 
Severe sepsis 
Uterine rupture 
Anaemia 
Straightforward to 
interpret by a trained 
clinician 
 
 
 
 
 
Common direct causes of 
maternal mortality may be 
omitted e.g. pulmonary 
embolus was omitted because 
of the difficulty of diagnosing 
pulmonary emboli accurately 
when they are not fatal. Early 
pregnancy complications such 
as those related to ectopic 
pregnancies and abortions are 
also often omitted in maternal 
near-miss studies. 
Data can be obtained 
retrospectively from 
case notes or registers if 
they are available and 
reliable. 
The quality of care of a 
particular disease or 
complication can be 
easily assessed against 
corresponding clinical 
guidelines 
Complication rates for a 
particular disease can be 
calculated 
Retrospectively-collected 
information might be 
problematic due to poor 
documentation and hence 
biased 
The criteria used to define 
morbidity often have too low a 
threshold of morbidity to be 
called maternal near-miss when 
compared with more recent 
stringent criteria. 
Intervention based 
indicators(102,103) 
Intensive care 
admission 
Emergency 
hysterectomy/ 
caesarean section 
Massive blood 
transfusion 
Anaesthetic 
accidents 
Simple to identify the 
cases, usually on the 
basis of retrospective 
analysis of a hospital 
register  
Allows the identification of only 
a fraction of all severe morbidity 
cases  
Variation in accessibility of the 
intervention, eligibility criteria 
for an intervention, or in the 
case of ICU, what constitutes an 
intensive care admission in 
different contexts makes 
comparability across hospitals 
and contexts difficult 
Biased by resources available 
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Near-miss indicator Examples of 
categories under 
each set of 
indicators used 
Advantages Disadvantages 
Organ system dysfunction 
indicators  (Mantel et al) (48)  
Cardiac 
dysfunction 
Vascular 
dysfunction 
Immunological 
dysfunction 
Respiratory 
dysfunction 
Renal dysfunction 
Liver dysfunction 
Metabolic 
dysfunction 
Coagulation 
dysfunction 
Cerebral 
dysfunction 
Mimics the confidential 
enquiries into maternal 
death systems, thus the 
same system could be 
used to complement 
maternal death 
enquiries. It might allow 
calculation of more 
comparable summary 
measures of morbidity/ 
mortality 
Allows for identification 
of critically ill women 
thereby establishing the 
pattern of diseases 
causing morbidity and 
their relative importance 
Allows for the 
identification of new and 
emerging disease 
priorities and study of 
health system response  
Variation in defining 
identification criteria can 
be avoided, particularly 
for similar settings, 
allowing the 
establishment of reliable 
summary estimates for 
maternal near-miss 
Dependent on existence of a 
minimum level of care including 
functioning laboratories and 
basic critical care monitoring 
Retrospective identification of 
cases might be difficult due to 
inability to identify cases from 
registers 
May generate  too small a 
number of cases for the purpose 
of evaluation (i.e. not add many 
cases to maternal deaths) 
Souza, P., Say, L., & Pattinson, R. C.  (2009). Maternal near-miss – towards a standard tool for monitoring quality of 
maternal health care., 23, 287–296. doi: 10.1016/j.bpobgyn.2009.01.007 
WHO recently proposed stringent standardized criteria to identify near-miss cases, 
endorsed by experts through an international consultative process (93,104) (Table 2-5) 
They are based on the organ-system dysfunction approach. These criteria aim to 
accommodate the diagnostic capacities of hospitals in different resource contexts by 
having three types of marker for each organ/system - clinical signs and symptoms, 
laboratory criteria and management-based proxies (93). The use of these criteria allows 
for the availability of comparable near-miss data and estimates from different contexts. 
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Studies in Brazil (105) and Tanzania (106) have attempted to validate these near-miss 
criteria. In Brazil, they were validated against the Sequential Organ Failure Assessment 
(SOFA) score which is used for quantifying organ dysfunction in the general population 
as a gold standard. In Tanzania the SOFA score was not used because of low health 
system capability to perform the necessary laboratory tests and because the study 
authors considered the near-miss criteria, derived from the SOFA score, could not be 
the gold standard for its validation. Instead, the WHO near-miss criteria were adapted 
for a low-resource setting and were validated with respect to their performance in 
identifying maternal deaths. To adapt the criteria, the clinical signs and symptoms were 
mostly used to identify cases but the cut off for blood transfusion was lowered to one 
unit of blood, and disease entities which were common causes of mortality in that 
hospital were also included. In both studies, the WHO near–miss criteria performed 
well against the gold standard used. However, studies comparing the performance of 
the WHO and previous near-miss criteria for the same population suggested that the 
WHO criteria omit cases of hypertensive diseases in pregnancy and severe 
haemorrhage (107,108). The WHO criterion for transfusions - an important marker of 
haemorrhage and common complication of unsafe abortions - appears too high for 
developing countries as most hospitals do not have good access to blood products, and 
it has been suggested that it be locally adapted (106,109). Additionally, the applicability 
of ICU admission and other laboratory criteria appears to be limited in resource-
constrained contexts, leading to reduced identification of cases or underestimation of 
case severity (104). The use of the near-miss criteria in developing countries as it 
currently stands without adaptation is therefore debated (106,109).  
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Table 2-5 WHO maternal near-miss identification criteria 
Dysfunctional 
system 
Clinical criteria Laboratory markers Management-based 
proxies 
Cardiovascular Shocka 
Cardiac arrest 
Severe hypoperfusion 
(lactate >5mmol/L or >45 
mg/dl) 
Severe acidosis  (pH<7.1) 
Use of continuous 
vasoactive drugsh 
Cardiopulmonary 
resuscitation 
Respiratory Acute cyanosis 
Gaspingb 
Severe tachypnea 
(respiratory rate >40bpm) 
Severe bradypnea  
(respiratory rate <6bpm) 
Severe hypoxaemia  (O2 
saturation <90% for >= 60 
minutes or PaO2/FiO2 <200) 
Intubation and ventilation 
not related to 
anaesthesia 
Renal Oliguriac non responsive to 
fluids or diuretics 
Severe acute azotemia  
(creatinine >= 300umol/l or 
3.5mg/dl) 
Dialysis for acute renal 
failure 
Hematologic or 
coagulation 
Failure to form clotsd Severe acute 
thrombocytopenia  (<50,000 
platelets/ml) 
Massive transfusion of 
blood/red cells  (>= 5 
units) 
Hepatic Jaundice in the presence of 
preeclampsiae 
Severe acute 
hyperbilirubinemia (bilirubin 
>100umol/l or >6.0 mg/dl) 
 
 
Neurologic Prolonged unconsciousnessf 
 (lasting >12h) 
Strokeg 
Uncontrollable fit/ 
total paralysis 
  
Alternative 
severity proxy 
  Hysterectomy following 
infection or haemorrhage 
Adapted from: i) Campbell, M., & Barrett, J.  (n.d.). (110); and ii) Souza, P., Say, L., & Pattinson,R. C.  (2009) 
 
i. Shock is a persistent severe hypotension, defined as a systolic blood pressure <90 mmHg for ≥60 min with a pulse rate at 
least 120 despite aggressive fluid replacement (>2 l). 
j. Gasping is a terminal respiratory pattern and the breath is convulsively and audibly caught. 
k. Oliguria is defined as a urinary output <30 ml/h for 4 h or <400 ml/24 h. 
l. Clotting failure can be assessed by the bedside clotting test or absence of clotting from the IV site after 7–10 min. 
m. Pre-eclampsia is defined as the presence of hypertension associated with proteinuria. Hypertension is defined as a blood 
pressure of at least 140 mmHg (systolic) or at least 90 mmHg  (diastolic) on at least two occasions and at least 4–6 h apart 
after the 20th week of gestation in women known to be normotensive beforehand. Proteinuria is defined as excretion of 
300 mg or more of protein every 24 h. If 24-h urine samples are not available, proteinuria is defined as a protein 
concentration of 300 mg/l or more  (≥1+ on dipstick) in at least two random urine samples taken at least 4–6 h apart 
n. Loss of consciousness is a profound alteration of mental state that involves complete or near-complete lack of 
responsiveness to external stimuli. It is defined as a Coma Glasgow Scale <10 (moderate or severe coma). 
o. Stroke is a neurological deficit of cerebrovascular cause that persists beyond 24 h or is interrupted by death within 24 h. 
p. For instance, continuous use of any dose of dopamine, epinephrine or norepinephrine.  
 
a. 
b. 
c
d. 
e. 
f. 
g
h
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2.6.1.2.3 Limitations of using near-miss 
The near-miss indicator has some limitations for estimating the burden of unsafe 
abortion. There is a small probability that near-miss events can occur after spontaneous 
abortions, or induced abortions performed optimally, leading to over-attributing near-
miss cases to unsafe abortions. In Warakamin et al’s 2004 study in Thailand, although 
29% of induced abortions resulted in near-miss (based on Adler et al’s 2012 study (10) 
where organ failure or dysfunction, in this case- septicaemia and uterine perforation, 
were used to indicate near-miss), 5% of spontaneous abortions also became near-miss 
complications (111). The UK confidential enquiry for 2006-2008 indicated that the 
mortality ratio per 100,000 maternities was 0.31 for spontaneous abortions and 0.09 
for induced abortions (112). Although induced abortions are more likely to result in a 
near-miss than spontaneous abortions in poor resource settings, distinguishing them 
remains challenging and cannot be attempted using this definition.  
It is also likely that as MA becomes more accessible within a country, the number of 
near-misses will decline over time due to the relative safety of MA compared with 
invasive procedures. In the long-term near-miss events will become much rarer and 
almost as challenging to measure as abortion-related mortality. 
Nevertheless, abortion near-miss is consistent with the suggestion that severe acute 
complications are the most important adverse events of interest for the measurement 
of safety, and that they most frequently occur after induced abortions performed 
illegally, or under poor clinical conditions. By incorporating the concept of abortion 
near-miss into the classification of morbidity, my PhD research will extend the current 
measurement of abortion-related morbidity because: (i) it allows researchers to 
generate comparable measurements of unsafe abortion using abortion near-miss 
morbidity as an indicator in different contexts. Using the WHO standardized definitions 
of the indicators of abortion near-miss will facilitate objective identification of cases 
and reduce the variation in how severe morbidity as defined by the PMM can be 
interpreted across contexts; (ii) it provides an indicator of unsafe abortion 
representative at the population-level. This also means abortion near-miss morbidity 
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can be used as indicator to monitor the impact of interventions, programs and policies 
on the most unsafe abortions over time.  
2.6.1.2.4 Integrating near-miss into the measurement of unsafe abortion 
Near-miss maternal morbidity has been used successfully in obstetric care to describe 
the burden of maternal illness and its long-term outcomes (26, 33, 34), understand the 
costs of severe morbidity to households (35), assess quality of care through audits and 
confidential enquiries (28, 36), and examine the determinants of maternal death(37). 
The majority of studies describing the burden of abortion-related near-miss using the 
WHO near-miss criteria have been carried out in Sub-Saharan Africa. They have 
collected data on maternal near-misses and not specifically on abortion-related near-
miss (83,113–117). They may thus miss many abortion cases as they are not focused 
on severe abortion-related morbidity and mortality (115).  
As recommended by WHO, abortion near-miss indicators such as the near-miss 
incidence ratio (per 1000 live births per year), and near-miss abortion rate (per 100,000 
women of reproductive age (15-49) per year)(29) can be calculated using national or 
regional level census information to generate comparable indicators between contexts. 
Since near-misses occur in greater numbers than mortality (23, 38), they may also be 
more satisfactory for regional comparisons of morbidity. Additionally, more 
information can be collected from auditing cases to evaluate the quality of maternal 
care provided in a facility or area. Near-miss can be used as an outcome indicator to 
track the impact of abortion-related interventions and policies on the most unsafe 
abortions in place of abortion-related mortality which is hard to capture. Furthermore, 
repeated estimates of the burden of near-miss can be used as an index of the safety of 
induced abortion services over time and access to post-abortion care at the population 
level. For example, a decline in the number of near-miss abortion complications over 
time could imply greater and timelier access to good quality services. Additionally, 
identifying near-miss cases provides an opportunity to understand the socioeconomic 
circumstances around the most unsafe abortions, possibly linked to abortion-related 
mortality, and to examine the effect of severe morbidity on future reproductive and 
health outcomes (118) 
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2.6.1.3 STEP 3-Incidence of induced abortion 
The incidence of induced abortion, whether safe or unsafe, has most frequently been 
estimated using health facility data in restrictive contexts. This data is often 
supplemented by additional information to account for abortions not admitted in 
health facilities. Community-based surveys have also occasionally been used to 
estimate the incidence of induced abortion. This section will describe some of the most 
common health facility and community-based approaches that have been used.  
2.6.1.3.1 Health facility-based methods 
These methods rely on facility-based data collected by interviewing providers and/or 
from medical records (119). They are expected to estimate a minimum abortion rate, 
and can also be used to estimate the cost of unsafe abortion to the health system. The 
most frequently used method is AICM. Data on all admissions for abortion-related 
complications are usually adjusted for complications of spontaneous abortions as 
described in section 2.1.6.1.2 (120) and weighted for study design and duration of data 
collection (38,87). Thereafter, context-specific, locally collected multipliers are applied 
to adjust data to include women who did not develop complications, and/or did not 
seek care for them (119). (see Chapter 6, section 6.3.1.1 for further details). 
The validity of multipliers to account for morbidity not identified within the facility, and 
extrapolate national estimates of all women undergoing induced abortion, depends on 
the accuracy of the research informing their assumptions (42). This is extremely 
important because the abortion rate/ratio estimated in any context is highly sensitive 
to the multiplier (67). The multiplier for the AICM is derived from numbers generated 
by quantitative interviews with experts within the country, which is subjective (30–
32,34). Furthermore, the multiplier may be overestimated or underestimated 
depending on the type of expert interviewed. Health professionals have been reported 
to underestimate the multiplier compared with non-clinicians (e.g. people with 
backgrounds in research, social work, policy development and members of women’s 
groups) when it is calculated separately for both groups. The underestimation of the 
multiplier by clinicians  is attributed to the fact that they tend to overestimate the 
proportion of women who receive care for complications accompanying unsafe 
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abortions (120,121). In some cases where multipliers are not available for a particular 
country, those from a country with similar parameters are applied to the data (39,42). 
This is likely to introduce more bias into these national estimates as accessibility to 
health services may differ between countries and over time.  
Another health facility based method that has provided data to estimate the 
prevalence of induced abortions is the prospective morbidity survey methodology. This 
was originally developed to classify abortion-related morbidity in hospital admissions 
according to severity (described in Chapter 5). The data collected using this method are 
combined with AICM data and the assumptions of the AICM applied to data to 
extrapolate overall prevalence in some countries (31,32). 
2.6.1.3.2 Self-reported survey methods 
Self-reported methods rely on respondents to report the occurrence of their own 
abortions or those of other women (122). Whilst most respondents are sampled at the 
community level, one self-reported method that has been tested within health facilities 
in Ghana (123) and Nigeria (124) is the preceding birth technique. This method was 
originally developed to estimate child mortality in settings where the majority of births 
are registered12. In this method, women are asked about outcomes (live birth, stillbirth, 
miscarriage or abortion) of all prior pregnancies. Questions for this method have been 
asked as part of routine prenatal care amongst a convenience sample. This data source 
is non-representative of the population and neither African study attempted to 
extrapolate results to all women of reproductive age. The quality of data collected is 
subject to women’s reports and provider attitudes (42).  
Community-based data on abortion in low- and middle-income countries is particularly 
scarce (125). Community-based survey methods that have been applied to measure 
the incidence of induced abortion include those (i) using a direct approach to 
interviewing women; (ii) adapting direct interview methods to improve reporting, 
including audio computer-assisted self-interviews (ACASI) (126), the randomized-
response technique (RRT) (127), the Sealed Envelope method (SEM), and  the list 
                                                        
12 http://demographicestimation.iussp.org/content/childhood-mortality-estimated-health-facility-data-preceding-
birth-technique 
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experiment (128), or (iii) using an indirect approach such as the Anonymous Third Party 
Reporting method (ATPR) where women are asked about the number and 
characteristics of abortions amongst people in their network, or the network scale-up 
(NSU) approach (129). Community surveys of women can be designed to be 
representative of the general female population. However, they may be expensive 
when conducted on a large scale. Their abortion incidence results also have low validity, 
as induced abortions are usually underreported due to social stigma or legal 
repercussions (67). Furthermore there is less research into possible correction factors 
to adjust national survey data for underreporting (42,130) than hospital-based studies. 
In one study in the United States, information from ACASI was more accurate than face-
to-face interviews (131). However, studies from Mexico triangulating different survey 
approaches to reduce underreporting suggest that in less educated and rural 
populations, the use of ACASI and RRT may be complex for women and yield less 
accurate information than face-to-face interviews (126,127). One study using the RRT 
in Botswana reported  successful adaptation of the technique for local use (42). The 
few studies attempting to triangulate different survey approaches suggest that 
community-based methods providing privacy, or indirect approaches may be practical 
to circumvent the substantial underreporting of induced abortions associated with 
direct interview approaches in restrictive contexts (42,126).  
Of the community-based methods listed above, the RRT has been used most 
frequently, for example in Turkey (132), Brazil, Mexico (127), and Botswana (42). This 
method measures the prevalence of induced abortion whilst protecting the 
respondent’s privacy. It uses a combination of two questions (a non-sensitive question 
e.g. were you born in April (126), and a sensitive one about abortion) with a yes or no 
response, and the researchers who should know the proportion of the population who 
will respond ‘yes’ to the non-sensitive question. The respondent randomly selects one 
question, which is unknown to the interviewer and answers it. The prevalence of 
induced abortion is estimated by subtracting the expected proportion of “yes” 
responses to the non-sensitive question from the overall prevalence of “yes” responses 
(122). The proportion of the population responding “yes” to the sensitive question is 
also related to the probability of selecting the sensitive question (where there are two 
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questions, 0.5).  Whilst it usually produces a higher estimate of the prevalence of 
induced abortion than direct questioning, it can be expensive and time consuming as it 
requires larger sample sizes than other indirect methods as it is based on the 
probability of respondents selecting the sensitive question. If the probability of 
selecting the sensitive question is 0.5 then the study will need twice the sample size to 
obtain the same power. If, in addition, the frequency of the sensitive event in the 
population is low, then an even larger sample size will be required. Furthermore, the 
accuracy of answers is affected by women’s literacy, and this method produces 
aggregated data with no descriptive information on women (42,126,127).  
The ATPR which uses an indirect interview approach was developed and conducted in 
Burkina Faso in 2001, and was fielded again in 2009 when it was compared with the 
AICM (30,119). It has also been tested in Rajasthan, India in 2004 where it 
underestimated abortion incidence compared with direct reports of women in a survey 
(122). It builds on the principle of network sampling where information is collected on 
the respondent’s personal network (defined by the researcher) rather than their 
personal experience. Since it is an indirect method asking anonymously about the 
respondents’ network, it has been used to estimate other sensitive populations such 
as HIV cases (130,133) and men who have sex with men (134), and may diminish the 
stigma associated with self-reporting an abortion. In addition to yielding estimates of 
the incidence of abortion, it provides individual level data on sociodemographic 
characteristics of women who have had an abortion and the health circumstances 
surrounding their abortions. It is also interesting because the data it produces can be 
used to calculate a multiplier to adjust health facility data, providing information to 
compare with other multipliers such as the AICMs. However, it is possible that with 
increased diffusion of MA, women are less dependent on their social networks to find 
methods which may cause them to confide less in their networks and result in 
underestimation of incidence using this method. 
In restrictive contexts, it is important to estimate the incidence of induced abortions to 
understand the overall need for safe abortion services. It also provides a broader 
estimate with which we can compare estimates of hospitalizations for complications 
and interpret important indicators such as contraceptive prevalence rate, fertility rate 
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and unmet need for contraception. In addition, since there is a strong relationship 
between abortion laws and the risk of unsafe abortions, the incidence of induced 
abortion provides a valuable insight into the potential burden of unsafe abortion in 
these contexts. However, there is no gold standard method of evaluating estimates 
from the different approaches used. One approach to exploring the convergent validity 
of estimates and their underlying assumptions (such as the multiplier) is to triangulate 
estimates from different approaches (30,42). Triangulation is also important for 
assessing the appropriateness of different methods in different abortion contexts. 
Currently there is only one study in Sub-Saharan Africa (Burkina-Faso) which uses 
different approaches to measure the incidence of abortion in clandestine contexts and 
triangulates estimates and multipliers from health facility and community-based 
methods (30). Comparing the frequently applied AICM with the ATPR is important 
because, in addition to the overall estimate of induced abortion from two different data 
sources, it provides the opportunity to compare the multiplier which is a key 
component of the AICM method and to which the overall estimate is very sensitive.   
2.7 Recent ideas on the definition and measurement of unsafe 
abortion 
A recent paper by Sedgh et al describing insights from an expert group meeting 
discusses the challenges of outcome versus process-based definition and 
measurement in the changing context of MA (135). It suggests that going forward, a 
reasonable approach would be to classify abortion safety along a spectrum 
incorporating both the processes that make it unsafe and the outcomes of different 
degrees of unsafe processes. A 5-category spectrum using this approach was  proposed 
with the following stages: very unsafe (not done in accordance with WHO guidelines 
that results in severe complications or death); unsafe (not done in accordance with 
WHO guidelines that results in mild or moderate complications); unsafe with low 
medical risk (not done in accordance with WHO guidelines with no medical risk); safe 
with nonmedical risk (done in accordance with WHO guidelines in contexts where 
abortion is illegal or stigmatized);  and safe (done in accordance with WHO guidelines 
in contexts where abortion is legal or with little/no stigma). This approach is more 
comprehensive that an outcome only or process only approach because in reality, both 
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abortion induction processes and subsequent outcomes are important components of 
safety and are interlinked. More unsafe processes are more likely to result in severe 
outcomes and vice versa.  
However, although incorporating both elements will help define abortion safety more 
holistically, obtaining data on a large scale to classify the safety of the process is likely 
to remain difficult in restrictive contexts. On the other hand, health-facility outcome 
data, which are often available and have been used for generating estimates could be 
used as a platform to explore how women obtain terminations of pregnancy and how 
safe these processes are.  
To achieve this, one strategy might be to conduct studies within communities and 
different levels of health-facility among women seeking induced abortions and those 
admitted for abortion-related complications to document the processes preceding 
different outcomes. A focus on understanding the outcomes of MA obtained and used 
under different conditions is particularly important. Data from such studies and other 
data on national sales of abortion medication and community data on how women 
obtain abortions may facilitate the modelling of process-based estimates of unsafe 
abortion to compare with the estimates derived from outcomes-based method such as 
the AICM. This would allow the reproductive health community to refine the 
approaches to operationally defining and measuring the burden of unsafe abortions. 
Such studies could also address another potential challenge of implementing an 
integrated process/outcome approach to measurement: how to specify discrete cut-
off points for each level of unsafe outcome that is associated with the process.  
2.8 Conclusion 
The issues that make induced abortion controversial and consequently unsafe in many 
countries have an impact not just on how unsafe abortions have been defined but also 
on how the definition is operationalized for measurement. The WHO definition of 
unsafe abortions and the newly introduced addendum linking the definition to the 
most current clinical guidelines highlight the importance of documenting the process 
under which abortions are induced. However, in practice, estimates are generated 
using data on outcomes. As long as induced abortion remains stigmatized, in countries 
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where it is restricted by law or policy, it will remain extremely challenging to capture 
the process of induced abortions and data on outcomes are likely to be more readily 
available and the use of such data is for measurement is justifiable.  
Improving the measurement of the commonest indicators of unsafe abortion is 
necessary to understand its associated burden. With the growing use of MA, and 
ongoing refinements in the definition of unsafe abortion, my PhD aims to improve the 
way in which outcome data from health facilities is used to generate indicators that can 
be measured to describe and track the burden of unsafe abortion. 
 54 
Chapter 3. Aim, objectives and design of PhD thesis 
This chapter provides an overview of the aim, objectives and design of my PhD thesis. 
The first section outlines the aims of the research and its specific objectives. The second 
section describes the context of my field research, outlines the framework of the larger 
project within which my research is embedded and describes my role within the project 
and how it contributes to my PhD thesis. Subsequent sections describe the sources of 
ethical approval, funding, fieldwork conducted, and the timeline within which this work 
was conducted. 
 
3.1 Study aim and objectives 
The aims of this PhD research are twofold: first, to contribute towards refinements to the 
conceptualization of unsafe abortion and to improve its measurement taking into 
account technological changes in medical provision in low- and middle-income countries 
where the burden is greatest; and second, to generate new substantive knowledge on 
the burden of unsafe abortion in Zambia.  
The specific objectives of this PhD are: 
1. To describe trends in the number of hospitalisations for abortion-related 
complications within the largest tertiary hospital in Zambia, over a 10-year period 
(2006 to 2015), and to examine for the effect of contextual changes on these trends 
using interrupted time series analysis. 
2. To estimate the incidence of abortion-related near-miss morbidity in Central, 
Copperbelt and Lusaka provinces.  
3. To estimate and compare the incidence of induced abortion in three provinces in 
Zambia using two methodological approaches, and to provide an empirical basis for 
exploring the strengths and limitations of these different methods.  
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3.2 Study context, project setting and role of the candidate 
3.2.1 Study context 
Zambia is located in Southern Central Africa and is a landlocked lower middle-income 
country that shares a border with the Democratic Republic of Congo, Tanzania, Malawi, 
Mozambique, Zimbabwe, Botswana, Angola and Namibia. Approximately 85% of the 
population is Christian and 16% of females and 13% of males have never been to school. 
Zambia attained independence from Britain in 1964, and administratively is divided into 
ten provinces and 74 districts. Of these ten provinces, Lusaka and Copperbelt provinces 
are the most urbanized and densely populated whilst the remaining provinces are 
predominantly rural. Figure 3-1 shows the provinces where the study was conducted 
highlighted with red stars. 
Figure 3-1 Map of Zambia showing where the study was conducted 
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The 2010 census recorded a population of 13.1 million at the national level and 5.5 
million in the provinces included in this study (Central, Copperbelt and Lusaka), and a 
population growth rate of 3 percent per annum. It also reported that the life expectancy 
at birth was 49 years for males and 53 years for females. The 2013/14 Zambian 
Demographic and Health Survey (ZHDS) (136) found a total fertility rate of 5.3 children 
per woman (136). It also established that the maternal mortality ratio (MMR) was 398 
per 100,000 live births and that this was significantly different from the ZDHS 2007 MMR 
of 591. Data from the 2013/14 Zambian DHS suggests that many women are not fulfilling 
their reproductive intentions. On the average, Zambian women ages 15-49 had 0.8 more 
children than they wanted, 37% of births in the five years preceding the survey were 
unintended, and the contraceptive prevalence rates of modern methods amongst 
sexually active women was estimated to be 32.5% (136). 
Zambia is a paradoxical abortion context. On one hand, it has one of the most liberal laws 
in Sub-Saharan Africa, allowing for research on induced abortion to be conducted with 
minimal risks of legal repercussions for participating women and providers. The 
Termination of Pregnancy Act (Act 26) which was fashioned after British legislation at the 
time it was enacted in 1972, was amended in 1994 and 2005. It permits pregnancy 
termination if the pregnancy constitutes a risk to the woman’s physical or mental health, 
or life; involves a risk to the physical or mental health the woman’s existing children; if 
there is substantial risk that the unborn child would suffer from physical or mental 
abnormalities as to be seriously handicapped or if rape or defilement occurs (17). 
Additionally, abortion services ought to be free for women at public health facilities with 
the exception of a registration fee ranging from USD1-11 (137). The government has 
taken many steps to reduce unsafe abortions and their consequences including: 
partnering with different organizations such as Ipas, Marie Stopes Zambia, Planned 
Parenthood Federation of Zambia, Society for Family Health and FHI 360 to increase 
access to contraceptive services; approving a standards and guidelines for 
comprehensive abortion care in all health facilities (17); partnering with NGOs to provide 
CAC training to health facility staff and; approving the combination MA pill and allowing 
it to be sold in pharmacies (138,139).  
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On the other hand, there is poor knowledge of the law amongst the public and substantial 
socio-cultural stigma associated with abortion (20,21,140,141). There are 
implementation barriers to accessing a safe abortion as termination requires the 
approval of three registered medical practitioners, one of whom has specialized in the 
branch of medicine relevant to the patient’s reasons for termination (in emergency 
situations, consent from only one physician is required). Furthermore, Zambia has a very 
low doctor-to-population ratio of about 1 per 14500 (142). These factors make access to 
safe abortion difficult for majority of women (143), and poorer and younger women will 
often resort to clandestine abortions (18). Additionally, a recently proposed change to 
the constitution may render abortion illegal if it is voted for during the referendum. This 
is the inclusion of Article 28 which states that “…life beings at conception” and may cause 
the current Termination of Pregnancy Act to become unconstitutional (144). However, 
when the Constitution of Zambia Amendment bill of 2015 was signed into law in January 
2016, Article 28 was not yet included. The enactment of this Article and other 
contentious amendments has been deferred till there is a consensus is reached amongst 
stakeholders (21). It is uncertain how this article will fare during subsequent debate, but 
the debate process and its subsequent outcome is likely to have a great impact on how 
the future legality of induced abortion and current social perceptions of abortion in the 
country.  
There are no national data available on the incidence of abortion (19), few recent 
published studies quantifying or describing abortion-related complications (18) or unsafe 
abortion, and no studies of near-miss morbidity in Zambia. A 2009 study in 5 major 
hospitals in Zambia showed that the number of women admitted with abortion 
complications almost doubled between 2003 and 2008, and that more women are 
admitted for abortion-related complications than voluntary terminations of pregnancy 
(about 85 to 1) (19).Evidence from hospital-based studies suggests that complications of 
illegal, induced abortions have long been an important cause of maternal mortality and 
the  Zambian Government estimates they may have been responsible for up to 30% of 
deaths in 2007 (141,145). A recent qualitative study by Coast et al interviewing 112 
women who had indicated that they had obtained safe and unsafe abortions in a 
government tertiary hospital in Lusaka suggests that many women use medical abortion 
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to terminate pregnancies in urban Zambia (140). Although majority of the women in this 
study (63%) obtained a safe abortion at the hospital, many of them (21%) obtained an 
unsafe abortion by ingesting or inserting herbs or overdoses of medicines and were 
subsequently admitted for PAC. Data from this study also suggests that poorer, younger 
and less educated women are more likely to undergo an unsafe abortion than a safe 
abortion in hospital (8) . Treating the complications of unsafe abortion cost women up to 
70% more than a safe abortion, and in this facility unofficial payments to providers 
constitute about 32% of the overall cost for abortion care seeking. Overall, providing PAC 
unsafe abortions was estimated to cost 20% (USD 1.4 million) of the Zambian Health 
budget in 2013 and the government could potentially save between USD 0.2-0.6 million 
if women were able to access safe abortion care (137). 
3.2.2 Project framework 
My PhD research was undertaken as part of the baseline of the external evaluation of the 
impact of preventing maternal deaths from unwanted pregnancy (PMDUP) program in 
Zambia. PMDUP is a 5-year DFID-funded program aimed at reducing maternal mortality 
from unwanted pregnancies by providing family planning and reducing recourse to 
unsafe abortions originally in 14 countries across sub-Saharan Africa and Asia. PMDUP is 
implemented by MSI and Ipas. The collaborating institutions for the evaluation and this 
baseline study are the London School of Hygiene and Tropical Medicine (LSHTM), 
Population Council and the Guttmacher Institute. Most evaluation activities are in Zambia 
and India, and my PhD research was conducted in Zambia with Population Council Zambia 
as the host organization. The PMDUP-funded interventions in Zambia are jointly 
implemented by Ipas and Marie Stopes International (MSI) and their service activities are 
concentrated in Central, Copperbelt and Lusaka provinces where the evaluation was 
conducted. The evaluation of PMDUP in Zambia(EVA-PMDUP) is comprised of 7 sub-
studies (sub-study 0- intensity study, sub-study 1- near-miss morbidity study, sub-study 
2- community-based survey, sub-study 3- signal functions study, sub-study 4- costs study, 
sub-study 5- policy study, sub-study 6- household consequences study). My PhD research 
was conducted within sub-studies 1 and 2, which have the following objectives within 
the larger evaluation project:  
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Sub-study 1: The overall near-miss morbidity study is a quasi-experimental study that will 
use hospital data to track the change over time in severe abortion-related complications 
(with a baseline and end line) and hospitalizations for post-abortion care over several 
years. The interventions evaluated were not implemented by the evaluation team and 
were not part of my PhD. My PhD utilized data from the evaluation baseline for its 
analyses. 
Sub-study 2: The community-based survey is a household survey conducted at baseline 
and end line. Through this sub-study, EVA-PMDUP investigates the dose response effect 
of the PMDUP intervention on reproductive health indicators in three provinces in 
Zambia. My PhD attempted to estimate the annual abortion rate of women of 
reproductive age using the data collected for the anonymous third party reporting 
method during the baseline community-based survey” 
My PhD research consisted of 4 studies to meet the three objectives. Below is a summary 
table describing each study and a designation by which it will subsequently be referred 
to in this chapter and the discussion. 
Table 3-1 Summary table briefly describing each study in my PhD and how it will be 
referred to subsequently 
Summary of study Study 
designation 
Objectives each study addressed 
Retrospective data extraction from 
University teaching hospital, Lusaka 
registers from 2006-2013 
Trend study Objective 1-To describe trends in the 
number of hospitalisations for abortion-
related complications within the largest 
tertiary hospital in Zambia, over a 10-
year period (2006 to 2015), and to 
examine for the effect of contextual 
changes on these trends. 
Cross-sectional study collecting hospital 
data on morbidity from women 
hospitalized for abortion-related 
complications in Lusaka, Central and 
Copperbelt provinces 
Near-miss study Objective 2- To estimate the incidence 
of abortion-related near-miss morbidity 
in Central, Copperbelt and Lusaka 
provinces.   
Cross- sectional study collecting data from 
hospital staff, provincial health registers 
and top ranking health officials to 
estimate the incidence of abortion 
Abortion 
incidence hospital 
study 
Objective 3-To estimate and compare 
the incidence of induced abortion in 
three provinces in Zambia using three 
different methodological approaches, 
and to provide an empirical basis for 
exploring the strengths and limitations 
of these different methods  
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Cross-sectional survey with women in 
community collecting data on abortions 
amongst their confidants to estimate the 
incidence of abortion 
Confidants study Objective 3-To estimate and compare 
the incidence of induced abortion in 
three provinces in Zambia using three 
different methodological approaches, 
and to provide an empirical basis for 
exploring the strengths and limitations 
of these different methods 
 
3.2.3 Role of the Candidate in EVA-PMDUP 
I am a medical doctor from Nigeria and received my Medical degree from the Obafemi 
Awolowo University in Nigeria in 2009 and my MSc in Global health science from 
University of Oxford in 2012. I developed my PhD research idea on near-miss abortion 
into a proposal for a different setting (Nigeria) before joining LSHTM. I contributed to 
writing the overall evaluation protocol and developed a protocol for my doctoral 
research, which was approved by LSHTM examiners as part of my upgrading document 
and seminar in July 2013. Thereafter I took the lead on the design and adaptation of the 
data collection tools for the hospital-based near-miss study at the beginning of my PhD, 
and subsequently for the trend study. To compare estimates of the incidence of abortion 
using different methodologies, I adapted data collection tools and conducted additional 
fieldwork for the abortion incidence hospital study and confidant’s study as part of my 
PhD research. 
I lived in Zambia for nine months September 2013 and June 2014 and managed the 
fieldwork for the near-miss study within EVA-PMDUP. Specifically, I oversaw getting the 
necessary local ethical and administrative permissions from the Ministry of Health, 
recruitment of participating hospitals from the public and private sectors, recruitment 
and training of field staff, data collection and data entry. I was also responsible for the 
design and implementation of the trend study at the University Teaching Hospital (UTH), 
Lusaka. I trained the community-survey enumerators to use the confidant study tool and 
assisted in piloting and implementation of the household survey. I was responsible for all 
the data analysis and interpretation from the aforementioned studies.  I have written the 
first drafts of the three papers included as results chapters and I am managing the 
process of collaborating with my co-authors. A summary of my contribution to each 
research activity and element included in this thesis is provided in Table 3-2. 
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Table 3-2 Summary of the role of the candidate in EVA-PMDUP research activities 
Component Activity Responsibility* Additional input* 
Preparatory work Site selection 
Ethics approval and amendment 
Ministry of Health, Provincial and District 
medical office and individual health facility 
permissions 
VF, JC, OO 
JC, OO, PCZ 
OO, PCZ 
 
Trend study, 
near-miss study 
and abortion 
incidence study  
Development of near-miss study tool 
Development of retrospective hospitalization 
(trend study) tool 
Development of AICM (abortion incidence 
hospital study) tools 
Piloting of all data collection tools 
Analysis of pilot data 
Modification of tools after pilot 
Coordination of field work 
Development of database for data entry 
Data entry 
Analysis of data 
OO, VF 
OO 
 
OO 
OO 
OO 
OO 
OO 
OO 
OO, RAs 
OO 
OO 
CR 
VF 
 
GI 
VF, JC 
VF, JC 
VF, JC 
PCZ 
 
PCZ 
JC 
JC, VF 
Community-
based survey and 
confidants study 
Survey design 
Development of abortion module (confidants 
study tool) 
Piloting of community survey tool 
Translation of tool 
Design of mobile data collection form for 
abortion module 
Community survey field work 
Analysis of abortion component of survey 
JC 
OO 
 
PCZ, JC, OO 
PCZ 
OO 
 
PCZ, OO 
OO 
VF 
VF 
 
 
 
PCZ 
 
JC 
JC, OC 
Research papers How policy and regulatory changes affect trends 
in abortion-related complications and deaths: 
An analysis of Zambian hospital data  
 
Incidence of abortion-related near-miss 
complications in Zambia: cross-sectional study 
in Central, Copperbelt, and Lusaka Provinces  
 
How do the numbers compare? Estimating the 
incidence of induced abortion in Zambia using 
indirect methodologies that rely on community-
based and facility-based data 
OO 
 
 
 
OO 
 
 
 
 
OO 
Co-authors: 
JC, MD, SA, MM, 
BV, OC, VF  
 
Co-authors: 
JC, BV, DO, VF 
 
 
Co-authors: 
JC, MD, AB, OC, 
BV, VF 
Supervision Sub-study 1 and 2 within project 
Overall PhD/Thesis 
VF, JC 
VF, JC 
PCZ 
*Individuals or group responsible for each activity denoted with acronym 
BV=Bellington Vwalika, CR=Carine Ronsmans, DO=David Osrin, GI=Guttmacher Institute, JC=Jenny Cresswell, 
MD=Mardieh Dennis, MM=Maurice Musheke, OC=Oona Campbell, OO=Onikepe Owolabi, PCZ=Population Council 
Zambia, RAs=Research assistants, SA=Schadrac Agbla, VF=Veronique Filippi,  
3.3 Ethical approval 
Ethical approval was granted by the University of Zambia Biomedical Research Ethics 
Committee (UNZABREC) on 3 September 2013 (protocol ID:016-04-13), the Population 
Council IRB on 16 January 2013 (protocol ID: 582), and the London School of Hygiene and 
Tropical Medicine Research Ethics Committee on 16 August 2013 (protocol ID: 6407). 
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Ethical review authorities in two of the participating private hospitals independently 
reviewed and approved the study. Individual written consent was not required for the 
near-miss, abortion incidence hospital or trend studies as no women or medical 
personnel were interviewed and anonymous data were extracted solely from hospital 
records. All women in the community survey gave written informed consent. See 
appendix 1 for copies of the ethical approval letters and appendix 2 for copies of the 
consent form. 
3.4 Funding 
Funding to support this research was received for student fees and allowances from the 
Economic and Social Research Council (ESRC) UK as an ESRC +3 studentship [grant 
number ES/J5000021/1], and for fieldwork from the UK Department for International 
Development through the EVA-PMDUP evaluation. I am also a member of the DFID-
funded Research Programme Consortium STEP-UP. Although STEP-UP did not directly 
contribute funds for fieldwork, I participated in some of its activities such as the 
consultation meeting on the definition and measurement of unsafe abortion for which I 
was rapporteur and my current role within STEP-UP is to contribute to the abortion 
measurement field. 
3.5 Research timeline 
This section provides a timeline of each of the activities involved in conducting my PhD 
research (Table 3-3). Over the course of my PhD work, I spent approximately 10 months 
in Zambia. 
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Table 3-3 Timeline of PhD research activities 
 
Year Month(s) Activities 
2012 September Developed the near-miss morbidity research tool 
  Ethical approval granted from LSHTM and TDRC for pilot 
in Zambia 
 October Piloted near-miss tool in Zambia 
Pilot analysis 
Redesign of tool 
2013 December 2012- July Literature review 
Development of conceptual chapter on defining unsafe 
abortions 
Upgraded from MPhil to RD student 
 September-October  Obtaining permissions from MoH  
Introductory visits to eligible hospitals 
Recruitment and training of field staff  
 November  Commenced data extraction for retrospective 
hospitalization study 
Training of clinicians in hospitals for near-miss morbidity 
study 
AICM commenced 
 December Commenced near-miss morbidity study and supervision 
visits 
2014 January Field work for AICM continued 
Near-miss supervision visits continued 
 February Piloted ATPR tool 
Redesign of tool 
Translation of tool 
Programming into open data kit (ODK) 
Preparation for field work 
Near-miss supervision visits continued 
 March Community survey commenced 
Data entry for near-miss study commenced 
Near-miss study concluded 
 May Oversaw near-miss validation study  
 June-December Data analysis commenced 
2015 January Had a baby 
 January-April Data analysis and writing up 
 May-June  Interruption of studies (maternity leave) 
 July- April 2016 Data analysis and writing up  
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Chapter 5. Incidence of abortion-related near-miss 
complications in Zambia: cross-sectional study in 
Central, Copperbelt and Lusaka Provinces 
Introduction 
This chapter describes the incidence of abortion-related near-miss morbidity in three 
provinces in Zambia. It utilizes the concept of abortion-related near-miss to quantify and 
describe the burden of unsafe abortion. The paper outlines how we incorporated near-
miss morbidity into the current criteria PMM used to define abortion-related morbidity 
from hospital data. The results of the study describe the characteristics of women 
hospitalized for abortion-related complications, provide abortion-related near-miss 
morbidity estimates for three provinces in Zambia, and discuss the challenges of utilizing 
the WHO near-miss criteria, without sufficient adaptation to a limited-resource context. 
The methods and methodological strengths and challenges section here is more 
extensive than the section in the published paper due to the word count limit in peer-
reviewed publications. Five tables presenting our morbidity criteria and results of the 
study were included in the publication and have been included in the chapter. Table 1 
presents additional results on the use of contraceptives before and after admission for 
abortion-related complications, which were not submitted with the paper. Appendix A 
defining study terms and appendix B describing the pilot study which were part of the 
journal submission are included immediately after the manuscript. The data collection 
tool for this study is included in appendix 7 (within the appendices after the thesis). 
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Published article- Incidence of abortion-related near-miss complications in Zambia: 
cross-sectional study in Central, Copperbelt and Lusaka Provinces 
Article reference: Owolabi, Onikepe O., et al. "Incidence of abortion-related near-miss 
complications in Zambia: cross-sectional study in Central, Copperbelt, and Lusaka 
Provinces." Contraception (2016). 
Abstract 
Objectives: To describe the magnitude and severity of abortion-related complications 
in health facilities and calculate the incidence of abortion-related near-miss 
complications at the population level in three provinces in Zambia, a country where 
abortion is legal but stigmatized. 
Study design: We conducted a cross-sectional study in 35 district, provincial, and 
tertiary hospitals over 5-months. All women hospitalized for abortion-related 
complications were eligible for inclusion. Cases of abortion-related near-miss, 
moderate, and low morbidity were identified using adapted WHO near-miss and the 
prospective morbidity methodology (PMM) criteria. Incidence was calculated by 
annualizing the number of near-misses and dividing by the population of women of 
reproductive age. We calculated the abortion-related near-miss rate, abortion-related 
near-miss ratio, and the hospital mortality index. 
Results: Participating hospitals recorded 26,723 births during the study. Of admissions 
for post-abortion care, 2406 (42%) were eligible for inclusion. Near-misses constituted 
16% of admitted complications and there were 14 abortion-related maternal deaths. 
The hospital mortality index was 3%; the abortion-related near-miss rate for the three 
provinces was 72 per 100,000 women, and the near-miss ratio was 450 per 100,000 
live births.   
Conclusions: Abortion-related near-miss and mortality are challenges for the Zambian 
health system. Adapted to reflect health systems capabilities, the WHO near-miss 
criteria can be applied to routine hospital records to obtain useful data in low-income 
settings. Reducing avoidable maternal mortality and morbidity due to abortion requires 
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efforts to de-stigmatize access to abortion provision, and expanded access to modern 
contraception. 
Implications: The abortion-related near-miss rate is high in Zambia compared with 
other restrictive contexts. Our results suggest that near-miss is a promising indicator of 
unsafe abortion, can be measured using routine hospital data, conveniently defined 
using the WHO criteria and can be incorporated into the frequently utilized prospective 
morbidity methodology. 
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5.1 Introduction 
Unsafe abortion is a leading and easily preventable cause of maternal mortality and 
morbidity (81,163). Globally, the highest regional estimate of abortion-related 
mortality (90 per 100,000 live births) comes from Sub-Saharan Africa, where most 
abortion laws are restrictive, abortion may bear greater societal stigma, poverty is 
common, and comprehensive abortion care services are limited (163). Unsafe abortion 
remains a contentious, poorly measured, and largely neglected health problem in this 
region. 
Obtaining accurate population-representative data on unsafe abortions is more 
challenging in such high-burden contexts(9,42). Women having terminations of 
pregnancy (TOPs) are unlikely to report them in surveys and providers are unlikely to 
maintain accurate reports. 
Hospital records on post-abortion care (PAC) admissions are the most frequently used 
source of data (10), but have limitations. Although national mortality may be high, 
numbers of deaths are often small at individual hospitals. All admissions for abortion-
related morbidity in hospitals may not be representative of morbidity in the community 
(36,164), and it is difficult to distinguish miscarriages (spontaneous abortions) from 
induced abortions (terminations of pregnancy) when morbidity is of low severity, as a 
means of identifying unsafe TOPs (25).  
The idea of near-miss morbidity aims to address some of these measurement 
challenges. The WHO operational definitions of maternal near-miss (93) define a level 
of morbidity so severe that, in women with abortion-related complications, it is most 
likely the result of a TOP rather than a miscarriage (89), such that survival requires 
hospital treatment. By extension, documented near-misses at health facilities can be 
assumed to represent all cases within the population (165), providing an indicator of 
the most severe unsafe TOPs that can be tracked over time. Since it has similar 
characteristics, near-miss can be used as a proxy for mortality. It occurs more 
frequently (115,166,167), and allows for larger samples and increased statistical power 
 87 
in quantitative analyses (100). To the best of our knowledge, no studies have yet 
estimated the incidence of abortion-related near-miss at the population level (10). 
Zambia has one of the most liberal abortion laws in Sub-Saharan Africa. 
Implementation is, however, impeded by a requirement for three signatories to 
support an elective TOP, except in an emergency. No recent studies have described the 
burden of TOPs or miscarriages in Zambia(143), but unsafe TOPs have been previously 
estimated to account for 30% of maternal deaths and 50% of gynecological admissions 
(17,145). Our study describes the magnitude and severity of moderate and severe 
complications from both miscarriage and TOP, and the incidence of abortion-related 
near-miss in three provinces.  
5.2 Methods 
5.2.1 Design, setting, and population 
We conducted a cross-sectional study in Central, Copperbelt, and Lusaka Provinces. 
Lusaka and Copperbelt account for 69% of Zambia’s total urban population (155), while 
Central Province is more rural. Forty-three level one (district), level two (provincial), 
and level three (tertiary and national) hospitals - which serve as public (N=30) or private 
(N=13) referral facilities and provide comprehensive care for severe complications - 
were eligible for inclusion and were invited to participate. 
We used the Zambian Ministry of Health definition of abortion (Appendix A) (17). All 
women admitted with an International Classification of Diseases (ICD-10) diagnosis of 
incomplete, complete, missed, septic, inevitable, or spontaneous abortion, who were 
hospitalized for greater than 24 hours or had any complication that could potentially 
lead to moderate (Table A1) or near-miss morbidity, or died between 1st December 
2013 and 31st April 2014, were eligible for inclusion. Each health facility was provided 
with two clinical algorithms containing these inclusion and exclusion criteria to display 
on the wall and assist data collectors with recruitment (Appendix 6). 
We defined morbidity categories by adapting the prospective morbidity methodology 
(PMM) initially proposed by WHO to determine whether abortion complications were 
related to miscarriages or unsafe TOPs, adapted by South African researchers, and 
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subsequently used in other studies to collect data on abortion-related morbidity and 
management (25,37,38,87–89). We changed the morbidity categories from low, 
moderate, and severe (87) to low, moderate, near-miss, and suspected near-miss. We 
introduced anemia cut-off levels for each category using the WHO cutoffs for pregnant 
women (168), except in the near-miss category in which we used a level of 4g/dl. This 
decision was based on discussions with clinicians and experts on maternal near-miss 
during the design of our adapted criteria. 4g/dl is also the cut-off for severe anemia 
requiring urgent transfusion according to the Zambia Transfusion Service.  We also 
revised the infection definition for the moderate category, and replaced the high-
severity category with a near-miss category. We introduced anemia into our 
classification because hemorrhage is a major complication of unsafe abortion (169), 
but the PMM does not include in its categories criteria other than shock to assess 
severity of blood loss. Many women and hospitals are unable to objectively quantify 
blood loss after an abortion, but it is possible to assess the effect of blood loss by 
measuring haemoglobin levels in such settings. We also adapted the WHO near-miss 
criteria to reflect a lower middle-income country context (Table 5-1). We excluded the 
laboratory and management-based criteria which are rarely measured in this context 
as such data is rarely present in patient case files(106,114). We included as criteria 
anemia alone (<4g/dl), and anemia in combination with blood transfusion (4-7g/dl with 
any blood transfused). These criteria are important adaptations because clinical 
information in medical records is often incomplete in low- and middle-income 
countries, and parameters to identify severe bleeding objectively and classify cases as 
hypovolemic shock are often not readily available.  We lowered the WHO near-miss 
threshold for a massive blood transfusion from 5 units of blood to 2 units in our adapted 
criteria. This is because of the scarcity of blood products in Zambia and was endorsed 
by our local investigator, BV. It has also been reported by maternal near-miss studies 
in similar settings such as Malawi(170) and Tanzania(106). Both studies suggest 2 units 
of blood as the optimal threshold for massive transfusion in such contexts. The 
suspected near-miss category was based on our experience in a pilot study in which 
cases were considered to be near-miss by clinicians, but the case file contained 
insufficient information to classify it objectively as such (Information on the pilot study 
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is included in Appendix B). We included the suspected near-miss cases in the near-miss 
category in the final analysis. 
Table 5-1 Differences between WHO near-miss morbidity criteria and criteria used 
in the study, adapted for abortion-related complications in Zambia 
NEAR-MISS SEVERITY 
WHO near-miss criteria Adapted near-miss criteria for study 
Clinical criteria 
Shock Hypovolemic shock 
Persistent systolic blood pressure <90 mmHg with pulse rate of at 
least 120 beats per minute); with or without blood hemoglobin 7-
9.9 g/dl or mucocutaneous signs 
 Septic shock 
Clinical diagnosis of septicaemia or one of the following: t>39C, 
t<36C, genital infection AND one of the following: systolic BP <90 
mmHg, icterus, altered consciousness, oliguria <100ml in 4 h. 
Oliguria not responsive to fluid or diuretics Oliguria not responsive to fluid or diuretics 
Uterine output <30ml/hour for four hours or <400ml/24 hours 
Cardiac arrest Cardiac arrest 
 Generalized peritonitis, tetanus, gangrenous uterus 
 Major trauma  
Uterine perforation, bowel injury 
Management-based criteria 
Hysterectomy following infection or 
hemorrhage 
Hysterectomy following infection or hemorrhage 
Massive blood transfusion  
(Transfusion of ≥5 units of blood) 
Massive blood transfusion 
Transfusion of ≥2 units of blood 
 Haemoglobin <4 g/dl 
 Hb 4.1-6.9 g/dl with >=1unit blood transfused 
  
SUSPECTED NEAR-MISS 
 
Clinically suspected case of organ/systemic compromise with incomplete documentation 
Cases transfused with one unit of blood and clinical symptoms/signs of anaemia, with haemoglobin 
level missing from the case file, and insufficient information to objectively classify in a near-miss 
category 
Haemoglobin between 4 and 7g/dl with no blood transfusion given 
MODERATE SEVERITY  
 
Prospective morbidity methodology Adapted study criteria 
Temperature 37.3-37.9 C Temperature >=37.3C and other signs of infection, e.g. 
chills and rigors, foul smelling discharge 
Offensive products Offensive products 
Localised peritonitis Localised peritonitis 
 Haemoglobin 7-9.9 g/dl alone or with blood 
transfusion 
  
LOW SEVERITY 
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Prospective morbidity methodology Adapted study criteria 
Temperature <= 37.2 C Temperature < 37.3C (but > 36C) 
No clinical signs of infection No clinical signs of infection 
No system or organ failure  
No suspicious finding on evacuation No suspicious findings on evacuation 
 Hemorrhage not requiring any blood transfusion 
 Haemoglobin 10-10.9g/dl 
 
5.2.2 Data collection 
We collected data continuously for five and a half months from 1st December 2013 to 
15th May 2014. Only women admitted from the 1st December 2013 to 30th April 2014 
were included in the analyses. We used a pre-tested standardized form structured to 
approximate patient care, in order to minimize the data collectors work and improve 
data quality. A one-day training was conducted with 67 data collectors (clinicians 
working in the wards in which eligible women were likely to be admitted) 
recommended by each hospital. Clinically trained study supervisors (namely OO, who 
is a medical doctor, and a Zambian nurse hired for the study) extracted data in three 
hospitals (9%) in which no in-facility data collectors were recommended. Data 
collectors extracted information from hospital files and did not interview women 
directly. They were instructed not to differentiate between complications resulting 
from miscarriages and TOPs. Health providers were, however, told to ask about and 
record reported attempts to induce abortion and to note physical evidence of 
attempted termination during clinical examination. Monthly supervision visits were 
conducted to collect completed forms and verify information from hospital files. Data 
collectors received a small financial incentive for participation. We collected the total 
numbers of women admitted for any abortion-related complication from hospital 
registers, regardless of complication severity and outcome, women provided with TOP, 
number of deliveries and total live births. 
After the main study, a validation study was conducted in one tertiary hospital to verify 
if all cases had been included in our study. One study supervisor retrieved case files for 
March 2014 from the medical records department and traced women from hospital 
registers. Data from eligible cases were extracted retrospectively into data forms and 
the degree of underreporting assessed. 
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5.2.3 Data analysis 
Data analysis was conducted in Stata 13.1, and an algorithm was used to assign 
morbidity level to cases using clinical signs and symptoms. We quantified the number 
of near-misses that would have been identified using our adapted study criteria and 
WHO near-miss criteria. Data from each hospital were calculated, divided by five, and 
multiplied by 12 to generate yearly estimates of abortion-related complications and 
near-misses for the 3 provinces. Data were weighted for non-response by each stratum 
(level of facility) in each province and for all three provinces based on the sampling 
fraction achieved. We derived population estimates of women of reproductive age 
from the Zambia 2010 census of population and housing, by assuming that women of 
reproductive age constituted 45.3% of all women. We used this estimate and estimates 
of live births from the 2013-14 Zambia Demographic and Health Survey (ZDHS) as 
denominators. 
We calculated the overall intra-hospital abortion-related mortality ratio, intra-hospital 
abortion-related near-miss morbidity ratio, hospital mortality index, abortion-related 
near-miss morbidity rate, and abortion-related near-miss morbidity ratio for each 
province and for the three provinces together (terms defined in appendix A) (93,171).  
5.3 Results 
Of the eligible private and public facilities, 35 (81%) agreed to participate, ranging from 
63% in Lusaka to 94% in Copperbelt province. Twenty-eight (93%) of public hospitals 
approached participated in the study, compared with seven (54%) of private hospitals. 
Most of the institutions that declined participation were private district-level hospitals, 
and most were in Lusaka province and were reluctant to provide information they 
considered to have legal implications. Information was recorded on 2404 cases within 
the study period. Data from 12 cases were excluded because gestational age was 
greater than 28 weeks. An additional 14 cases (11% of the total that month) were 
missed, but were identified in the validation study and included in the final analysis. 
The cases missed included 7 low-severity admissions, 5 moderate-severity admissions, 
and two deaths. Table 5-2 presents the complication severity of cases included and 
missed in the original and validation study. Other than the severity of cases, there were 
 92 
no significant differences in demographic characteristics, reproductive history and 
hospital management of the women missed in the original study. 
Table 5-2 Comparing between the level of morbidity amongst cases in the original 
study and the validation study 
Complication 
severity 
Women 
included in both 
the original and 
validation 
dataset 
Women 
included in 
only the 
original 
dataset 
Women 
included in 
only the 
validation 
dataset 
Total number of 
women admitted 
in March 2014 in 
validation 
hospital 
All women in 
study sample 
Low 32 (33%) 7 (35%) 7 (50%) 49 (37%) 1405 (58%) 
Moderate 20 (21%) 4 (20%) 5 (36%) 29 (22%) 595 (25%) 
Near-miss 44 (46%) 8 (40%) 0 52 (40%) 392 (16%) 
Death 0 1 (5%) 2 (14%) 3 (2%) 14 (1%) 
Total 96 (100%) 20 (100%) 14 (100%) 130 (100%) 2406 (100%) 
 
There were 26,723 births in the study period, 791 TOPs were recorded in the hospital 
registers, and 5771 admissions for PAC, of which we included 2406 morbidity cases 
(42%) after miscarriages and TOPs. Near-miss morbidity constituted 7% of PAC 
admissions. Amongst all the cases in our study, majority were classified as low-severity 
(58%), followed by moderate (25%) and near-miss (16%). We identified 14 abortion-
related maternal deaths. We did not identify any near-miss cases in the validation 
study. A death identified in the main study was missed in the validation study, and 
deaths identified in the validation study had been missed in the main study.  There 
were no differences in demographic characteristics, reproductive history, or hospital 
management between missed cases identified in the validation study and cases 
collected prospectively.  
Women in our sample ranged from 12 to 49 years of age (mean 26.7), with a mean 
parity of 2. Altogether, 13% (95% CI 12-14) of women reported that they were using 
contraception at conception and most women presented in the first trimester of 
pregnancy (41%, 95% CI 39-43) (Table 5-3). The proportion of women reporting a 
termination attempt, or in whom an attempt was identified by a clinician, was 5% (95% 
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CI 4-6). Majority of the women in our study (94%) received antibiotics as part of their 
treatment whilst 50% received intravenous fluids. 61% of women included in our study 
were referred to the hospitals where they received care, whilst only 2% of cases were 
referred outwards from these hospitals for further care. Abortion-related maternal 
deaths were more likely to show clinical evidence of unsafe abortion (14%) than near-
miss (6%), moderate-severity (7%), or low-severity cases (4%) (p=0.004). Table 5-4 
shows the conditions associated with near-miss morbidity and mortality. Many near-
miss cases presented with severe anemia (44%), 24% had massive blood transfusion, 
27% had hypovolemic shock, and 10% had septic shock. 66% of women counselled 
accepted a method of contraception. 
Table 5-3 Sociodemographic and reproductive characteristics of 2406 women 
seeking post abortion care 
 Total 
Age in years 
Mean (95% CI) 
26.7 
(26.4-27.9) 
  
Number of pregnancies 
Mean (range) 
3 
(0-15) 
Number of births 
Mean (range) 
2 
(0-13) 
Number of pregnancy losses 
Mean (range) 
1 
(0-7) 
  
Reported use of contraception at time of 
conception 
Proportion (95% CI) 
12.8 
(11.6-14.2) 
  
Termination attempt reported or detected 
Proportion (95% CI) 
4.8 
(4.0-5.8) 
  
Gestational age 
Proportion (95% CI) 
 
First trimester 41.0 
(39.1-43.0) 
Second trimester 25.1 
(23.4-26.8) 
28 weeks to 28weeks 6 days 0.04 
(0.02-0.08) 
Missing 33.5 
(31.6-35.4) 
  
Received post abortion care family planning 
counseling  
35 
(33-37) 
 94 
Proportion (95%CI) 
  
Had PAC counseling and accepted a method of 
family planning 
Proportion (95%CI) 
66 
(63-70) *These cases were analysed as eligible cases with gestational ages less than 28 weeks, based on other clinical 
information on procedures used to evacuate the uterus 
 
Table 5-4 Clinical conditions in abortion-related near-miss cases and abortion-
related deaths  
Causes (Not mutually exclusive) Near-miss (n=392)  
 n (%) 
Abortion-related death (n=14)  
n (%) 
Severe anaemia 173 (44) 4 (29) 
Massive blood transfusion 94 (24) 4 (29) 
Cardiac arrest 1 (<1) 6 (43) 
Hypovolemic shock 104 (26) 2 (14) 
Septic shock 39 (10) 7 (50) 
Oliguria 1 (<1) 3 (21) 
Trauma to bowel or uterus 3 (1) 0 
Generalized peritonitis 0 1 (7) 
Our adapted study criteria identified considerably more near-misses (392) than the 
WHO criteria (115). The main difference was in the massive blood transfusion category, 
where our definition yielded 94 cases while the WHO definition yielded five (Table 5-5). 
Our anemia category identified 86 near-miss cases with a diagnosis of severe or very 
severe anemia and no other inclusion criteria; these cases would not have been 
captured by the WHO criteria. Table 5-5 compares the relationship between massive 
blood transfusion, as defined by our study and the WHO, and anemia severity.  
Table 5-5 Overlap between blood transfusion and haemoglobin levels based on 
WHO near-miss criteria and Zambia study adapted criteria 
 Massive blood transfusion 
according to WHO near-miss 
criteria (>=5 units of blood) 
Massive blood transfusion 
adapted for Zambia near-miss 
study (>=2 units of blood) 
Haemoglobin level n (%) n (%) 
Very severe anaemia 
(<=4g/dl) 
3 (60) 21 (22) 
Severe anaemia  
(4.1-6.9g/dl) 
0 (0) 34 (36) 
Moderate anaemia  
(7-9.9g/dl) 
2 (40) 8 (8) 
Missing 0 (0) 31 (33) 
Total 5 (100) 94(100) 
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The intra-hospital abortion-related mortality ratio was 52 per 100,000 live births, the 
intra-hospital abortion-related near-miss morbidity ratio was 1467 per 100,000 live 
births, and the mortality index was 3%. We projected the annual number of near-miss 
complications, taking account of facility weights within each province. We estimated 
the annual number of near-miss cases in the three provinces in 2014 at 1022. The rate 
of abortion-related near-miss morbidity was 72 per 100,000 women of reproductive 
age, while the abortion-related near-miss ratio was 450 per 100,000 live births (Table 
5-6). Lusaka province had the highest abortion-related near-miss rate at 88 per 100,000 
women of reproductive age, followed by Copperbelt province at 65, and Central 
province at 55 (Table 5-6). 
Table 5-6 Near-miss outcome indicators by province 
Location Number of 
women aged 
15-49, 20141 
Number of 
near-miss2 
cases, 2014 
Incidence of near-miss 
morbidity2 per 100,000 
women of reproductive 
age, 2014 
Number of 
live births, 
20141 
Incidence of near-
miss morbidity2 
per 100,000 live 
births, 2014 
Central 
province 
329,506 182 55 65,995 280 
Copperbelt 
province 
506,280 329 65 75,747 430 
Lusaka 
province 
575,160 509 88 83,933 610 
3 provinces 
1,410,945 1022 72 225,674 450 
1 Derived from Zambian 2010 Census projections using a medium level multiplier and the Zambia 2013/14 DHS for live births 
2 Near-miss consists of both near-miss and suspected near-misses within the study  
5.4 Discussion 
Our study showed that, despite relatively liberal laws, high numbers of abortion-related 
near-miss morbidities and deaths occur in Zambian hospitals. There was also a high 
incidence of near-miss morbidity at the population level, with the most urbanized 
provinces having the highest tolls. Sequelae of hemorrhage were the most frequently 
occurring complications in near-miss cases and deaths. There were very few cases of 
injuries within our sample suggesting that women are utilizing less invasive means of 
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unsafe abortions and/or that abortion providers are perpetuating less traumatic 
damage to abdominopelvic organs(150). This has implications for research trying to 
quantify induced abortions in Zambia. Few women reported that they have induced an 
abortion, and with changing patterns in morbidity as procedures become safer it is 
increasingly difficult to objectively identify terminations of pregnancy in health 
facilities. 
The abortion-related near-miss rate (72) and ratio (450) in our study were higher than 
those estimated in most studies included in a 2012 systematic review by Adler et al 
(range for near-miss rate 14-121, range for near-miss ratio 91-1892), while the 
proportion of near-miss cases amongst all abortion-related admissions (7%) was similar 
to their median value (6%). Near-miss occurred most frequently in urban provinces 
with the highest concentration of skilled providers and health facilities. This may be 
because, despite the availability of health facilities, urban areas have higher population 
densities and may have higher abortion rates amongst women who want to meet their 
reproductive intentions(172,173). In this scenario poor knowledge of the abortion 
law(21), societal stigma around unintended pregnancy(141,174) and reluctance to 
provide TOPs by health facilities may predispose more Zambian women to access 
clandestine abortions with varying levels of safety, which may increase the risk of 
severe complications requiring post-abortion care (141). It may also be that women 
from nearby provinces travel to seek care for serious complications in the large tertiary 
hospitals in these provinces, either because they are referred or in the hope of better 
or more anonymous care.  
Our abortion-related near-miss ratio appears to be consistent with estimates from 
recent studies. The 2013-14 ZDHS estimated the national maternal mortality ratio at 
398 per 100,000 live births (95% CI, 323-474) and a 2004 systematic review estimated 
an obstetric near-miss ratio of 380-1090 per 100,000 live births in studies using organ 
dysfunction criteria (98). Abortion-related near-misses constitute a proportion of all 
maternal near-misses and the abortion-related near-miss ratio should be higher than 
abortion-related mortality ratios. Similar to observations in other studies, haemorrhage 
accounted for the greatest proportion of near-misses and deaths (104,115,175).  In 
comparison with a study in South Africa by Rees and colleagues, our retrospective 
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validation study identified fewer cases than did prospective data collection (87). To our 
knowledge, no other studies of abortion-related morbidity using this methodology 
have attempted to assess the degree of underreporting. 
Only about a third of women in our study were reported to have received post abortion 
contraceptive counselling.  However, 66% of women counselled accepted a method. 
This suggests that the quality of post abortion care services provided in Zambian 
hospitals is low as it neglects contraceptive counselling which is an integral component 
of PAC. PAC provides an opportunity to provide family planning to women who most 
likely have an unmet need for contraception, enable them avoid repeat unintended 
pregnancies, and reduce the future risk of maternal ill-health or death associated with 
another unwanted birth or unsafe abortion. 
5.4.1 Strengths of this study 
We think that ours is the first hospital-based study to focus on quantifying the burden 
of abortion-related near-miss morbidity and to use it as a measure of unsafe abortion. 
A large proportion of eligible hospitals participated in our study including 50% of private 
hospitals which have rarely been included in such studies. We extended the PMM 
framework by introducing a near-miss category based on standardized WHO criteria 
and incorporating anaemia in all the categories.  Our adaptations reflect the 
commonest complications of unsafe abortion and apply to low-income contexts where 
the burden is greatest.  Although seasonal variation cannot be excluded, our study was 
longer (5 months) than most abortion morbidity studies (2-4 weeks), presumably 
improving the precision of our annual estimates (87). 
5.4.2 Methodological challenges 
Prospective data collection was more effective in identifying near-miss cases, which 
were all missed in the retrospective validation study. On the other hand, neither 
prospective data collection nor the retrospective validation study identified all the 
deaths which occurred in the largest facility in this study. Identifying abortion-related 
deaths was particularly challenging in tertiary hospitals as hospital records were 
generally poor or unavailable particularly for women who died soon after admission, 
death certificate registers were not always available to extract data from and the cause 
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of death was not always recorded as abortion on the death certificate but reported by 
clinical staff who remembered the patient for some of the cases included. Although 
deaths records were also poor in provincial and district hospitals, due to the smaller 
patient caseload, it was easier for clinical staff to find and identify maternal death for 
our study. Overall, we have most likely underestimated the numbers of abortion-
related deaths occurring in hospitals during the study. 
It was feasible to collect information on abortion-related near-miss from routine clinical 
records on a large scale using the adapted WHO criteria in a resource-poor context. 
The quality of our data however depended on the quality of records, which varied by 
type and level of facility and may have been subject to error. Due to incomplete 
information or unavailability of blood products, 44% of near-miss cases were initially 
categorized as suspected near-miss. Additionally, a third of women had missing 
information on their gestational age. We classified them as eligible for our study based 
on the basis of information from data collectors and other clinical criteria e.g. most of 
these cases (~77%) were managed using manual vacuum aspiration which is not 
recommended for pregnancies over 14 weeks. The remainder were managed using 
medical abortion and dilatation and evacuation (some of which may have been second 
trimester abortions).  However, it is unlikely that many of these cases are third 
trimester abortions as most spontaneous and induced abortions occur before 28 
weeks. We are hence certain that majority of these cases were eligible for inclusion in 
our analysis.  
This challenge of data completeness is common in low- and middle-income country 
hospital records(73,106). While the influence of missing data on severity classification 
may not be random, it is not clear how it affects the data. On one hand, more severe 
cases may have poorer information recorded as staff focus more on their treatment 
than keeping notes. On the other hand, more severe cases may have better chart 
information as they stay longer in hospital with more documentation by multiple 
clinicians(73). One study in Nepal attempted to address the data collection challenge 
by classifying severity based on treatment instead of clinical signs and symptoms. The 
ability to classify cases was improved using this approach as there was less missing data 
on management  in the case files(73). However, unlike in this study where 
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administration of IV fluids and IV antibiotics appeared to be associated with severity, 
these interventions were provided to majority of the women in our study. Hence we 
cannot use them to objectively distinguish between severity levels. A treatment based 
index is likely to be sensitive to clinical protocols in different health facilities and 
contexts, hence it is less viable as a standardized measure than a clinical sign and 
symptom-based index.  
Whilst classifying severity during the data analyses, we discovered that the categories 
in our study classification study are not exhaustive, with a gap between the clinical signs 
and symptoms of near-miss severity and moderate severity cases. For example, a 
woman with systolic blood pressure consistently around between 92-98mmHg who 
was a few points away from the cut off for hypovolemic shock (90mmHg) and had the 
other diagnostic symptoms (e.g. pulse rate) consistently close to the cut-off or missing 
from the case file was not classified in the near-miss category. If the clinician failed to 
recognize her as a suspected near-miss case, and there was no information to classify 
her as moderate severity according to the adapted criteria, we put her in the low 
category. However, despite the missing information clinically it is likely that such a case 
may have been managed as a hypovolemic shock case and would not be considered 
moderate morbidity. One way to deal with this is to include a severe category similar 
to life threatening conditions (PLTC) group in the WHO near-miss approach to classify 
women whose signs and symptoms fall between the moderate and near-miss 
categories. This category could also replace the suspected near-miss morbidity which 
is subjective. To improve and standardize the categorization of abortion-related 
morbidity expert consensus might be required on a classification system with mutually 
exclusive and exhaustive categories and objective criteria for each level of morbidity. 
There should also be a clear protocol for handling morbidity cases with missing 
information. 
We included the clinical and management criteria which were  most relevant in Zambia, 
and comparable to studies conducted in neighbouring countries (106,170). Similar to 
recent study findings in Tanzania (106,114), the WHO massive transfusion threshold 
(≥5 units of blood) would have excluded many eligible women in our study because 
many facilities did not have adequate blood banks. Using anaemia as an indicator 
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improved our ability to identify near-miss cases in the context of limited blood 
transfusion. Haemorrhage is a major complication of unsafe abortion (169), and its 
degree can be proxied by anaemia criteria, more readily assessed in low-income 
countries.  Clinical information in medical records is often incomplete and parameters 
to identify severe bleeding objectively and classify cases as hypovolemic shock are 
often not readily available. Adding anaemia severity to the near-miss criteria and other 
morbidity categories of the PMM provides additional value in such contexts.  
Setting a suitable cut-off for anaemia within the near-miss category and other 
morbidity levels is challenging. In this study since we analysed both near-miss and 
suspected near-miss cases as near-misses, we ultimately included three categories of 
women as near-miss anaemia cases. From table A1, the three categories were: women 
who survived with less than 4g/dl of haemoglobin; women with haemoglobin less than 
7g/dl who any blood transfusion, and women with haemoglobin between 4 and 7g/dl 
regardless of whether they received blood. In summary, we included women with 
haemoglobin less than 7g/dl regardless of whether they received blood or not. A study 
in Malawi used a haemoglobin level below 6g/dl after vaginal bleeding in its near-miss 
criteria(109). The cut-off for severe anaemia based on the WHO categorization of 
anaemia severity in pregnant women is 7g/dl (168). However, this level of haemoglobin 
may be too high for a stringent near-miss classification in which near-misses can only 
survive due to hospital intervention and aimed at providing population representative 
estimates and for monitoring and evaluation.  
Other limitations include the higher proportion of public than private hospitals that 
participated, which might limit generalizability. We did not collect data on all women 
admitted with abortion complications and, despite efforts to ensure the eligibility 
criteria were applied correctly, we may have missed some cases. However, we 
screened hospital logbooks during supervision visits to identify missed cases and 
relevant data were retrieved if found. Although we collected information on referral to 
and from facilities, we treated each entrance to a health facility as a discrete case. Only 
2% of cases were referred elsewhere and it is unlikely that double-counting was 
substantial.  
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5.5 Conclusions  
The frequency of abortion-related near-miss morbidity and mortality suggests that 
access to abortion services in Zambia remains poor despite the favourable liberal 
abortion law. Although collecting comprehensive and representative data on abortion-
related mortality is difficult, it was feasible to identify abortion-related near-miss cases, 
which are a useful indicator of the most unsafe abortions and a proxy for mortality.  
With reasonable adaptation, the WHO criteria can be applied to routine hospital 
records to obtain useful data.  We recommend lowering the threshold for blood 
transfusion, incorporating severe anaemia, and providing a standardized definition of 
septic shock to reflect the capabilities of health systems in low-resource contexts and 
to adequately capture the commonest causes of near-miss morbidity and mortality. 
We also recommend the development of standardized, clearly defined classification 
criteria to improve the classification of hospitalizations for abortion-related 
complications. To reduce avoidable maternal mortality and morbidity due to abortion, 
there is a need for concerted efforts to make women aware of the legal status of 
abortion and to de-stigmatize service provision and access.  In addition, expanded 
access to modern contraceptives is essential to reduce unmet need and the occurrence 
of unintended pregnancies. 
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Appendix A: Definition of terms 
Abortion: “Termination of pregnancy, expulsion of embryo/foetus before viability”. The date 
of viability in Zambia is 28 weeks [20]. 
Maternal near-miss: A woman who nearly died, but survived a complication that occurred 
during pregnancy, childbirth or within 42 days of termination of pregnancy (93)·(93)·  
Abortion-related near-miss: A maternal near-miss case that occurs due to miscarriage or 
termination of pregnancy. 
Maternal death: Death of a woman while pregnant or within 42 days of termination of 
pregnancy, irrespective of the duration and the site of the pregnancy, from any cause related 
to or aggravated by the pregnancy or its management, but not from accidental or incidental 
causes (ICD-10)(93)·  
Abortion-related maternal death: Maternal death due to miscarriage or termination of 
pregnancy. 
Live Birth (LB): Birth of an offspring who breathes or shows evidence of life [26]· 
Woman of reproductive age (WRA): Woman aged 15 to 49. 
Abortion-related near-miss ratio: Number of abortion-related near-miss cases per 100,000 
live births. This indicator gives an estimate of the amount of care and resources that would 
be needed in an area or facility. 
Abortion-related near-miss rate: Number of abortion-related near-miss cases per 100,000 
women of reproductive age.  
Intra-hospital abortion-related near-miss ratio: Number of abortion-related near-miss cases 
that occur in hospitals, per 100,000 live births. 
Intra-hospital abortion-related mortality ratio: Number of abortion-related maternal deaths 
that occur in hospitals, per 100,000 live births. 
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Intra-hospital abortion-related mortality ratio: Number of abortion-related maternal deaths 
that occur in hospitals, per 100,000 live births. 
Intra-hospital mortality index: Number of maternal deaths in hospitals divided by the number 
of women with life-threatening conditions in hospitals (i.e. maternal near-miss cases plus 
maternal deaths) expressed as a percentage. The higher the index, the more women with 
life-threatening conditions who die: an indicator of quality of care (93). 
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Appendix B: Description of the pilot study   
The pilot was conducted by OO in October 2012. Data was extracted from 122 patient 
files at the largest public tertiary hospital in Zambia providing PAC and from 11 patient 
files at a private hospital. Thereafter OO analyzed the pilot data and amended the tool 
accordingly.  
71% of cases were low severity, 20% moderate, 4% near-miss and 5% (N=6) suspected 
near-misses.  
The suspected near-miss cases included:  
2 women who were clinically managed as shock but had a pulse rate or blood pressure 
reading missing from the case files for the duration of admission. Hence we could not 
objectively use the study definition of shock.  
4 women who were transfused with a unit of blood, had clinical signs of anaemia- 
pallor, cold extremities, were admitted for more than 24 hours but did not have pulse 
rates, blood pressures or haemoglobin measurements recorded in their case files.  
After the pilot, we removed some questions which were usually unavailable in case 
files from the form. These included: woman’s occupation, date of termination if 
abortion was induced, time of post abortion care procedure performed and time of 
discharge.  
We also revised the massive blood transfusion criteria to >= 2 units of blood and 
introduced a suspected near-miss category to accommodate clinically severe cases 
with incomplete information in case-files. These included: 
Cases managed as near-miss cases with organ compromise (manged as hypovolemic 
or septic shock, but with incomplete clinical signs in case file and perceived the 
clinicians in the hospital to be a near-miss) 
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Women who received a unit of blood with insufficient additional information 
(haemoglobin level, pulse rate and blood pressure) in the case file to classify them 
objectively as having severe anaemia or shock.  
Women who fell within the criteria for severe anaemia according to the WHO 
(between 4-6.9g/dl) who were not transfused with blood even when it was requested 
by the managing clinician 
These criteria were discussed with our local investigator BV who is the head of the 
obstetrics and Gynaecology department at the largest tertiary hospital in Zambia and 
has extensive experience practicing in rural areas in Zambia. They were also discussed 
with doctors, nurse midwives and clinical officers during the data collectors training 
and there is consensus that these cases count as near-misses.  
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Chapter 7. Discussion 
This chapter synthesizes the findings of my PhD by objective and discusses the findings 
together.  For each objective, I discuss the empirical results from Zambia and the 
methodological strengths of the approaches used and the challenges encountered 
(without repeating those mentioned in the results chapters). Thereafter I discuss the 
implications of my research for measurement and make recommendations for Zambia 
and for future research.
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7.1 Summary of the key findings 
Unsafe abortion is a leading and preventable cause of maternal death and ill health that 
disproportionately affects poor, less-educated, rural and young women in low- and 
middle-income countries. The circumstances that facilitate unsafe abortions in a 
context– including legal restriction, poor access to contraceptives, unavailable or poor 
quality health services and social stigma, infringe on the rights of women to fulfil their 
reproductive intentions and to make informed and independent decisions about their 
sexuality and health. Reducing the number of unsafe abortions globally is essential to 
achieve the sustainable development goals (SDGs) related to women’s health and gender 
quality. Hence, despite its challenges measuring unsafe abortion is essential to 
understand the magnitude of this problem and monitor progress at global, national and 
sub-national levels.   
Zambia’s liberal abortion law but restrictive implementation, the regulatory changes that 
have occurred since 2009, and the lack of representative data on induced and unsafe 
abortion make it an appealing setting to conduct research on abortion. My research in 
Zambia aimed to achieve two broad goals. The first was to contribute towards 
refinements to the conceptualization of unsafe abortion, and to improve its 
measurement considering technological changes in medical provision in low- and middle-
income countries where the burden is greatest. The second was to generate new 
substantive data on the burden of unsafe and induced abortion in Zambia using data 
from health facilities and a community-based survey in order to demonstrate the need 
for greater access to comprehensive abortion care services.  
7.1.1 Summary of background- defining and measuring unsafe abortions 
Clearly defining and measuring abortion safety in restrictive contexts is challenging due 
to the societal stigma and/or legal restrictions around the practice, causing abortions to 
be underreported. The increased availability of medical abortion (MA) also makes it 
difficult to distinguish from spontaneous abortion. There is an emerging consensus 
amongst some researchers that abortion safety should not be dichotomized into 
safe/unsafe but defined and measured along a spectrum incorporating both the process 
of the abortion and the outcomes (morbidity and mortality). However, my background 
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concludes that in restrictive contexts, outcome data on complications from health 
facilities is more readily available than process data on how women obtained pregnancy 
terminations from surveys or providers and therefore measurement approaches using 
outcome data only might be more useful for monitoring unsafe abortion. The data source 
that has been predominantly used to estimate the indicators of unsafe abortion is health 
facility data. My background chapter outlined how health facility data has been analysed 
and proposed refinements on how this data can be used to achieve different objectives. 
I discuss the benefits of exploiting the largely untapped potential of routine facility data 
to assess the impact of policy/regulatory and other contextual or service-based changes 
(not just legal changes) in abortion-related admissions over time using time series 
analysis. I also argue for the advantage of utilizing the concept of abortion-related near-
miss, first as a proxy to mortality, to assess the quality of the health system and clinical 
care, and second to derive population representative indicators of very unsafe abortions 
for the purpose of evaluation (as has now been done by EVA-PMDUP). Lastly, I discuss 
the substantial need for additional studies to triangulate estimates from different 
approaches in the absence of a gold standard to estimate the incidence of all induced 
abortions. 
7.1.2 Summary of substantive estimates in results chapters 
My results show that Zambia has a high incidence of induced and, worryingly, unsafe 
abortions. A considerable number of admissions (~40,000) for abortion-related 
complications occurred in UTH, Lusaka compared with 233 terminations of pregnancy 
(TOP’s) between 2006 and 2015 This suggests that unsafe abortions outnumber safe 
abortions in Lusaka district and its environs. Following the introduction of standards and 
guidelines for comprehensive abortion care by the Ministry of Health and capacity 
strengthening of health facilities and providers in 2009 there was a significant decline in 
the monthly number of abortion-related complications at UTH. However, the availability 
of combination MA for private pharmacies to sell in early 2012 did not have a significant 
impact on the declining hospitalization trend after May 2009.  
Using both health facility and community-based methods of estimating abortion 
incidence in Central, Copperbelt and Lusaka Provinces, the incidence of induced abortion 
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is high (ranging from 30-80 per 1000 women depending on the method applied) 
compared to neighboring countries, and using the community-based estimate of 
abortion incidence and data from the near-miss study at least 1 in every 110 induced 
abortions becomes a near-miss case. Overall women with near-miss complications 
constituted 7% of all admissions for post abortion care (PAC), and there were 14 
abortion-related deaths within the 5-month study period. Very few cases of trauma due 
to invasive unsafe abortion techniques were reported in the near-miss study, with similar 
data from the confidant’s study suggesting that about 19% of women used invasive 
traditional methods to obtain their induced abortion compared with 38% who obtained 
abortion services from a health worker (25% of whom used tablets provided by the 
health provider) and 36% who ingested off counter medication and herbal or homemade 
concoctions. The results of the health professionals survey similarly suggest that at least 
a quarter of all women except the rural poor terminate their pregnancies using medical 
abortion and that 50% of all women except the urban non-poor induce abortions 
unsafely using other/traditional methods. 
The quality of PAC provided was frequently inadequate in at least one aspect, as only a 
third of women in the near-miss study were documented to have received contraceptive 
counselling. Two-thirds of those counselled accepted a method highlighting the 
importance of contraceptive counselling after clinical management of abortion-related 
complications.  
7.1.3 Internal consistency of substantive estimates and limitations of the study 
There is consistency in the results for Zambia obtained by the three studies (trend study, 
near-miss study and abortion incidence studies). The low number of invasive injuries 
observed amongst near-miss cases is consistent with results from the confidant’s study 
and the health professional’s survey within the abortion incidence hospital study 
estimating that at least a quarter of all women were likely to have terminated their 
pregnancy using medical abortion. Using the population level estimate of the incidence 
of abortion  from the confidant’s study and the incidence of abortion-related near-miss 
from the near-miss study, near-misses are thought to occur in 1% of induced abortions 
which is consistent with the rates observed for obstetric near-miss(98). The results of the 
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near-miss study and abortion incidence hospital study both show that the incidence of 
induced abortions and abortion-related near-miss complications is highest in the most 
urbanized Provinces. These indicators are greatest in Lusaka province followed by 
Copperbelt and then Central province. I am however not able to generate provincial level 
estimates for the confidant study to compare their levels. 
Nevertheless, there is a very wide range in the estimated incidences of abortion in 
Zambia using data from the near-miss, confidants and abortion incidence hospital studies 
(AICM). The final estimate of the incidence rate is much greater in the confidant’s study 
(80 per 1000 women years) compared with the AICM (48) and the near-miss study (30). 
95% confidence intervals (CI) were calculated for the abortion incidence hospital study 
(95% CI 27-68) and the confidant’s study estimate exceeds its upper 95% confidence 
interval (68 per 1000 women). The AICM incidence rate of 48 is the most conservative 
value possible using this approach because private health centers did not contribute any 
cases to the sample. Exploring an alternative scenario where private health centers have 
the same caseload as public health centers, the AICM rate becomes 68 per 1000 women 
(95% CI 47-89) which encompasses the confidant estimate of 80 per 1000 women. The 
data used to generate the multiplier in the AICM and confidant’s studies also gives very 
different results. Whilst the AICM suggests that 23% of women having an induced 
abortion get care for complications, the confidant’s study suggests that 37% of women 
do so estimating a smaller multiplier 1.6 times smaller than the AICM. Overall, the 
confidant method suggests the incidence of abortion is higher and that more women get 
health facility care for abortion-related complications compared with the AICM. 
However, it is likely that the confidant method point estimate is too high because if the 
caseload of induced abortion complications in health facilities is extrapolated using 
information from the confidant method it is three times the yearly caseload generated 
from the AICM (14,740). This seems implausibly large for the three provinces in one year.  
Specific limitations for each of the analyses conducted have been noted in the relevant 
chapters. Overall, the main limitation in this PhD is that although the conceptual 
definition of an unsafe abortion is widely understood, it is hard to operationalize the 
definition collect data on the process of induced abortions and measure it uniformly in 
different contexts. Going forward I recommend that the WHO build on the concepts it 
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has discussed in a recent publication on how the definition of unsafe abortion should be 
interpreted and work by other researchers(135,188). Their focus should be on laying out 
measurable components of a safety spectrum incorporating processes and outcomes 
based on data that can be collected in restrictive contexts. Thereafter this scale should 
be piloted in multiple countries to assess its feasibility and refined. 
7.2 Interpretation within the literature on abortion 
7.2.1 Trend study 
As noted in the background section, previous studies  of the impact of contextual events 
on abortion-related admissions have utilized a before and after approach (75,77,78) or 
simply described numbers hospitalized over time(65,69). A before and after approach 
does not account for the properties of longitudinal data. One 2013 study by Henderson 
et al in Nepal, utilized a segmented Poisson regression to examine the impact of changes 
in abortion legislation on admissions for abortion-related complications taking account 
of the secular trends in their analysis and discussion. This study has attempted to 
overcome the limitations of not accounting for the nature of time in longitudinal data as 
much as possible by using an interrupted time series analysis. 
The contextual event most frequently examined in studies looking at a specific 
intervention has been a change in abortion legislation within a country. Two studies from 
Latin America have considered the impact of misoprostol introduction on the trends 
observed. Miller et al’s 2005 study in the Dominican Republic suggests there is temporal 
association between the introduction of Misoprostol in 1986 and the decline in abortion-
related morbidity (65). Singh’s et al’s 2012 study on Brazil similarly suggests that 
increased and more effective use of misoprostol is likely to have contributed to the large 
decline in hospital admissions for abortion-related morbidity (69). The Nepal study 
highlights the significant effect of training midlevel providers on declining admission 
trends as part of its discussion although the event included in the segmented regression 
analysis was the implementation of the liberalized abortion law (74).  To the best of my 
knowledge, my PhD trend study seems to be the first explicitly examining the effect of 
other type of interventions such as the impact of clinical guidelines and training 
interventions on trends in admissions for abortion-related complications. It is relatively 
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easier to explore the impact of a legal change - as it is often clearly defined and likely to 
have substantial impact on the abortion context- than regulatory or policy changes, 
which may not have been implemented at a precise point, or executed uniformly in 
different parts of a country or at different levels of the health system. My result showing 
a reduction in the absolute number of admissions for abortion-related complications 
after clinical guidelines were instituted and capacity building for health provider and 
facilities on medical abortion occurred are similar to evidence from the Nepal study (74). 
In the Nepal study, the steepest decline in admission trends for severe abortion-related 
complications occurred in 2008, which was when the safe abortion program was 
expanded to include midlevel providers, second trimester training, and medication 
abortion.  
All the previous studies listed above were able to obtain data on the severity of cases 
admitted, whilst some have information on the socio-demographic and reproductive 
characteristics of women.  One major limitation of the trend study in my PhD is that there 
was no data available in the hospital registers on the severity of the complications 
admitted. Hence, I was unable to describe how contextual events in Zambia affect the 
severity caseload admitted at UTH compared with all abortion-related admissions. To 
address this limitation, I collected data on abortion-related deaths from the hospital 
information systems for the period examined (2006-2015), but the number of deaths 
recorded were very few with little variation over time. Hence, they did not provide 
additional insight into temporal changes in admission trends for severe complications. 
Abortion-related mortality is underreported in health facility data as many women will 
not die in a health facility, and cause of death may be unknown or misreported for 
women who die in health facilities.  
In my trend study, after medical abortion was introduced in pharmacies there was an 
immediate significant increase in the number of admissions for abortion-related 
complications. This is most likely because of greater PAC seeking behavior for normal side 
effects of MA, or non-severe complications accompanying TOPs commenced with 
medical abortion in a restrictive context. This is similar to, Coelho’s 1993 study in Brazil 
suggesting that the total number of admissions may increase following the availability of 
MA (161). Although we were unable to assess severity of complications, other studies 
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provide compelling evidence that increased and more effective use of misoprostol can 
contribute to reduction in severe complications of unsafe abortions. Singh et al’s study 
from Brazil showing a sizeable decline in admission for serious complications attributes a 
great deal of this change to the use of misoprostol for TOPs (69). Similarly, Miller et al’s 
2005 study in the Dominican Republic also shows a drop in proportion of serious 
complications after 1986 when misoprostol became available (65). Another study in Iran 
concludes that medical abortion improved abortion outcomes in women between 1994 
and 2002 (78). However, medical abortion in this study was intramuscular prostaglandins 
(Prostine). Similarly, the interventions precipitating the steep decline in admissions with 
serious complications in the Nepal study included the introduction of MA for safe 
abortion in the health system. The possibility of increased or unchanged admissions 
following the availability of MA however suggests that it may not lower the cost to the 
health system of treating PAC. It is necessary that MA availability be accompanied by 
training interventions to ensure all providers properly prescribe it and its use is 
monitored to avoid unnecessary admissions for PAC. 
7.2.2 Near-miss study 
Like in this PhD, haemorrhage and sepsis were the most common causes of abortion-
related morbidity and mortality in most studies and sepsis was the main cause of death 
except in a study in Uganda where fewer deaths were due to sepsis (116).  
Adler et al’s 2012 systematic review estimated the incidence of abortion-related near-
miss  at the population level to be 18 per 100,000 women (range 14-121)(10) , but  
included articles with  near-miss definition based on clinical diagnoses only as the WHO 
organ dysfunction criteria had not been widely used(10). All the more recent studies I 
identified which were able to describe the burden of abortion-related near-miss 
complication using the WHO near-miss criteria or adapting it have collected data on 
maternal near-misses and not specifically on abortion-related near-miss (83,113–117). 
Four of these were conducted in Sub-Saharan African countries (Ghana, Nigeria, 
Tanzania, Uganda and a WHO multi-country study), and all of them collected data 
prospectively. Like the near-miss study in my PhD, the Tanzania study adapted the WHO 
criteria to the local context. Comparably, they mainly used the clinical criteria within the 
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WHO near-miss approach. They reduced the threshold for massive blood transfusion to 
one or more units of blood and included sepsis or severe systemic infection. No study 
identified has attempted to generate population representative estimates of the 
incidence of near-miss abortion complications as done for this PhD (106,114).  
The intra-hospital abortion mortality index in our study (3%) was lower than in Tanzania 
(7%) (114), the WHO multi-country study (8.3%)(115), Brazil (16%)(83) and Ghana (44%) 
(117). Comparing data from the original prospective and retrospective validation studies 
of my PhD for March 2013, the two deaths identified in the validation study were missed 
in the original study whilst the death identified in the original study was missed in the 
validation study. This suggests that the mortality index I estimated is too low. It may also 
be that the modified criteria in my PhD classified more complications as near-miss cases 
than if we had used the WHO criteria increasing the denominator and affecting the 
mortality index. It may be possible that the studies in other countries missed out a 
substantial number of abortion-related near-misses reducing the denominator used to 
calculate the index and inflating the mortality indexes.  
Obstetric near-miss is a marker of quality of care, as delays can lead to worse outcomes 
for women with complications. Ghana’s very high mortality index was attributed to the 
poor quality of care women receive in health facilities. However, it is unlikely that the 
higher mortality index in Brazil compared with Zambia, Nigeria and Tanzania means that 
quality of care is better in those contexts. Brazil has good health information systems 
compared with many Sub-Saharan African countries, and a health system capable of 
conducting the investigations needed to apply the stringent WHO criteria and providing 
high-quality care for complications. Perhaps if data quality was better in African hospitals 
and fewer cases were missing, their mortality indices would be as high as or higher than 
the estimate from Brazil. It was however surprising that in the Brazil study, the majority 
of the abortions included as life threatening conditions and severe maternal outcomes 
were procedures conducted out at the study hospital where data was collected. Evidence 
suggests that few TOPs induced by qualified providers within the right environment 
should become near-misses.  
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7.2.3 Abortion incidence hospital study and confidants study 
Majority of the studies estimating the incidence of induced abortion in restrictive 
contexts and in Sub-Saharan Africa have applied the AICM method (30–
33,35,37,176,189), and a two have combined data from the PMM (which collects data 
from hospital records)  with the AICM’s HFS (which interviews hospital staff and asks 
them to estimate the abortion caseload in their health facility)  to generate estimates of 
incidence (31,32). Like in my PhD, hospital admission caseload generated using the PMM 
was averagely lower than estimates from the AICM HFS in the Malawi study (32) (24% 
and 12% respectively). The Ethiopia study does not present the results from both 
methods.  
The confidant method has been applied in Burkina Faso (30,119) and India where it was 
compared to women’s self-reports of their abortion in a survey (122). To the best of my 
knowledge, there has been only one study in Burkina Faso comparing the confidant 
method and AICM in the same context, and no study comparing it with any other method 
of estimating abortion incidence in Africa. Some major components of the confidant 
study, which will ultimately affect the estimates generated, are defining: who a confidant 
is, and how the question used to generate a network of confidants is asked.  
In the first study in Burkina Faso, a confidant was defined as “a person who shared or 
could have shared intimate information with the respondent over the past year” (119). In 
the second Burkina Faso study, confidants were “…all the women and girls who confide 
in you, who trust you, who share their secrets and problems with you in order to get your 
advice. We are interested in all women who confided in you during the preceding year, 
and who are aged between 15 and 49 years” (30). In the India study, the question asked 
to elicit confidants was “It is very common for people to discuss important matters and 
share secrets with friends or family members that they are close to. I want to know a few 
things about the people you share the most with. I do not need to know their names, only 
their initials. Please tell me the initials of up to five women aged 15-44 who are either 
currently married or have been married before and with whom you discuss important 
matters” (122). Applying the confidant method properly is dependent on ensuring we 
collect information on the women who confide in the respondent interviewed, not the 
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women who they confide in. Hence there is need to clearly distinguish between these 
two categories of women in the network generating question. The question asked in India 
unlike in Burkina Faso asked women to list the people they shared with the most, not 
specifically those who shared with them. The network-generating question in my PhD 
was modelled on the Burkina Faso questions and inquired about people who confided in 
the respondent. Another important consideration is how to covey the concept of 
confidence accurately to the respondents without introducing biases in the answer 
provided e.g. by asking specifically women who would confide in them about abortions. 
This is important as limiting confidence to as a very specific issue such as abortion may 
stop respondents from providing a representative list of women who could confide such 
secrets in them and encourage them focus on those they know have had an abortion. 
This would affect the denominator and inflate the overall estimate. Hence applying the 
confidant method to estimate abortion incidence requires qualitative information on the 
study context to develop the most appropriate network generating questions and 
provide the most representative sample of women in the community.  
Additionally, unlike the studies in Burkina Faso and in my PhD where we asked 
respondents to list all possible confidants who would tell them reproductive health 
secrets, the confidants tool in India was limited to married women and asked 
respondents to list a maximum of 5 confidants. This was based on research showing that 
network generator of five explained most of the variance in the total network (190). The 
mean number of confidants reported in all studies applying this method have not 
exceeded five confidants. The average number of confidants reported in my PhD (2.4) 
was similar to the 2.7 confidants per respondent reported in the 2001 Burkina Faso study 
but higher than the 1.9 reported in the 2008 study in Burkina Faso and the 1.3 reported 
in India. Although results from India reported that self-report produced higher estimate 
than the  confidant method, my PhD and the studies in Burkina Faso (30,119) suggest 
that the  confidant method is a viable method to apply to collect data on the incidence 
in abortion in Sub-Saharan Africa compared with India (122). This is most likely because 
women still rely on their networks to obtain information on terminating pregnancies and 
are willing and able to report on pregnancy termination in their networks.  
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Unlike the study comparing the confidant method and AICM in Burkina Faso, the 
estimated incidence of abortion with the confidant method is about 2 times higher than 
the AICM estimate in Zambia, and the multipliers estimated in Zambia are dissimilar 
whilst those in the Burkina Faso study are comparable. In addition to the possible reasons 
for these differences discussed in chapter 6, and the limitations of each methodology, 
(namely our network generating question for the  confidant method may have been 
restrictive inflating our estimates, respondents were unable to provide additional 
information on 50% of abortions reported and the health professionals survey 
component of the abortion incidence hospital method is a relatively subjective method 
of estimating the multiplier) it is likely that the availability and use of medical abortion in 
Zambia has an impact on the magnitude of estimates from both methods and the 
differences observed. The 95% confidence intervals around the conservative AICM 
estimates suggest that even if the confidant method has overestimated the incidence of 
induced abortion, it is much higher in Zambia than other countries in the region.  
7.3 Implications for understanding and measuring abortion safety  
A 2010 publication on providing an overview of existing methods to measure induced 
and unsafe abortion highlights how methods focused on measuring abortion-related 
morbidity are less developed those measuring abortion incidence (42). My PhD has 
focused on improving the use of health facility data on morbidity to estimate the burden 
of unsafe abortions and conducted a triangulation study of different approaches to 
estimating abortion incidence taking the use of medical abortion into consideration.  
Measuring the incidence of induced abortion may appear important to understand the 
need for safe abortion care and family planning in a context. However, it is resource 
intensive, imperfect and difficult to do at regular intervals, and may not be the most 
practical indicator to evaluate the impact of programs and policy changes. Examining 
trends in admissions for abortion-related complications from large hospitals with large 
service areas as done in this PhD and Nepal (74) is easier to implement, can provide 
estimates of the burden of complications from abortion over time and can be used to 
assess the impact of contextual changes. Although I was not able to obtain this 
information in my PhD, this kind of data may be used to compare trends in admissions 
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for severe to non-severe complications, understand what procedures are used for TOPs 
and PAC over time, and estimate the cost of abortion-related admissions to the health 
system over time.  
On the other hand, when the purpose of measurement is to measure the most unsafe 
abortions and evaluate changes in their incidence, the abortion-related near-miss rate or 
ratio is a useful and population-representative indicator to use and should be utilized in 
conjunction with abortion-related mortality estimates. This PhD suggests that it is 
feasible to collect data on abortion near-miss from routine hospital records and 
incorporate near-miss into the commonly used morbidity severity criteria. However, the 
strict WHO criteria need to be adapted to reflect the health system capability of the 
contexts that typically have a high burden of unsafe abortion.  
Validating and interpreting the estimates from two approaches to measuring the 
incidence of induced abortion is challenging in the absence of a gold standard method. 
However, my PhD study has helped highlight some additional limitations of the 
frequently applied AICM, namely that the health facility survey may overestimate patient 
caseload and this may differ by type of health facility. It also corroborates evidence from 
Burkina Faso that the confidant method is a viable approach for estimating abortion 
incidence in Sub-Saharan Africa and emphasizes the need for preparatory qualitative 
research to develop an appropriate network-generating question for the study context. 
In addition to estimates of the incidence of abortion, these methods can be strengthened 
to provide important contextual data necessary to understand abortion safety by 
expanding the questions asked to women. Future confidant studies should attempt to 
collect information on how medical abortion is accessed and used by different categories 
of women, care seeking after medical, surgical abortions, and other abortion procedures 
as well as more detailed sociodemographic characteristics of women using various 
methods to induce abortions.  
At the global level, estimating the incidence of unsafe abortion along a spectrum of safety 
as suggested by Sedgh et al (135) is likely to rely on a model-based approach. Recent 
estimates of the incidence of induced abortion in 2016 have utilized a Bayesian model 
informed by a conceptual framework where women are divided into subgroups based on 
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marital status and contraceptive need (191).  It is likely that this approach can be 
extended to estimate global and regional levels of unsafe abortions. Theoretically, 
abortion safety incorporates both the process and outcome. Although it is possible to get 
some outcome data on abortion-related morbidity and mortality from many restrictive 
contexts, data on the process of induced abortions is not readily available. To include 
process data into how safety is modelled, it may be useful to incorporate data on medical 
abortion sales and availability (such as from the AICM and confidant method), 
predominant methods used to provide PAC and safe abortion (such as from the near-
miss study) as well as legal sanctions for women or providers. This information can be 
used to create subgroups of safety based on the abortion process in different contexts.  
Outcomes can be compared for women using different processes in different countries, 
to examine variation and inform the final model.  
7.3.1 Medical abortion is changing how we can measure the burden of unsafe 
abortions 
Increased diffusion of medical abortion has transformed the circumstances under which 
women terminate their pregnancies in all contexts regardless of the legal status of 
abortion. Even when obtained clandestinely and used sub optimally, the associated side 
effects and complications are much less severe than invasive abortions (traditional and 
surgical). Hence, studies in Latin America where utilization is high have documented 
changing patterns in the severity of abortion-related complications in hospitals. There 
are no population level estimates of the proportion of women using MA in restrictive 
contexts, but evidence from our community based study and interviewing experts 
suggest that about 25% of women use MA to terminate their pregnancies in three 
provinces in Zambia. Hence, although the near-miss study reported a high incidence of 
near miss, there were few invasive injuries reported. This is a substantial proportion of 
women which is important to consider when describing how safe abortions are in 
Zambia. Collecting data on the method used to induce abortions including MA is 
challenging and very few women in the near miss study reported inducing their abortion 
(5%), whilst information on method of induction was missing for 50% of abortions 
reported in the confidant study. Data from the trend study suggests that after the 
availability of MA in pharmacies there was a jump in admissions for abortion-related 
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complications, which are more likely to be non-severe complications or normal side 
effects of MA use. Going forward this means that interpreting morbidity data from health 
facilities will be more challenging in an era of greater MA use in persistently restrictive 
contexts. There appears to be some consistency between estimates from the expert’s 
survey and the community based survey, however, due to how easy it is to hide MA use, 
expert guesses are more likely to be inaccurate to understand MA use compared with 
invasive abortions which have more severe physical outcomes. To understand the 
burden of unsafe abortions in the future, there is a need for consensus on a clear and 
concise definition of unsafe medical abortions to fit within the proposed safety spectrum 
used to model estimates. There is also a critical need for data to inform national and 
global estimates on the methods women are using to terminate their pregnancies. The 
most viable approach to collecting this data will most likely be community-based studies 
of women including both surveys and in-depth interviews to understand the changing 
context and how women choose what method to use 
7.4 Implications for provision of abortion care in Zambia 
Although the Zambian abortion law is relatively liberal, and the government has endorsed 
policy changes and clinical interventions to improve provision of contraceptive 
commodities and comprehensive abortion care, administrative restrictions to 
implementation of the law and policies and sociocultural stigma contribute to the high 
burden of induced and unsafe abortions. These unsafe abortions are a reflection the 
unfulfilled reproductive intentions of Zambian women and constitute a substantial cost 
to the government and economy (8,150).  
My research suggests improving quality of clinical care through the introduction of 
clinical guidelines and capacity building of health workers contributed to a steep 
reduction in abortion-related hospitalizations. With the increased use of medical 
abortion legally and clandestinely, it is important that interventions to improve abortion 
care using medical abortion are instituted across the country particularly amongst 
providers outside of health facilities such as pharmacies and drug sellers. Additionally, 
the Zambian Ministry of Health should undertake regular audits of abortion-related near-
miss cases and deaths to evaluate the standards of abortion care provided and 
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adherence to national clinical guidelines. Near-miss audits can look through patient 
records, interview clinical staff and interview women to provide valuable information on 
clinical deficiencies in patterns of care, the delays women face in accessing care before 
arriving at a health facility and their experiences thereafter (192–194). Such information 
can be used to generate action plans for the health system and at the community level 
to manage deficiencies in the care pathway. In addition to the WHO near-miss criteria 
which I have adapted for the Zambian context, there is an accompanying WHO audit tool 
(171) which has been applied in over 30 countries (195) and can be used in Zambia for 
abortion-related near-miss audits. 
It is also essential that provision of high quality post abortion counselling for all women 
receiving CAC be instituted in all health facilities. To achieve this without creating 
additional workload for staff in a health system with a high patient to staff ratio mobile 
phone based interventions may be added to the existing PAC services to enhance 
availability of information and counselling support for women. This approach has been 
evaluated in a randomized trial in Cambodia and had increased short-term use of 
effective contraception and long term use of long-acting contraceptive methods (196).    
Furthermore, it is necessary to increase public awareness about the abortion law and 
access to free safe abortion care in public health facilities (21,150) to increase demand 
for safe services instead of unsafe providers (140) particularly amongst vulnerable groups 
of women. Accurate information on the current legal status of abortion for providers and 
women is particularly important with ongoing debates about the including the “right to 
life clause” in the Zambian constitution which may restrict the liberal abortion law.  
7.5 Recommendations for research and policy 
A number of recommendations for future research and policy on how outcome data from 
health facilities is used to measure the burden of unsafe abortion has been generated 
from the analyses done in my PhD. I summarize them in this section. 
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7.5.1 Refine the assumptions used to adjust health facility outcome data in 
methods like the AICM    
There are two important research questions based on how health facility data is usually 
adjusted to estimate population-level abortion estimates:  how to exclude spontaneous 
abortions from abortion-related hospitalizations and how to estimate a multiplier that 
accounts for all women who had unsafe abortions missed within hospital data.  
The AICM attempts to exclude spontaneous abortions by combining a biological estimate 
of spontaneous abortions from clinical studies with assumptions about care-seeking 
behaviour for early and late miscarriages. However, a 2-year cohort concluded in 2013 in 
Kenya suggest that the proportion of spontaneous abortions they apply to health facility 
data (3.41%) may be low in African settings. This will result in overestimation of the 
number of induced abortions admitted. Using available data, the biological proportion of 
spontaneous abortions should be updated. It would also be useful to conduct additional 
cohort studies in low- and middle-income countries to estimate the week-by-week 
patterns of pregnancy loss.  
There is little research showing how women actually seek care for early and late 
miscarriages. Whilst this behaviour might differ by sociodemographic characteristics, it 
would be valuable to conduct both qualitative and quantitative studies to understand 
when women become aware of their pregnancies in different low- and middle-income 
contexts and their care seeking behaviour for morbidity in early pregnancy and 
pregnancy loss. Empirical estimates of the proportion of women with miscarriage who 
seek care would improve the accuracy of the adjustment of health facility data 
The multiplier used to inflate health facility abortion cases to obtain a population-level 
estimate is a key component of the accuracy of abortion estimates. The approach used 
to calculate the multiplier within the AICM is to interview professionals/experts and ask 
them in what proportion of abortion cases do women seek care. However, our study 
triangulating different methods shows multipliers estimated from the perspective of 
experts may differ considerably from that estimated from women in the confidant 
method, asking them what proportion of their friends sought care after an abortion. I 
recommend that data informing the multiplier is collected from a wider range of people 
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who partake in and are knowledgeable about the abortion process and context, including 
a range of women in the community, notably adolescents and single women, as well as 
health providers. The multipliers generated by different categories of participants (e.g. 
women versus health providers) should be compared to allow researchers to understand 
their different perspectives. 
The growing use of medical abortion in restrictive contexts affects the likelihood of 
women having abortion-related complications requiring care and how they seek care for 
them. Both factors have an impact on the final multiplier generated. It is necessary to 
conduct studies recruiting women who have obtained medical abortion from various 
sources to understand the subsequent outcomes of the pregnancy. Whilst this is 
challenging in restrictive contexts, small hospital studies recruiting women admitted for 
complications who provide information on using MA and those who obtain MA within 
the hospital would provide valuable information.  
There has been no way of validating the AICM multiplier as there is no gold standard 
source of data on induced abortion in most restrictive contexts. However, indirect 
community-based approaches such as the confidant method (ATPR) can provide valuable 
data on the process and outcomes of induced abortions amongst a population-
representative sample of women. This information can in turn be used to generate a 
multiplier that can be compared with the AICM multiplier using from a purposive sample 
of all respondents and from a sub-group of women.  
7.5.2 Explore approaches to improve reporting in community-surveys of women to 
generate data on provision and care-seeking for induced abortions  
Surveys with women can provide valuable information of how women obtain their 
induced abortions. These surveys are becoming more crucial now that women are 
obtaining abortion at home, sometimes in substandard circumstances and in countries 
where health facility data is substandard. In the near future community-based surveys 
are more likely to provide relevant data than standalone health facility studies because 
of the shift towards medical abortion. However, underreporting in surveys is common 
due to the sensitive nature of the topic. Typically, surveys have attempted to estimate 
the incidence of induced abortions. Direct survey approaches have tested different 
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means to reduce underreporting, but none stands out as a viable solution to the problem 
particularly in restrictive contexts.  
The ATPR method used in this PhD is an indirect method that asks women about their 
network. In Burkina Faso and Zambia, it has been successfully conducted because the 
underlying assumption that women find it easier to speak about abortions in their 
networks than their own has been true. Since respondents provide information on other 
people’s abortions, they are likely to also be more willing to provide information on the 
process and outcome of the abortion. Thus, the data collected from confidant methods 
can be used to generate the prevalence of unsafe abortion as well as induced abortion. 
Refining this method is important, because it can generate information that can be 
compared with health facility outcome data to understand how consistent its estimates 
are, and why. Since the success of this method is greatly dependent on the validity of the 
network-generating question, rigorous qualitative studies to understand how women 
understand the concept of confidants and how they confide in other women about sexual 
and reproductive health secrets should be conducted in different settings.  
Other important topics for future research include comparing self-report by women with 
how they report on confidants using the ATPR in Sub-Saharan Africa to compare 
estimates and calculate an underreporting factor. To advance the measurement of 
unsafe abortion, it is critical that future research attempt to triangulate estimates from 
different community-based approaches. Such research can be used to test refinements 
to existent approaches, explore in-depth the biases of each approach, improve individual 
approaches and develop novel methods for capturing information on induced and unsafe 
abortions in restrictive contexts. Examples of such studies include comparing indirect 
methods such as the ATPR with direct methods focused on improving reporting. Methods 
which may be appropriate for low- and middle-income contexts include the list 
experiment which has been applied in Liberia (128) and the Randomized Response 
Technique (RRT) which has been applied in Botswana (42) and do not necessarily require 
respondents to be literate like other popular methods such as audio computer-assisted 
self-interviews (ACASI) (126).   
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7.5.3 Refine the criteria used to describe abortion-related morbidity and the WHO 
near-miss criteria to increase applicability in low income contexts 
The research presented in this thesis suggests that it is feasible to collect data on abortion 
near-miss from routine hospital records and incorporate near-miss into the commonly 
used morbidity severity criteria. However, the strict WHO criteria need to be adapted to 
reflect the health system capability of the contexts that typically have a high burden of 
unsafe abortion.  
The PMM criteria used to classify abortion-related morbidity can help improve estimates 
of unsafe abortion if they are incorporated into how safety is classified along a spectrum. 
I propose that instead of replacing the severe category in the PMM with a near-miss 
category as I have done in this PhD, both categories are included, since there were many 
cases that were not near-miss but were more severe than the moderate category criteria. 
The criteria for women in the moderate, and severe groups could be aligned with the 
criteria for non-life threatening complications, potentially life threatening complications, 
as applied in a 2014 study of maternal morbidity in Ghana (197) as these are part of the 
spectrum of abortion safety within the WHO near-miss approach. It would also be helpful 
to include a “no complications” group will help account for abortion-related admissions 
due to expected side-effects of medical or surgical abortions processes that do not 
actually require clinical intervention to resolve. It is important that clear criteria are 
specified for each level and that multiple strategies for rigorously dealing with how to 
classify women with incomplete data within clinical records are developed and tested.   
It is also important to understand the patterns and extent of abortion-related morbidity 
in a context of increasing medical abortion use outside of health facilities. I recommend 
that studies examining the extent of blood loss, and the need for subsequent clinical 
intervention in women obtaining medical abortion from various sources (particularly 
outside public health facilities e.g. private facilities, drug sellers) in restrictive countries 
in Sub-Saharan Africa are conducted. For ethical and legal reasons such research would 
be most feasible in countries where the law is fairly liberal but the social context is 
restrictive such as Zambia. Most studies describing blood loss after medical abortion with 
mifepristone and misoprostol are clinical trials, majority have been conducted in high-
income countries (198–200), and majority have included women with gestational age of 
 153 
up to 63 days (9 weeks). These trials have found that bleeding may occur from 1-69 days 
(198,201–204). However even with long durations of bleeding, clinically significant 
changes in haemoglobin levels (a drop exceeding 2g/dl) have rarely been reported and 
the risk may be lower among women with gestational age less than 49 days’ than among 
those with gestational age greater than 49 days (57,200). In a number of trials 0.1-0.9% 
of women undergoing mifepristone misoprostol medical abortion subsequently required 
transfusions(202,205), whilst 0.4-2.6% required a curettage (202,206). One trial 
comparing the side effects of misoprostol abortion with surgical abortion in China, Cuba 
and India shows that although women undergoing medical abortion report heavier 
bleeding, indicators of clinically significant blood loss were similar between both groups. 
In reality however, it is likely that some women obtaining MA in restrictive contexts will 
have pregnancies with gestational age greater than 9 weeks, may not use the 
combination pill which is more effective, may use the drug obtained for MA unsupervised 
or may not be prescribed an appropriate dose or adhere to the dosage used in these 
trials. These factors may increase the risk of bleeding and be accompanied with greater 
anaemia requiring intervention. There is also need for expert consensus on appropriate 
cut-offs for abortion-related near-miss anaemia within the morbidity classification.  
7.6 Conclusion 
The studies in this thesis have contributed knowledge on how to improve the 
measurement of the burden of unsafe abortion in restrictive contexts taking note of the 
growing use of medical abortion. The availability of health facility data in many 
restrictive abortion contexts provides an opportunity to refine how data is analysed to 
assess the impact of contextual policy and regulatory changes, monitor and evaluate 
the incidence of the most unsafe abortions and measure the incidence of induced 
abortion. However, it is necessary to refine community-based data collection 
approaches to capture the changing context of abortion. Zambia has a high burden of 
unsafe abortion and needs to improve access to safe comprehensive abortion care 
services to improve the reproductive health of its women. To advance the reproductive 
health and rights of women and reduce the burden of preventable maternal mortality, 
it is necessary to make the research investment in improving the methods and 
indicators used to measure the burden of unsafe abortions.  
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APPENDIX 2: Consent forms for women of reproductive age 
participating in the community survey 
Adult Information Sheet for Sub-Study 2 (Community-Based Survey) 
(English version, was translated into Bemba and Nyanja) 
Good (morning/afternoon). My name is ____________________________ and I am working 
with Population Council, an international organization that works to improve public health. You 
are invited to take part in a research study being led by the Population Council in collaboration 
with the London School of Hygiene and Tropical Medicine. Before you decide whether to 
participate, you need to understand, why the research is being done and what it would involve. 
Please take the time to read or to listen as I read the following information.  Please ask me if 
there is anything that is not clear, or if you would like more information. When all of your 
questions have been answered and you feel that you understand this study, you will be asked if 
you wish to participate in the study, and if yes to sign this Informed Consent form. You will be 
given a signed copy to keep. 
Purpose of the Study and Study Requirements 
What is the study?  The purpose of the study is to gather information that will help to 
improve healthcare for women in Zambia, especially as relates to pregnancies. We would 
like to understand how the health services available in your community impact your 
health and well-being. This study will take place in Central, Copperbelt, and Lusaka 
provinces.  
Why have I been invited to take part? You have been invited to take part because your 
household was selected by chance to participate in the study and you are a woman 
between the ages of 15-44 years living in Central, Copperbelt, or Lusaka province.  
What will happen if I take part?  If you agree to take part in the study, we will ask you to 
sign this form. You will also be asked to answer questions about your background and 
your health. For example, you will be asked about your age, education, and your 
experiences with pregnancy and giving birth. 
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How long will the interview last? The interview will take 45 minutes to complete. We will 
be doing another survey in 2016 and you may be contacted again if your household is 
selected by chance to participate in the follow-up study.  
Benefits & Risks 
What are the benefits and risks of the study? There are no direct benefits or risks to you 
for participating in this study. You may be embarrassed by a few of the questions. 
However, the information that you provide will be used by health program managers to 
improve health services for women in Zambia. 
Confidentiality 
Will my participation in the study be kept confidential? The information that is collected 
during the interview will be kept private.  No one will be told that you have participated 
in the study. Every member of the study team, including the research assistant who has 
come to visit you today, has been trained to protect your privacy and maintain the 
confidentiality of all of the information that you provide. The only place your name will 
be written down is on this informed consent sheet. Data will be stored in a secure 
location that only the study team can access. 
Voluntariness 
What are my rights as a research participant? Your participation in this study is completely 
voluntary. If any questions make you uncomfortable or you don’t want to answer them, you do 
not have to respond. You can decline to participate and are free to stop your participation at any 
time without any consequences for you.  
Additional Information 
What will I receive for participating?  Your opinions and experiences are very important 
to us. You will receive KR 30 as a token of appreciation for your valuable contributions 
and time spent participating in this study. 
Who has reviewed the study for ethical issues? This study has been reviewed by the 
University of Zambia, Population Council, and London School of Hygiene and Tropical 
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Medicine Research Ethics Committees. These are the groups that make sure people 
participating in research studies are treated fairly and properly. 
What if I need more information?  If you have a concern about any aspect of the study, 
you should contact the Principle Investigator: 
Scott Geibel 
Population Council 
Plot 3670, No. 4 Mwaleshi Road 
P/Bag RW 319X 
Lusaka, Zambia 
Telephone: +260 211 295925 
 
What if there is a problem? Any complaint about the way you have been treated during 
the study or any possible harm you might suffer will be addressed. Please contact the 
University of Zambia Research Ethics Committee: 
University of Zambia Biomedical Research Ethics Committee  
Ridgeway Campus 
P.O. Box 50110  
Lusaka, Zambia 
Telephone: +260 211 256067 
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Parental Permission for Sub-Study 2 (Community-Based Survey) 
(English version, was translated into Bemba and Nyanja) 
Good (morning/afternoon). My name is ____________________________ and I am working 
with Population Council, an international organization that works to improve public health. Your 
child is invited to take part in a research study being led by the Population Council in collaboration 
with the London School of Hygiene and Tropical Medicine. Before you decide whether to allow 
your child to participate, you need to understand why the research is being done and what it 
would involve. Please take the time to read or to listen as I read the following information.  Please 
ask me if there is anything that is not clear, or if you would like more information. When all of 
your questions have been answered and you feel that you understand this study, you will be 
asked if you would like your child to participate in the study, and if yes to sign this Informed 
Consent form. You will be given a signed copy to keep.  
Your child will also be asked whether she wants to participate in this study.  
Purpose of the Study and Study Requirements 
What is the study?  The purpose of the study is to gather information that will help to 
improve healthcare for women in Zambia, especially as relates to pregnancies. We would 
like to understand how the health services available in your community impact your 
health and well-being. This study will take place in Central, Copperbelt, and Lusaka 
provinces.  
Why has my child been invited to take part? Your child has been invited to take part 
because your household was selected by chance to participate in the study and your child 
is a woman between the ages of 15-44 years living in Central, Copperbelt, or Lusaka 
province. 
What will happen if my child takes part?  If you agree to let your child take part in the 
study, we will ask you to sign this form. Your child will be asked to answer questions about 
her background and her health. For example, she will be asked about her age, education, 
and your experiences with pregnancy and giving birth. 
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How long will interview last? The interview will take 45 minutes to complete. We will be 
doing another survey in 2016 and you may be contacted again if your household is 
selected by chance to participate in the follow-up study.  
Benefits & Risks 
What are the benefits and risks of the study? There are no direct benefits or risks to you 
or your child for participating in this study. Your child may be embarrassed by a few of 
the questions. However, the information that she provides will be used by health 
program managers to improve health services for women in Zambia. 
Confidentiality 
Will my child’s participation in the study be kept confidential? The information that is 
collected during the interview will be kept private.  No one will be told that your child has 
participated in the study. Every member of the study team, including the research 
assistant who has come to visit you today, has been trained to protect your child’s privacy 
and maintain the confidentiality of all the information that she provides.  The only place 
her name will be written down is on the informed consent sheet. Data will be stored in a 
secure location that only the study team can access. 
Voluntariness 
What are my child’s rights as a research participant? Your child’s participation in this study is 
completely voluntary. If any questions make her uncomfortable or she doesn’t want to answer 
them, she does not have to respond. You can decline to allow your child to participate and are 
free to stop her participation at any time without any consequences for you or your child.  
Additional Information 
What will my child receive for participating?  Your child’s opinions and experiences are 
very important to us. Your child will receive KR 30 as a token of appreciation for her 
valuable contributions and time spent participating in this study. 
Who has reviewed the study for ethical issues? This study has been reviewed by the 
University of Zambia, Population Council, and London School of Hygiene and Tropical 
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Medicine Research Ethics Committees. These are the groups that make sure people 
participating in research studies are treated fairly and properly. 
What if I need more information?  If you have a concern about any aspect of the study, 
you should contact the Principle Investigator: 
Scott Geibel 
Population Council 
Plot 3670, No. 4 Mwaleshi Road 
P/Bag RW 319X 
Lusaka, Zambia 
Telephone: +260 211 295925 
 
What if there is a problem? Any complaint about the way you have been treated during 
the study or any possible harm you might suffer will be addressed. Please contact the 
University of Zambia Research Ethics Committee: 
 
University of Zambia Biomedical Research Ethics Committee  
Ridgeway Campus 
P.O. Box 50110  
Lusaka, Zambia 
Telephone: +260 211 256067 
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Adolescent Assent for Sub-Study 2 (Community-Based Survey) 
(English version, was translated into Bemba and Nyanja) 
Good (morning/afternoon). My name is ____________________________ and I am working 
with Population Council, an international organization that works to improve public health. You 
are invited to take part in a research study being led by the Population Council in collaboration 
with the London School of Hygiene and Tropical Medicine. Before you decide whether to 
participate, you need to understand why the research is being done and what it would involve. 
Please take the time to read or to listen as I read the following information.  Please ask me if 
there is anything that is not clear, or if you would like more information. When all of your 
questions have been answered and you feel that you understand this study, you will be asked if 
you wish to participate in the study, and if yes to sign this Informed Consent form. You will be 
given a signed copy to keep. 
Your parent or guardian has already given permission. However, you do not have to say 
yes. We have talked to your parent or guardian and he/she agrees that you do not have 
to say yes.  
Purpose of the Study and Study Requirements 
What is the study?  The purpose of the study is to gather information that will help to 
improve healthcare for women in Zambia, especially as relates to pregnancies. We would 
like to understand how the health services available in your community impact your 
health and well-being. This study will take place in Central, Copperbelt, and Lusaka 
provinces.  
Why have I been invited to take part? You have been invited to take part because your 
household was selected by chance to participate in the study and you are a woman 
between the ages of 15-44 years living in Central, Copperbelt, or Lusaka province.  
What will happen if I take part?  If you agree to take part in the study, we will ask you to 
sign this form. You will also be asked to answer questions about your background and 
your health. For example, you will be asked about your age, education, and your 
experiences with pregnancy and giving birth. 
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How long will the interview last? The interview will take 45 minutes to complete. We will 
be conducting another survey in 2016 and you may be contacted again if your household 
is selected by chance to participate in the follow-up study.  
Benefits & Risks 
What are the benefits and risks of the study? There are no direct benefits or risks to you 
for participating in this study. You may be embarrassed by a few of the questions. 
However, the information that you provide will be used by health program managers to 
improve health services for women in Zambia. 
Confidentiality 
Will my participation in the study be kept confidential? The information that is collected 
during the interview will be kept private.  No one will be told that you have participated 
in the study. Every member of the study team, including the research assistant who has 
come to visit you today, has been trained to protect your privacy and maintain the 
confidentiality of all of the information that you provide. The only place your name will 
be written down is on this informed consent sheet.  Data will be stored in a secure 
location that only the study team can access. 
Voluntariness 
What are my rights as a research participant? Your participation in this study is completely 
voluntary. If any questions make you uncomfortable or you don’t want to answer them, you do 
not have to respond. You can decline to participate and are free to stop your participation at any 
time without any consequences for you. 
Additional Information 
What will I receive for participating?  Your opinions and experiences are very important 
to us. You will receive KR 30 as a token of appreciation for your valuable contributions 
and time spent participating in this study. 
Who has reviewed the study for ethical issues? This study has been reviewed by the 
University of Zambia, Population Council, and London School of Hygiene and Tropical 
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Medicine Research Ethics Committees. These are the groups that make sure people 
participating in research studies are treated fairly and properly. 
What if I need more information?  If you have a concern about any aspect of the study, 
you should contact the Principle Investigator: 
Scott Geibel 
Population Council 
Plot 3670, No. 4 Mwaleshi Road 
P/Bag RW 319X 
Lusaka, Zambia 
Telephone: +260 211 295925 
 
What if there is a problem? Any complaint about the way you have been treated during 
the study or any possible harm you might suffer will be addressed. Please the University 
of Zambia Research Ethics Committee: 
 
University of Zambia Biomedical Research Ethics Committee  
Ridgeway Campus 
P.O. Box 50110  
Lusaka, Zambia 
Telephone: +260 211 256067
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Appendix 3: Data collected from hospital registers for trend study 
S/N Date of 
extraction 
Patient’s hospital 
number 
Sex  Age Religion Date of 
admission 
Diagnosis Ward Disease 
code 
Date of discharge Death 
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APPENDIX 4: Correlogram and partial correlogram graphs for data on the abortion-related complications  
Correlogram of admissions for abortion related complications.  
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Partial correlogram of admissions for abortion related complications  
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APPENDIX 5: Results of interrupted time series describing trends in 
death rate for chapter 4 
Interrupted time series analysis on UTH deaths per 1000 abortion-related complications 
between two important contextual changes affecting access to abortion care  
Admissions for abortion-related complications in UTH Coefficient 95% CI p-value 
Constant 1.37 0.79,1.95 <0.001 
Pre-intervention slope 
(Secular trend per month) 
-0.01 -0.03,0.05 0.629 
Change in level after Ministry of Health guidelines 
(Immediate effect) 
0.31 -0.54, 1.15 0.471 
Change in slope after Ministry of Health guidelines 
(Gradual effect per month) 
-0.03 -0.09, 0.01 0.108 
Change in level after availability of mifepristone for pharmacies  
(Immediate effect) 
0.53 -0.23, 1.31 0.172 
Change in slope after availability of mifepristone for pharmacies  
 (Gradual effect per month) 
0.03 -0.01, 0.06 0.148 
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APPENDIX 6: Data extraction algorithm for near miss study 
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APPENDIX 7: Near-miss study tool 
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 APPENDIX 8: Data collection tools for Abortion Incidence 
Complications Method (AICM) 
A. Health professionals survey questionnaire 
 
Investigation about Abortion and Post abortion Care 
“Survey of Health Professionals in Zambia--2014” 
Respondent Identification number:___________ Region:___________ 
                       
My name is ___________________ and I am working with the London School of Hygiene and 
Tropical Medicine in conjunction with the Population council, and the Guttmacher Institute, 
conducting a national study to assess abortion care. We would like to ask for your cooperation 
in getting a better picture of the situation in Zambia. This research will provide information 
about the reproductive health care system in Zambia, which will contribute to the 
improvement of women’s health. 
We would greatly appreciate if you base your answers on your experience and knowledge, or 
if you lack actual experience, on your perception of the situation. We will be asking you 
questions about legal induced abortion as well as all other ways that women induce abortion. 
Questions are asked separately about abortion practices in urban and rural areas, and 
separately about poor women and women who are relatively well-off (non-poor).  If your 
experience or perceptions are insufficient to enable you to answer questions on a sub-group 
of women, please feel free to point this out.   We urge you, however, to answer as fully as 
possible because your perceptions and opinions are valuable information where factual data 
are lacking. 
Your responses to this questionnaire will be completely confidential and will be used for 
research purposes only.  No personal reference will be made to your participation in this 
survey of health professionals.  We will combine your responses with those of other health 
professionals to describe the general picture of induced abortion practice in Zambia. 
Do I have your 
permission to proceed 
with the interview?          Yes    No        
 
If you have any questions about this survey or the study please call Dr Onikepe Owolabi at the 
Population council Zambia. Dr Owolabi may be reached at (+260)975910361 (mobile) or by email 
at oowolabi@popcouncil.org. 
Thank you 
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MODULE 1: Basic information 
S/N Questions and Filters  Responses and Codes 
101 Gender of respondent 1 Male 
  2 Female 
102 Which of the following 
categories describes your 
primary profession?     1 Researcher 
 [Interviewer: If more than one 
applies, tick the category that 
accounts for the greatest 
proportion of the respondent’s 
time.] 2 OBGYN specialist 
  3 Other medical professional (specify): __________ 
  4 Program manager 
  5 Policy maker/policy advisor 
  6 Advocate or activist, e.g. in women's 
organizations   
(specify):_________________________________ 
  96 Other (specify): __________________________ 
103 In which sector do you work 
primarily? 1 Public sector (Government) 
 [Interviewer: If the respondent 
works in more than one sector, 
tick the category corresponding 
to the sector where he/she 
contributes the most time. If the 
respondent works equally in 
both the private and the public 
sector, they can fill that in under 
“Other”.] 2 Private for profit sector 
  
3 
Private not-for-profit sector (NGO/CBO/Religious 
organization) 
  
4 
In a non-medical framework (research, policy, 
counseling, law) 
  
96 
Other (specify) 
_____________________________ 
104 How long have you been 
working in this field? 
___ Years 
105 Is this information you are 
providing us about this 
province/district or another 
province/district?   
 
Fill in Province(s): _______________________ 
   Fill in District(s): ________________________ 
   Rural area (Yes or N0)? 
106 Do you have experience working 
in rural areas for six months or 
more in the last five years? 
___ 1 Yes 
2 No 
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   List the names of the rural areas where you have 
worked for six months or more in the last five 
years 
 
 
________________________________________ 
107 Please identify the different 
situations in which you have 
encountered the issue of 
abortion. 1 
Personally, in a public health center 
 [Interviewer : Please tick all that 
apply, but do not suggest the 
answers]   2 
Personally, in a private health center 
  
3 
Personally, in a non-medical framework 
(research, policy-making, counseling, advocacy, 
law, etc.) 
  4  Through colleagues in any of the above settings 
  5 Other (specify) ________________________ 
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MODULE II: SERVICE PROVISION 
Little is known about the provision of safe abortion in Zambia. Nevertheless, we would like to have your opinion about several aspects of this area of 
reproductive behavior, insofar as you are able to give an informed opinion or an educated guess. When we talk about woman, we mean any female who 
can become pregnant. 
201 As far as you are aware, what methods are used in urban areas of Zambia to induce abortion? 
[Interviewer: Please read out each type of method for urban areas, tick the appropriate response and then repeat the same questions 
for rural areas. Please tick all that apply from the list below, regardless of the type of practitioner who may use the method.] 
How about in rural areas? 
 TYPE OF METHOD RURAL AREAS  URBAN AREAS 
 1. YES 2. NO 3. DON’T 
KNOW 
 1. YES 2. NO 3. DON’T 
KNOW 
 a. Dilation and Evacuation (D&E)        
 b. Dilation and curettage (D&C)        
 c. Manual vacuum aspiration (MVA)        
 d. Electric vacuum aspiration (EVA)        
 e. Medication abortion (e.g. Cytotec/misoprostol)         
 f. Oral introduction of drugs, solutions or other 
substances (e.g. through the mouth) 
       
     i. Hormonal drugs (e.g. Contraceptive pills)        
     ii. Herbs/ Teas/ Solutions         
     iii. Caustic agents (e.g. Washing detergent)        
     iv. Overdose of pharmaceuticals (e.g. Quinine, SP 
3 tablets) 
       
     v. Other (Specify) _________________________        
 g. Injectables 
specify____________________________ 
       
 h. Cervical/ Vaginal  introduction of drugs, 
solutions or other materials 
       
     i. Hormonal drugs (e.g. Contraceptives)        
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     ii. Herbs/Teas/ Solutions (Using form of insertion)        
     iii. Catheter        
     iv.Piercing objects (e.g. Plant stems and roots e.g. 
cassave, sticks, wires, knitting needles) 
       
     v. Other (specify) _________________________        
 i. Heavy massage/physical exertion, physical blows, 
jumping, falling, marching 
       
 j. Other means (Specify any additional method/s 
not listed 
above)________________________________ 
       
 
 
 
Q202.  
Now we want to understand the distribution of 3 broad categories of abortion women in Zambia use to obtain an induced abortion?The sum of women 
in each of the 3 categories should add up to 100%. The following questions are asked about women who live in urban and rural areas.  Each one asks you 
to consider two broad income groups – the poor and the relatively well-off (non-poor).  Looking at this province as a whole and bearing in mind the 
differences in this province, I want you to give us your opinion on the following. 
 
*[Interviewer: You can mention that there are not exact definitions for “poor” and “non-poor,” but by “poor” we mean women with lower income 
levels/cash incomes and/or education.]                                                                                                                                                                                                                                    
1. What percentage of all induced abortions among poor women in urban areas do you think are medication abortion? By medication abortion, we mean 
an oral introduction of drugs (Mifepristone and misoprostol or misoprostol alone).                                                                       
2.What percentage of all induced abortions among poor women in urban areas do you think are surgical abortions?  By surgical abortions, we mean 
vacuum aspiration (MVA or EVA) or dilation and curettage (D&C).                                                                                                                                     
3.What percentage of all induced abortions among poor women in urban areas do you think are other types of abortion? By other types of abortion, we 
mean oral introduction of other substances, vaginal introduction of drugs, solutions, or other materials, physical methods, or any other means.   
                                                                                                                                                                                                       
 [Interviewer: Please ensure all percentages total to 100%. If not, please ask respondent to adjust percentages. After asking about poor women in 
urban areas, go back through and repeat questions for each of the other subgroups] 
   
    
202 
 Medication abortion Surgical abortion Other types of abortion Total 
Q202a. Urban poor women    100% 
Q202b. Urban non-poor women    100% 
Q202c. Rural poor women    100% 
Q202d. Rural non-poor women    100% 
 
 
In the next 4 questions (Q203-206), we are going to expand on the questions we have asked for each category of women in Q202. 
 
Q303.  
What percent of all induced abortions performed through medication abortion to POOR women in URBAN areas do you think are being performed by 
each type of provider? Give an approximate percentage (all providers sum to 100%). Now, let's turn to surgical abortion. Next, we will look at other 
types of abortion. Next, we will look at complications from each type of abortion at each provider. 
POOR URBAN WOMEN 
a. Medical 
doctor 
b. Nurse or 
midwife 
c. Clinical officers 
and medical 
licentiates  
d. 
Traditional 
provider** 
e. pharmacist, 
dispenser, 
drugstore 
f. Woman 
(self-
induced) Total 
Q203a. percent going to each type of provider for 
medication abortion 
       
Q203b. Percent experiencing complications from 
medication abortion at each provider. 
       
Q203c. Out of 10 women who have complications from 
medication abortion at each provider, how many do you 
think actually get treated by a trained person in a health 
facility? 
       
Q203d. percent going to each type of provider for 
surgical abortion 
       
Q203e. Percent experiencing complications from 
surgical abortion at each provider 
       
Q203f. Out of 10 women who have complications from 
surgical abortion at each provider, how many do you 
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think actually get treated by a trained person in a health 
facility? 
Q203g. percent going to each type of provider for other 
types of abortion 
       
Q203h. Percent experiencing complications from other 
types of abortion at each provider 
       
Q203i. Out of 10 women who have complications from 
other types abortion at each provider, how many do you 
think actually get treated by a trained person in a health 
facility? 
       
 
 
Q304.  
What percent of all induced abortions performed through medication abortion to NON-POOR women in URBAN AREAS do you think are being 
performed by each type of provider? Give an approximate percentage (all providers sum to 100%). Now, let's turn to surgical abortion. Next, we will 
look at other types of abortion. Next, we will look at complications from each type of abortion at each provider. 
NON-POOR URBAN WOMEN 
a. Medical 
doctor 
b. Nurse or 
midwife 
c. Clinical officers 
and medical 
licentiates  
d. 
Traditional 
provider** 
e. pharmacist, 
dispenser, 
drugstore 
f. Woman 
(self-
induced) Total 
Q203a. percent going to each type of provider for 
medication abortion 
       
Q203b. Percent experiencing complications from 
medication abortion at each provider. 
       
Q203c. Out of 10 women who have complications from 
medication abortion at each provider, how many do you 
think actually get treated by a trained person in a health 
facility? 
       
Q203d. percent going to each type of provider for 
surgical abortion 
       
Q203e. Percent experiencing complications from 
surgical abortion at each provider 
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Q203f. Out of 10 women who have complications from 
surgical abortion at each provider, how many do you 
think actually get treated by a trained person in a health 
facility? 
       
Q203g. percent going to each type of provider for other 
types of abortion 
       
Q203h. Percent experiencing complications from other 
types of abortion at each provider 
       
Q203i. Out of 10 women who have complications from 
other types abortion at each provider, how many do you 
think actually get treated by a trained person in a health 
facility? 
       
 
 
 
 
Q303.  
What percent of all induced abortions performed through medication abortion to POOR women in RURAL areas do you think are being performed by 
each type of provider? Give an approximate percentage (all providers sum to 100%). Now, let's turn to surgical abortion. Next, we will look at other 
types of abortion. Next, we will look at complications from each type of abortion at each provider. 
POOR RURAL WOMEN 
a. Medical 
doctor 
b. Nurse or 
midwife 
c. Clinical officers 
and medical 
licentiates  
d. 
Traditional 
provider** 
e. pharmacist, 
dispenser, 
drugstore 
f. Woman 
(self-
induced) Total 
Q203a. percent going to each type of provider for 
medication abortion 
       
Q203b. Percent experiencing complications from 
medication abortion at each provider. 
       
Q203c. Out of 10 women who have complications from 
medication abortion at each provider, how many do you 
think actually get treated by a trained person in a health 
facility? 
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Q203d. percent going to each type of provider for 
surgical abortion 
       
Q203e. Percent experiencing complications from 
surgical abortion at each provider 
       
Q203f. Out of 10 women who have complications from 
surgical abortion at each provider, how many do you 
think actually get treated by a trained person in a health 
facility? 
       
Q203g. percent going to each type of provider for other 
types of abortion 
       
Q203h. Percent experiencing complications from other 
types of abortion at each provider 
       
Q203i. Out of 10 women who have complications from 
other types abortion at each provider, how many do you 
think actually get treated by a trained person in a health 
facility? 
       
 
 
 
 
Q304.  
What percent of all induced abortions performed through medication abortion to NON-POOR women in RURAL AREAS do you think are being 
performed by each type of provider? Give an approximate percentage (all providers sum to 100%). Now, let's turn to surgical abortion. Next, we will 
look at other types of abortion. Next, we will look at complications from each type of abortion at each provider. 
NON-POOR RURAL WOMEN 
a. Medical 
doctor 
b. Nurse or 
midwife 
c. Clinical officers 
and medical 
licentiates  
d. 
Traditional 
provider** 
e. pharmacist, 
dispenser, 
drugstore 
f. Woman 
(self-
induced) Total 
Q203a. percent going to each type of provider for 
medication abortion 
       
Q203b. Percent experiencing complications from 
medication abortion at each provider. 
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Q203c. Out of 10 women who have complications from 
medication abortion at each provider, how many do you 
think actually get treated by a trained person in a health 
facility? 
       
Q203d. percent going to each type of provider for 
surgical abortion 
       
Q203e. Percent experiencing complications from 
surgical abortion at each provider 
       
Q203f. Out of 10 women who have complications from 
surgical abortion at each provider, how many do you 
think actually get treated by a trained person in a health 
facility? 
       
Q203g. percent going to each type of provider for other 
types of abortion 
       
Q203h. Percent experiencing complications from other 
types of abortion at each provider 
       
Q203i. Out of 10 women who have complications from 
other types abortion at each provider, how many do you 
think actually get treated by a trained person in a health 
facility? 
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To get a summary estimate of what we have asked in Q203-206, answer Q207 and 208. 
 
Q207 a. Think about poor women in urban areas: out of 10 poor 
urban women who experience a medical complication due to 
an induced abortion, how many do you think actually get 
treated by a trained person in a health facility? 
Urban poor women with 
complications: # out of 10 treated in 
a health facility 
 
 
_________________ 
 b. What would the number be for non-poor women living in 
urban areas? [Interviewer: explain that we mean health 
facilities that can provide PAC care in all sectors - public, 
private, and NGO] 
Urban non-poor women with 
complications: # out of 10 treated in 
a health facility 
 
 
_________________ 
    
Q208 a. Think about poor women in rural areas: out of 10 poor urban 
women who experience a medical complication due to an 
induced abortion, how many do you think actually get treated 
by a trained person in a health facility? 
Rural poor women with 
complications: # out of 10 treated in 
a health facility 
 
 
_________________ 
 b. What would the number be for non-poor women living in 
rural areas? [Interviewer: explain that we mean health facilities 
that can provide PAC care in all sectors - public, private, and 
NGO] 
Rural non-poor women with 
complications: # out of 10 treated in 
a health facility 
 
 
_________________ 
 
 
Q209 In your opinion, among 10 women who have 
spontaneous abortion in the first trimester, 
how many are likely to seek care from a skilled 
health provider? 
 
 
 
FIRST TRIMESTER 
RURAL URBAN 
Q210 In your opinion, among 10 women who have 
spontaneous abortion in the second trimester, 
how many are likely to seek care from a skilled 
health provider? 
 
 
 
SECOND TRIMESTER 
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Q211 
The preceding sections included questions that 
required you to give your opinion on concepts 
that are not easily measured. On a scale of 1 to 
10, with 1 being "not at all sure" and 10 being 
"very sure", what is your degree of certainty 
that the answers you've given reflect the real 
situation encountered in your province? 
 10 (Very sure) 
9 
8 
7 
6 
5 
4 
3 
2 
1 (Not at all sure) 
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B. Health facility survey questionnaire 
 
A. Demographic characteristics 
1. Name of participant: 
_______________________________________________________ 
2. Gender: a. Male   b. Female 
 
3. Name of the facility you work for: 
____________________________________________ 
4. Your position in the facility: 
_________________________________________________ 
5. Number of years you have worked in your facility: 
_______________________________ 
6. What ward/department do you work in presently? 
_______________________________ 
7. Number of years you have worked in your current ward/department: 
___________________ 
8. Province where your facility is located: 
________________________________________ 
9. Date of training: 
 
B. Hospital context 
1. In your facility are post-abortion care patients usually treated as outpatients (they 
do not spend the night in the hospital) or inpatients (they spend at least one night 
in the facility) 
A. Outpatient  B. Inpatient 
 
In the next few questions, we would like to understand the patient flow for post 
abortion care (PAC) when women come into your facility with abortion-related 
complications 
 
2. When a patient comes in, where is/are their usual first destination(s) in the 
hospital:  
__________________________________________________________________
___________ 
3. After this where is/are the next place(s) the client is usually transferred to: 
__________________________________________________________________
____________ 
4. If a client needs to be admitted for 24 hours or greater as an in-patient, what 
ward(s) is/are they usually admitted into: 
__________________________________________________________________
____________ 
5. If the patient is not admitted for 24 hours but is treated as an outpatient where 
do they stay before receiving treatment: 
__________________________________________________________________
____________ 
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6. If a procedure is needed to evacuate the uterus where is it done: 
__________________________________________________________________
____________ 
7. What procedures are usually performed in your facility to evacuate the uterus 
(Tick all that apply): 
a. MVA d. Oxytocin or Syntocinon infusion   
b. D&C e. Medical abortion (e.g. cytotec/ misoprostol)  
c. EPRC f. Other please specify: 
____________________________ 
 
8. After the evacuation procedure in-patients (admitted for 24 hours or greater) are 
usually transferred to: 
__________________________________________________________________
_____________ 
9. After the evacuation procedure out-patients (not admitted for 24 hours) are 
usually transferred to: 
__________________________________________________________________
_____________ 
10. Is family planning counselling done before the woman is discharged: 
_____________________? 
11. Where is the family planning counselling done: 
_______________________________________? 
12. What methods are available to the woman immediately after discharge from 
PAC (tick all that apply) 
a. Male condoms  e. IUDs 
b. Female condoms f. Vasectomy 
c. Oral contraceptives  g. Bilateral tubal ligation 
d. Injectables h. Rhythm (periodic abstinence)  
e. Implants i. Withdrawal 
 
 
Patient caseload: 
1. In the past month (October 2013) how many patients with abortion-related 
complications (include all post abortion care patients whether they are due to 
spontaneous or induced abortions) do you estimate were treated at your facility 
as in-patients: __________________ 
 
2. In the past month (October 2013) how many patients with abortion-related 
complications (include all post abortion care patients whether they are due to 
spontaneous or induced abortions) do you estimate were treated at your facility 
as out-patients: _________________ 
 
3. In an average month how many patients with abortion-related complications 
(include all post abortion care patients whether they are due to spontaneous or 
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induced abortions) do you estimate were treated at your facility as in-patients: 
_____________________ 
 
4. In an average month how many patients with abortion-related complications 
(include all post abortion care patients whether they are due to spontaneous or 
induced abortions) do you estimate were treated at your facility as out-patients: 
_____________________ 
 
5. To confirm your previous answers, in the past month (October 2013) you estimate 
that your facility treated a total of ________________________ patients with 
abortion-related complications (include all post abortion care patients whether 
they are due to spontaneous or induced abortions) 
 
6. To confirm your previous answers, in an average month you estimate that your 
facility treated a total of ________________________ patients with abortion-
related complications (include all post abortion care patients whether they are 
due to spontaneous or induced abortions) 
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C. ADAPTATION OF KEY QUESTIONS IN THE AICM 
The tools for this study were developed by adapting AICM tools that had been used in 
Ethiopia and Kenya provided by the Guttmacher Institute.  
Health facility survey 
The HFS tool was shortened considerably for this study. It solicited information on 
characteristics of the survey respondents, patient flow for women admitted for PAC, 
clinical management of PAC, family planning methods available in the facility 
immediately after discharge and the patient caseload.  Questions taken out included 
those about the country’s abortion law, opinions on barriers to PAC, and how PAC 
services can be improved. These questions are usually asked after the key questions to 
estimate incidence and have no impact on their answers. 
Health professionals survey 
The HPS tool was adapted from the original version to reflect the Zambian context, and 
to include questions on medical abortion, which has anecdotally become more widely 
available in Zambia and is used increasingly to induce abortion in many low- and 
middle-income contexts. The adaptations are compared with the way the questions 
were typically asked in former versions of the tool in (Table 7-1). These adaptations 
were discussed with senior staff members at the Guttmacher Institute where the AICM 
methodology was developed and who made suggestions on how to field the questions 
appropriately.  
Both questionnaires were pretested and edited before data collection to ensure clarity 
and accuracy.  
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Table 7-1 How the HPS questions were adapted for the Zambia AICM 
Questions in original Kenya HPS tool Adapted questions for Zambia HPS** 
“I will mention the main types of people who 
perform induced abortions in Kenya. Considering first 
rural areas, indicate whether, in your opinion, each 
type of provider is used rarely, sometimes or 
commonly by poor rural women seeking abortion. 
[Interviewer: Please read each type of provider and 
circle the respondent's answers for poor rural women. 
Mark all the respondent’s answers relating to poor 
rural women, then ask the next question.] 
Now indicate whether, in your opinion, each type of 
provider is used rarely, sometimes or commonly by 
poor/non-poor & rural/urban women. “  
Provider types: TBA/traditional healer, Clinical 
officer, Nurse, trained midwife, Doctor, 
Pharmacist/chemist, Woman-self induced 
Now we want to understand the distribution of 3 broad 
categories of abortion women in Zambia use to obtain an 
induced abortion? The sum of women in each of the 3 
categories should add up to 100%. The following questions 
are asked about women who live in urban and rural areas.  
Each one asks you to consider two broad income groups – 
the poor and the relatively well-off (non-poor).  Looking at 
this province as a whole and bearing in mind the 
differences in this province, I want you to give us your 
opinion on the following. 
*[Interviewer: You can mention that there are not exact 
definitions for “poor” and “non-poor,” but by “poor” we 
mean women with lower income levels/cash incomes and/or 
education.]                                                                                                                                                                                                                                        
What percentage of all induced abortions among 
poor/non-poor & rural/urban women do you think are 
medication abortion? By medication abortion, we mean an 
oral introduction of drugs (Mifepristone and misoprostol 
or misoprostol alone).                                                                       
What percentage of all induced abortions among 
poor/non-poor & rural/urban do you think are surgical 
abortions?  By surgical abortions, we mean vacuum 
aspiration (MVA or EVA) or dilation and curettage (D&C).                                                                                                                                     
What percentage of all induced abortions among 
poor/non-poor & rural/urban do you think are other types 
of abortion? By other types of abortion, we mean oral 
introduction of other substances, vaginal introduction of 
drugs, solutions, or other materials, physical methods, or 
any other means.                                                                                                                                                                                                         
[Interviewer: Please ensure all percentages total to 100%. If 
not, please ask respondent to adjust percentages. After 
asking about poor women in urban areas, go back through 
and repeat questions for each of the other subgroups] 
In your opinion, what percent of all induced 
abortions in poor/non-poor & rural/urban do you 
think are being performed by each type of provider? 
Give an approximate percentage (all providers sum 
to 100%) 
[Interviewer: Confirm that all providers sum to 100%.  
If they do not, probe for a correction, and adjust the 
answers below.] 
What percent of all induced abortions performed through 
medication abortion to poor/non-poor & rural/urban do 
you think are being performed by each type of provider? 
Give an approximate percentage (all providers sum to 
100%). Now, let's turn to surgical abortion. Next, we will 
look at other types of abortion. Next, we will look at 
complications from each type of abortion at each provider. 
Then we will consider how many out of 10 women who 
have complications from each type of abortion at each 
provider, actually get treated by a trained person in a 
health facility? Not all abortions that happen in this province are 
unsafe. There could be situations under which a 
woman is able to obtain an abortion that does not 
result in any complications for the woman. Now I am 
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going to ask you a few questions about how often 
you think abortions don’t result in any complications 
for the four sub-groups we’ve been discussing above.   
Thinking now of (i) poor/non-poor & rural/urban 
women in the province, what percent of abortions 
would you say are without complications? 
Provider types: Traditional provider, Clinical 
officers/medical licentiates, Nurse, trained midwife, 
Doctor, Pharmacist/dispenser/drug store, Woman-self 
induced 
Think about poor women in rural areas: Out of ten 
poor rural women who have an abortion performed 
by each type of provider that I will mention, how 
many would experience a medical complication that 
should receive medical treatment? 
What would the number be for poor/non-poor & 
rural/urban? 
[Interviewer: Ask for each type of provider separately; 
insert a number in each column, even though it might 
be “0.”] 
**Questions are asked in a table so each question is asked for each category of women according to 
wealth/residence, for each type of abortion and for each group of provider. 
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D. Additional sampling information 
 
Figure 7-1 Flowchart showing how eligible hospitals were identified for the EVA-
PMDUP study 
 
Table 7-2 shows the sampling fraction achieved with hospitals that participated in the 
AICM study out of all eligible hospitals.
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Table 7-2 Sampling facilities achieved with hospitals included in the AICM study 
FACILITY 
CLASSIFICATION LOCATION 
Facility 
ownership 
Facility 
level Central province 
Copperbelt 
province Lusaka Province 
3 provinces 
together 
    Eligible facilities 
Sampled 
facilities 
(%) 
Eligible 
facilities 
Sampled 
facilities 
(%) 
Eligible 
facilities 
Sampled 
facilities 
(%) 
Eligible 
facilities 
Sampled 
facilities 
(%) 
Government  District 7 6(85.7) 2 2(100) 6 4(67) 15 12(80%) 
 Provincial 2 2(100) 4 4(100) 1 1(100) 7 7(100%) 
 Tertiary 0 0 2 2(100) 1 1(100) 3 3(100%) 
Private District 0 0 4 2(50) 6 3(50) 10 5(50%) 
 Provincial 0 0 3 1(33) 0 0 3 1(33%) 
 Tertiary 0 0 0 0 0 0 0 0 
Mission District 1 1(100) 2 2(100) 2 2(100) 5 5(100%) 
 Provincial 0 0 0 0 0 0 0 0 
 Tertiary 0 0 0 0 0 0 0 0 
PROVINCE 
TOTAL  10 9(90) 17 13(76.4) 16 11(68.8) 43 33(76.7) 
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E. Weights generated for study by type of health facility 
We weighted the results to be representative of each province. The weighting factor 
used for each facility type/ownership group included in the study was the inverse of 
that group’s sampling fraction (number of facilities for which caseload data was 
available divided by the total number of facilities theoretically capable of providing PAC 
in that group). These weights were generated for each province.  Weights were then 
applied to the 86 facilities in the sample to construct data for the total 229 facilities.  
Table 7-3 presents the distribution of the facilities capable of providing PAC and 
sampled health facilities and weight within the three provinces by ownership and type 
of facility.  
Table 7-3 Distribution of facilities in Central, Copperbelt and Lusaka provinces 
capable of providing PAC and samped according to ownership and level of facility 
Ownership Type of facility Number of health facilities 
in adjusted universe in 
Central, Copperbelt and 
Lusaka provinces 
Number of sampled 
health facilities in 
Central, Copperbelt 
and Lusaka provinces 
Weight within the 
three provinces 
Public  Rural Health centres 20 17 1.18 
Urban Health centres 36 34 1.06 
Level 1 hospitals 15 12 1.25 
Level 2 hospitals 7 7 1.00 
Level 3 hospitals 3 3 1.00 
Private Rural Health centres 0 0 0 
Urban Health centres 127 0 0 
Level 1 hospitals 10 5 2.00 
Level 2 hospitals 3 1 3.00 
Level 3 hospitals 0 0 0 
Mission Rural Health centres 3 2 1.50 
Urban Health centres 0 0 0 
Level 1 hospitals 5 5 1.00 
Level 2 hospitals 0 0 0 
Level 3 hospitals 0 0 0 
TOTAL 229 86   
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F. Additional results 
Characteristics of HPS respondents 
A list of 23 possible respondents from the three study provinces was generated, out of 
whom 19 (83%) participated. Amongst the respondents to the HPS 42% were female. 
53% were trained doctors (half of whom were medical officers and the other half 
obstetrician/gynaecologists), 27% were nurses and midwives. The remaining had 
backgrounds in research and programme management. The majority worked primarily 
in the public sector (10 out of 19), whilst six people worked in the private not-for-profit 
sector, two in the private-for-profit sector and one person worked in an international 
parastatal. However, many of those in the public sector also worked simultaneously in 
the private sector. They had an average of 12 years of work experience in their primary 
profession (ranging from 3 to 30 years) 
42% reported primarily working in only urban areas, whilst 58% had worked in rural 
areas in the six months prior to the survey. 
Methods of abortion 
HPS participants were asked to identify the method of abortion commonly used to 
induce pregnancy termination in urban and rural areas. They believed that amongst the 
urban poor, rural poor and rural non-poor majority of women used other means (non-
medication and non-surgical) to induce termination or pregnancy, whilst amongst the 
urban non-poor majority (55%) of women used medical abortion. The proportion of 
women using other means was highest amongst the rural poor (82%), whilst it was 
similar amongst the rural non-poor (57%) and urban poor (58%) (Table 7-4). In all 
categories of women except the urban poor, the respondents believed that at least a 
quarter of women used medication abortion to terminate their pregnancies. 
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Table 7-4 HPS respondent’s views on types of abortions obtained by different 
categories of women 
Type of abortions obtained by 
different categories of women 
Urban Poor 
(%) 
Urban Non Poor 
(%) 
Rural Poor 
(%) 
Rural Non Poor 
(%) 
Medical abortion 25.4 55.3 11.1 28.2 
Surgical abortion 15.9 25.9 7.4 15.4 
Other kinds of abortion 58.7 18.8 81.6 56.5 
TOTAL 100 100 100 100 
 
Percentage distribution amongst different types of abortion according to 
type of provider 
Respondents believed that the four categories of women were likely to access 
medication abortion from different kinds of providers. Urban poor women were more 
likely to get MA from pharmacists/dispensaries, urban non-poor from doctors or 
pharmacists/dispensers, whilst rural poor and rural non-poor were more likely to get it 
from nurses. 
For surgical abortion urban poor and non-poor women were believed to be most likely 
to see a doctor, whilst rural poor and non-poor women were more likely to receive 
services from a nurse. 
For other types of abortion, urban poor women, rural poor and rural non-poor were 
believed to be more likely to receive services from traditional providers, urban non-
poor from pharmacists/dispensers. In each category, respondents also believed that at 
least 25% of women would attempt to self-induce the abortion. 
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Probability of complications amongst different types of abortion according 
to type of provider 
For all categories of women, respondents believe that the highest proportion of 
complications using MA was likely to occur when the woman herself prescribed it. This 
was closely followed by when MA was provided by pharmacists/dispensers. 
For women receiving surgical abortion in all groups, the highest proportion of 
complications for all categories was believed to occur when the provider was a clinical 
officer or medical licentiate, except for rural poor women, where nurses were believed 
to cause the highest rates of complications. 
For all categories of women using other types of abortions, the highest proportion of 
complications were believed to occur when self-induced by the woman followed.  
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APPENDIX 9: Anonymous Third Party Reporting Method 
(ATPR) 
A. Adaptation of ATPR questionnaire 
We adapted the ATPR tool that was created by Clementine Rossier, and used in Burkina 
Faso. The Burkina Faso questionnaire was provided by the Guttmacher institute who 
also worked on the Burkina Faso study. In September 2013, we (OO with help from VF) 
translated the tool, modified it to suit the Zambian context, and shortened to include 
the key questions needed in order to fit the data collection timeframe for the broader 
evaluation. Between January and February 2014, we pretested the tool with Zambian 
women. Thereafter we modified the network-generating question (see the next 
paragraph) to suit the local context, revised other aspects of the tool, and trained 
interviewers. The tool was piloted as part of the community survey in February 2014. 
Finally, we programmed the tool into Open Data Kit (ODK) for mobile data collection 
and piloted the mobile version.  
The ATPR module had four sections. The first part of the data collection tool was a 
network-generating question that asked women to list and characterize all women 15-
49 currently confiding in them. In a focus group with field interviewers, we applied the 
broad network-generating question and found out that women confide different kinds 
of secrets to different confidants. For example, in Zambia confiding in someone about 
marital or financial challenges did not translate into sharing reproductive health secrets 
such as abortions. Thereafter we adapted the question to ask about women who would 
confide in respondents about reproductive and sexual health secrets and compared 
the numbers of confidants and information on abortion provided from both types of 
questions. Using a broad definition of confidence (secrets), most participants knew 
nothing about the abortion behaviour of most confidants. When confidences were 
limited to reproductive health secrets, they were aware if many of the confidants listed 
had procured an induced abortion or not in the years of interest. Based on this 
evidence, the question was worded: 
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“We would like to speak about those women and young women who confide in you. 
Count the women and young women in your surroundings that you are their confidant. 
They trust you and talk to you or seek your advice about things that concern them (their 
problems), or things close to their hearts (secrets) related to their reproductive and 
sexual lives. We would like you to mention only women or girls who are currently 
between 15 and 49 years “ 
In section 2, respondents were asked to define each confidant’s relationship, the 
duration of confidence, age, educational level and main place of residence in 2013 and 
2014. The larger community survey interviewed respondents 15-44 years old, while the 
ATPR module asked for information on confidants aged 15-49 years old. In section 3, 
respondents were asked whether each confidant had undergone an induced abortion, 
and if so, how many abortions they had in the year preceding the survey (2013) and 
the year of the survey (2014).  The fourth section collected information on the 
circumstances around each induced abortion including where it was conducted, who 
conducted it, occurrence of complications following the procedure, whether 
complications were managed in a health facility, and if so, which kind of facility. 
Additional questions were asked for each abortion mentioned to ensure it was not a 
miscarriage or an unsuccessful termination of pregnancy. This included: 
Was it a miscarriage or an induced abortion? 
Was the pregnancy really interrupted or was there a birth?  
The final English version of the tool can be found in Appendix 9, section B. 
In addition to the data collection tool on the tablets, interviewers were provided with 
a paper table to list out each confidant mentioned in section one under the network 
generating question, assign them a confidant number (which was intended to be a 
unique identification number for each respondent’s confidants), assign a nickname and 
record the number of abortions they had if any. This was because they did not collect 
names and surnames for each confidant but defined them based on their relationship 
to their respondent. Hence they needed a simple means of referring to them 
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throughout the interview. A copy the paper table can be found above in Appendix 9, 
section C. 
B. Data collection tool 
We would like to speak about those women and young women WHO CONFIDE IN YOU. Count the women 
and young women in your surroundings that you are their confidante. They trust you and talk to you or seek 
your advice about things that concern them (their problems), or things close to their hearts (secrets) related 
to their reproductive and sexual lives. We would like you to mention only women or girls who are currently 
between 15 and 49 years;          
 
SUPERVISOR REMINDER: EACH CONFINDANT MUST BE METIONED ONLY IN ONE CATEGORY i.e. the same 
woman cannot be both a sister and friend she should be put in only one group.         
 
N°  Relationships Number Filter 
601 Among your sisters between 15 and 49 years, how many confide in you? 
   
602 
Among your cousins (or similar) 
between 15 and 49 years, how many 
confide in you? 
 
  
603 Among your nieces between 15 and 49 years, how many confide in you? 
   
604 Among your daughters between 15 and 49 years, how many confide in you? 
   
605 Among your neighbours between 15 and 49 years, how many confide in you? 
   
606 Among your friends between 15 and 49 years, how many confide in you? 
   
607 
Among your colleagues at work/ 
employees/bosses (or similar) between 
15 and 49 years, how many confide in 
you? 
 
  
608 
Among your mothers and aunts 
between 15 and 49 years, how many 
confide in you? 
 
  
609 Among your sisters-in-law between 15 and 49 years, how many confide in you? 
   
610 What other people ages 15 to 49 years 
confide in you? How many are they? 
  
611 Calculate the total number of women 
that confide in the respondent 
TOTAL 
 
If total =00  
 
 
>>>Q646 
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In the table below, attribute a number to every person who confides in the respondent as listed above, then ask the questions 612 to 619 for each person.  
612 613 614 615 616 617 618 619 
Confidant 
number (in 2 
figures) 
Current residence of 
the confidant? 
Age on 
last 
birthday 
What is their 
level of 
education? 
What is their 
relationship with the 
respondent? 
For how long has 
she confided in 
you? 
How many other 
people does she 
confide in?   
 
Where has the person 
lived during the past 
year (2013)? 
 PROVINCE: _____ 
URB/RURAL:_____ 
     PROVINCE: _____ 
URB/RURAL:_____ 
 PROVINCE: _____ 
URB/RURAL:_____ 
     PROVINCE: _____ 
URB/RURAL:_____ 
 PROVINCE: _____ 
URB/RURAL:_____ 
     PROVINCE: _____ 
URB/RURAL:_____ 
 PROVINCE: _____ 
URB/RURAL:_____ 
     PROVINCE: _____ 
URB/RURAL:_____ 
 PROVINCE: _____ 
URB/RURAL:_____ 
     PROVINCE: _____ 
URB/RURAL:_____ 
 PROVINCE: _____ 
URB/RURAL:_____ 
     PROVINCE: _____ 
URB/RURAL:_____ 
 PROVINCE: _____ 
URB/RURAL:_____ 
     PROVINCE: _____ 
URB/RURAL:_____ 
 PROVINCE: _____ 
URB/RURAL:_____ 
     PROVINCE: _____ 
URB/RURAL:_____ 
 PROVINCE: _____ 
URB/RURAL:_____ 
     PROVINCE: _____ 
URB/RURAL:_____ 
 PROVINCE: _____ 
URB/RURAL:_____ 
     PROVINCE: _____ 
URB/RURAL:_____ 
  
PROVINCE: _____ 
URB/RURAL:_____ 
      
PROVINCE: _____ 
URB/RURAL:_____ 
 PROVINCE: _____      PROVINCE: _____ 
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URB/RURAL:_____ URB/RURAL:_____ 
 PROVINCE: _____ 
URB/RURAL:_____ 
     PROVINCE: _____ 
URB/RURAL:_____ 
 PROVINCE: _____ 
URB/RURAL:_____ 
     PROVINCE: _____ 
URB/RURAL:_____ 
 PROVINCE: _____ 
URB/RURAL:_____ 
     PROVINCE: _____ 
URB/RURAL:_____ 
 PROVINCE: _____ 
URB/RURAL:_____ 
     PROVINCE: _____ 
URB/RURAL:_____ 
 PROVINCE: _____ 
URB/RURAL:_____ 
     PROVINCE: _____ 
URB/RURAL:_____ 
 PROVINCE: _____ 
URB/RURAL:_____ 
     PROVINCE: _____ 
URB/RURAL:_____ 
 PROVINCE: _____ 
URB/RURAL:_____ 
     PROVINCE: _____ 
URB/RURAL:_____ 
 PROVINCE: _____ 
URB/RURAL:_____ 
     PROVINCE: _____ 
URB/RURAL:_____ 
 
Q613 and Q619: Place of 
residence 
Q 615: Education Q616: Relationship with the confidante Q617: Duration of 
relationship 
Q618: Does she confide in 
any other people ? 
Province                   
Lusaka =1              
Central = 2                 
Copperbelt =3      
Other = 4                      
Urban/rural  
Urban= 1 
Rural= 2 
Don't know = 
99
No education = 0                                
Primary = 1                                
Secondary = 2 
Higher = 3  
Don't know = 99 
Sister =1            
Cousin  =2                
Niece =3                       
Daughters =4    
Neighbour= 5  
Friend = 6 
Colleague/employee= 7 
Aunt/Mother = 8 
Sisters-in-law= 9 
Others (Specify) = 10 
<1 year=1 
1 year =2  
2 years = 3 
3 years = 4 
4 years = 5 
5 years or more= 6 
 
Me alone= 1 
1 or 2 people = 2 
More than 2 people= 3 
Don't know = 99 
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SECTION 3: ABORTIONS AMONGST CONFIDANTS  
Now we would like to speak about the cases of induced abortion that you have heard about. We 
would like to remind you that this questionnaire is absolutely confidential and anonymous. We are 
trying to measure the extent of abortions because it is a serious problem, which causes many 
illnesses and deaths that can be avoided.       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
ENTER THE CONFIDANTS IN THE SAME ORDER THAT YOU LISTED THE CONFIDANTS IN THE 
PREVIOUS SECTION AND ASK QUESTIONS 620 TO 622 ABOUT THEIR ABORTIONS. WE WOULD LIKE 
TO COLLECT INFORMATION ABOUT INDUCED ABORTIONS AND NOT SPONTANEOUS 
ABORTIONS/MISCARRIAGES). NOTE THAT WE ARE INTERESTED ONLY IN THE INDUCED ABORTIONS 
THAT SUCCEEDED AND NOT IN ABORTION ATTEMPTS THAT FAILED. 
 
Did (the person who confides in the respondent) have an induced abortion in 2014 or 2013? If no, 
are you sure that she didn't have an abortion or not sure? 
 
 
Q620 – Q622, If YES, RECORD THE NUMBER OF INDUCED ABORTIONS (range: 1-7) 
None…….………….…0            Yes………………….1 to 7          
Not sure………99    
Confidant 
number (in 2 
figures) 
620 621 622 
 2014 2013 TOTAL 
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
TOTAL    
If TOTAL =00  >>>CONCLUDE 
CONFIDANTS’ MODULE 
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CONFIDANT 
NUMBER 
In this section we want to ask some more questions about the abortions listed for each confidant the respondent mentioned in the previous section.   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
ENTER THE CONFIDANTS IN THE SAME ORDER THAT YOU LISTED THE CONFIDANTS IN THE PREVIOUS SECTION. FOR EACH CONFIDANT, ASK QUESTIONS 
623 TO 630 ABOUT ALL OF THEIR INDUCED ABORTIONS STARTING FROM THEIR MOST RECENT (I.E. INDUCED ABORTIONS IN 2014 FOLLOWED BY 2013).  
                                                                                                                                                                                                                                                                                     
IF THE RESPONDENT MENTIONED THAT ANY CONFIDANT HAS HAD MORE THAN ONE INDUCED ABORTIONS IN ANY YEAR (E.G. THEY HAD 2 INDUCED 
ABORTIONS IN 2014), ASK QUESTIONS 623-630 FOR EACH INDUCED ABORTION IN THAT YEAR SEPARATELY (I.E. ASK ABOUT THE 2 INDUCED 
ABORTIONS IN 2014) BEFORE MOVING TO THE NEXT YEAR (2013). OTHERWISE END THE CONFIDANT MODULE  
  623. 
Was it a 
miscarriage or 
an induced 
abortion? 
 
Induced 
abortion= 1 
Miscarriage 
=0 
Don't know 
=99 
 
If it is a 
miscarriage or 
Not sure, go 
to the next 
case.  
624. 
Was the 
pregnancy 
really 
interrupted or 
was there a 
birth?  
 
Interrupted 
pregnancy= 1 
A birth 
occurred= 0 
Don't know= 99 
 
If there was a 
birth or it is Not 
sure, go to the 
following case  
625.  
Who conducted 
the induced 
abortion?  
ATTENTION: Note 
the last person 
who successfully 
triggered the 
induced 
abortion.  
 
Traditional 
practitioner=1 
Herself=2 
Health worker (or 
similar)=3  
Don't know=   99 
626 
What 
method was 
used to 
provoke the 
induced 
abortion?  
 
ATTENTION, 
NOTE THE 
LAST 
METHOD 
USED (THE 
ONE WHICH 
TRIGGERED 
THE 
INDUCED 
ABORTION)  
627 
Afterwards, did 
the woman have a 
post-abortion 
health problem 
health related to 
the induced 
abortion?  
 
Yes = 1 
No = 0 >> go to 644 
Don't know = 99 >> 
go to 644 
628 
Did she 
receive 
medical 
treatment? 
 
 
Yes=1  
 
No=0  >>go to 
644 
Don't know= 
99 >>go to 
644 
629 
If the woman received 
medical treatment, in 
what kind of facility 
did she get it?  
 
Public hospital =1                                          
Public health 
centre/health post =2 
Private hospital =3                                       
Private clinic =4 
Pharmacy or chemist 
shop OR drug seller =5 
Traditional birth 
attendant =6                         
Other(Please specify) 
=7 
Don't know= 99 
630 
Amongst the 
other 
confidantes of 
the woman 
being 
discussed, (See 
Q618), how 
many are aware 
of the abortion? 
 
Me alone…1 
Some of her 
confidantes…2 
All………...…...3 
NSP…..……... 8 
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  623. 
Was it a 
miscarriage or 
an induced 
abortion? 
 
Induced 
abortion= 1 
Miscarriage 
=0 
Don't know 
=99 
 
If it is a 
miscarriage or 
Not sure, go 
to the next 
case.  
624. 
Was the 
pregnancy 
really 
interrupted or 
was there a 
birth?  
 
Interrupted 
pregnancy= 1 
A birth 
occurred= 0 
Don't know= 99 
 
If there was a 
birth or it is Not 
sure, go to the 
following case  
625.  
Who conducted 
the induced 
abortion?  
ATTENTION: Note 
the last person 
who successfully 
triggered the 
induced 
abortion.  
 
Traditional 
practitioner=1 
Herself=2 
Health worker (or 
similar)=3  
Don't know=   99 
626 
What 
method was 
used to 
provoke the 
induced 
abortion?  
 
ATTENTION, 
NOTE THE 
LAST 
METHOD 
USED (THE 
ONE WHICH 
TRIGGERED 
THE 
INDUCED 
ABORTION)  
627 
Afterwards, did 
the woman have a 
post-abortion 
health problem 
health related to 
the induced 
abortion?  
 
Yes = 1 
No = 0 >> go to 644 
Don't know = 99 >> 
go to 644 
628 
Did she 
receive 
medical 
treatment? 
 
 
Yes=1  
 
No=0  >>go to 
644 
Don't know= 
99 >>go to 
644 
629 
If the woman received 
medical treatment, in 
what kind of facility 
did she get it?  
 
Public hospital =1                                          
Public health 
centre/health post =2 
Private hospital =3                                       
Private clinic =4 
Pharmacy or chemist 
shop OR drug seller =5 
Traditional birth 
attendant =6                         
Other(Please specify) 
=7 
Don't know= 99 
630 
Amongst the 
other 
confidantes of 
the woman 
being 
discussed, (See 
Q618), how 
many are aware 
of the abortion? 
 
Me alone…1 
Some of her 
confidantes…2 
All………...…...3 
NSP…..……... 8 
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Q 626 Methods used to provoke the induced abortion 
Traditional practice Herself Health workers 
· Cassava root……………………...01 · Caustic agents (acid, bleach)………05  Tablets…………….…….11 
· Another plant stem…………………...02 · High doses of medicine. (e.g. Cafemol, 
paracetamol aspirin, malaria 
tablets)………………...06 
· Injection……………………12          
· Herbal concoction………….03 · Strong tea or Coffee, Guinness, Coke, etc. alone 
or mixed with other substances………..…..…07 
· Curettage, aspiration………………....13         
· Other (please specify)………………04 Crushed bottle or other crushed glass……..  08 Others (please specify)………………………14 
 
Cytotec tablets in any combination…………..09 · Don't know……………….……….88 
 
· Other (please specify)……………..………….10 
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C. Paper table used to record information the Anonymous Third Party Reporting 
Method (ATPR)  
Date of interview: DD/MM/YYYY   Time of interview: HH:MM 
Name of interviewer: ___________________________________________________ 
Team supervisor: ______________________________________________________ 
Province_______________________ District_____________________ 
Ward_____________________ 
Woman’s ID____________________________________________________________ 
 
 
CONFIDANT 
NUMBER 
Category of 
confidant e.g. 
sister, cousin, 
friend etc. 
Confidant’s ID e.g. 
name, nickname, 
initials etc. 
Total number of 
abortions confidant 
had in 2013 and 2014 
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